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ABSTRACT
This thesis outlines the results of occupational respiratory health surveillance at
Minara Resources, Murrin Murrin mine site. The research was conducted as part of a
collaborative agreement between Edith Cowan University and Minara Resources, the
overarching title of which was ‘Establishing best practice protocols in the management
of occupational and environmental health in a high-risk mining and ore-processing
environment’.
To form the basis of this research it was hypothesised that although the chemical
hazards had been adequately identified, and the occupational exposures in each work
area at Murrin Murrin were generally well below their respective occupational exposure
levels, it was still possible that additive, or even synergistic biological effects could
cause adverse respiratory health effects due to the exposure to a combination of these
atmospheric contaminants. This was the perception and a concern voiced by the Murrin
Murrin workforce.
Therefore, in working through the hypothesis, a literature review concentrating on
the gaps in current knowledge and research for the early detection of occupational
respiratory diseases was conducted, and the research tool and experiment design
determined. The case for using pulmonary function tests in conjunction with a
respiratory questionnaire in assessing early respiratory changes due to occupational
exposures was established.
Over a period between 17 February 2004 and 21 June 2006, a longitudinal study was
conducted to ascertain the prevalence of respiratory symptoms and lung function of
employees at the Murrin Murrin Operation, and compared with a local control group
consisting of catering staff who resided at the accommodation camp approximately
eight kilometres from the mine site. Lung function data were also compared to
established predicted normal values from a reference population with normal lung
function. Lung function data were analysed to determine whether there was an effect
due to the area worked, and the employee’s length of service. The lung function
parameters of the study group, corrected for age and height were compared using linear
regression analysis with both the control group and the predicted normal values. Repeat
lung function tests were conducted on a sample of the original study group
approximately two years after the initial study and statistically analysed to determine
iii

whether there was an effect on lung function over this time period. In addition, lung
function tests were conducted for a cohort of refinery workers at the start and end of
their two-week work period to determine whether there was a before-and-after effect
due to their working conditions.
The prevalence of respiratory symptoms was less in the study group compared to the
controls; and these respiratory symptoms were determined to be non-work-related. On
statistical analysis, for the ‘presumed healthy’ workers (minus the smokers and those
with known non-work-related respiratory symptoms) there was no overall decrement in
lung function. Similarly, there was no overall statistically significant decrement in lung
function for the ‘presumed healthy’ workers in the repeat study conducted
approximately two years after the initial study. There was no decrement in lung function
associated with area work; nor was there a decrement in lung function for the cohort of
refinery workers from the start to completion of their two-week work period. However,
there were decrements in lung function for the smokers in the study and control groups.
There was a significant difference in FEV1 between non-smokers and smokers with
length of service (p <0.05); and a significant difference (p <0.05) in FEV1 from first
spirometry test compared with the repeat spirometry test for the smokers/asthmatics
sub-group in the repeat study. This in effect acted as ‘internal validity’ indicating that
spirometry was sensitive enough to detect a decrease in lung function due to smoking in
the initial and repeat studies; and that if there were adverse respiratory health effects due
to the exposure of atmospheric contaminants at the Murrin Murrin Operation, that this
would have been detected.
Hence the concern shown by the employees at the Murrin Murrin Operation, that
workplace emissions may be harming their respiratory health, appears to be dispelled by
this study.
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1. INTRODUCTION
The extent to which occupational respiratory disease contributes to work-related
illness in Australia remains unknown although estimates have been made. Two main
reasons for this are that the aetiology of occupational respiratory disease is difficult to
establish largely due to the long latency period, and the effect confounding such as
environmental exposures and lifestyle factors such as smoking (Morrell, Kerr, Driscoll,
Taylor, Salkeld, & Corbett, 1998). The magnitude of occupational injury is far easier to
establish than for occupational diseases as there is a clear cause and effect for an injury.
Worldwide it has been estimated that approximately two million people die every year
as a result of work-related injury and/or illness (CCH, 2009). The National
Occupational Health and Safety Commission (NOHSC, 2003) estimated there are more
than 2,000 workplace-related fatalities every year in Australia. This figure is thought to
be only an estimate, because the long latency period of some diseases and the difficulty
in relating some conditions to periods of work make it difficult to quantify the precise
number of deaths. Nevertheless, it has been estimated that 85% of workplace deaths
worldwide are due to occupational diseases and, apart from cancer, the most common
job-related health problems are respiratory diseases, musculoskeletal disorders, hearing
loss, circulatory diseases and communicable diseases (CCH, 2009).
To add to the complexity of this issue, available statistics (such as workers’
compensation data) suggest that musculoskeletal injury and dysfunction are the main
cause of occupational abnormalities in Australia. However, these data sources have
been reported to be misleading, because the more recognisable problems (such as
musculoskeletal disorders) are more likely to be reported and recorded. By contrast,
health problems related to substances (for example, toxic dust exposure) are often hard
to identify because the early effects can be subtle and the time between exposure and
the development of symptoms can be substantial (Morrell, Kerr, Driscoll, Taylor,
Salkeld, & Corbett, 1998).
Although it is well known that exposure to irritant gases, aerosols and particulates in
ambient air can cause adverse effects in the respiratory system (Balmes, 2002) the
Parliament of Australia (2004) reported a paucity of data in Australia on morbidity and
mortality associated with workplace toxic dust exposure. It also highlighted the need for
robust surveillance systems and early accurate diagnosis of loss of lung function.
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On inhalation of toxic agents there is a continuum of effects which may range from
acute reversible effects through to chronic respiratory disease (Meldrum, 2001;
McCance & Huether, 1999) and even fatality at concentrations immediately dangerous
to life (National Institute for Occupational Safety and Health [NIOSH], 2005). This
embodies the ‘threshold concept’ where a small amount of a toxic agent produces little
or no effect, but as the dose increases the incidence of a health effect in an exposed
population exceeds that of a control population not exposed to the toxic agent (Cohen,
2002, p. 126). At the cellular level, injured cells affected by inhaled toxic agents may
recover (i.e., a reversible effect) or die (i.e., an irreversible effect) (McCance & Huether,
1999). Such effects have been reported to be dependent on the chemical and physical
properties of the toxic agent (or mixture of agents); the concentration in the air; the
duration and frequency of exposure; the respiratory rate; and the susceptibility of each
individual (Witschi, Pinkerton, Van Winkle, & Last, 2008; Cohen, 2002).
Inhalation of irritant gases or particulates can result in inflammation of the airways
and lung parenchyma and can therefore affect lung function and initiate respiratory
disease (Mitchell, 1997; Schwartz, 2002). The Australian Safety and Compensation
Council (2006, p. 2) defined occupational respiratory disease (in contrast to non-workrelated respiratory disease) as “caused or exacerbated by work factors”. Moreover, the
Australian and New Zealand Society of Respiratory Science (ANZSRS) considered it
feasible to provide early detection of occupational respiratory disease (Parliament of
Australia, 2004).
It is not, however, always clear whether respiratory disease is in fact occupational as
there are normally confounding non-occupational factors that contribute to the disease
burden in the individual. Cigarette smoking has been regarded as the classic example of
this phenomenon in that regular smoking is widely regarded as the major risk factor for
respiratory disease (Wewers et al., 2010). Likewise, asthma may be initiated and/or
exacerbated by occupational exposures. In combination, mixed exposures to such nonoccupational and occupational factors have been suggested to be additive or even
synergistic (Tranter, 2004; Burge, 2002)
This research examined the respiratory health of workers at the Murrin Murrin
lateritic nickel and cobalt extraction and processing operation in Western Australia. This
chapter provides the rationale and background to the study including information on the
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occupational setting, an overview of the respiratory health hazards associated with this
occupational setting, and a summary of the possible pathophysiological effects of
exposure to airborne contaminants. This is followed by the justification, significance,
and purpose of the study.

1.1 Problem Statement
The respiratory health effects of concurrent and repeat exposures to complex
mixtures of low-level airborne hazardous substances at the Murrin Murrin Operation
remain unknown. Traditionally, health risk assessments are based on measurement of
the airborne concentrations of hazardous substances independently. Such monitoring
was conducted as a precursor to this study to determine the occupational exposures in
each work area at Murrin Murrin (Oosthuizen & Cross, 2004). Although they were
generally well below their respective occupational exposure levels, it is possible
however, that additive, antagonistic, potentiated or even synergistic biological effects
could occur due to exposure to a combination of these atmospheric contaminants
(Zeliger, 2008). Moreover, it was the perception of the Murrin Murrin workforce that
such exposures may result in adverse health effects not predicted by atmospheric
monitoring (Oosthuizen & Cross, 2004).

1.2 Background
The Minara Resources’ Murrin Murrin mine site is located approximately 60 km east
of Leonora and 60 km west of Laverton in the north eastern Goldfields region of
Western Australia. The primary business at Murrin Murrin is to produce nickel and
cobalt from laterite ore. The operation exists to extract lateritic ore through open cast
mining and then to process the ore using the Sherritt International Pressure Acid Leach
(PAL) technology to recover nickel and cobalt (Mining-Technology.Com, 2010) whilst
at the same time preventing or minimising unwanted releases of hazardous materials
that could expose employees. This biological monitoring study was commissioned by
Minara Resources to monitor the process safety and control measures at the Murrin
Murrin Operation.
Atmospheric exposure measurements (also known as occupational hygiene
monitoring) have been conducted since the Murrin Murrin mine operation commenced
in 1999, in order to evaluate the adequacy of the primary preventive measures. As a
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precursor to this study, in 2004 a systematic approach to occupational health and
hygiene was adopted in order to develop best practice protocols for the management of
occupational hygiene hazards at the Murrin Murrin mine site (Oosthuizen & Cross
2004; Wing, 2005; Wing & Oosthuizen, 2007). During the systematic identification and
evaluation of all occupational health and hygiene hazards associated with the complex
chemical extraction process of nickel and cobalt from ore at the Murrin Murrin mine
site, a number of potentially irritant gases, aerosols and dusts were identified, the most
notable being hydrogen sulphide, ammonia, sulphur dioxide/trioxide, oxides of
nitrogen, sulphur dust, nickel dust, cobalt dust, calcrete dust and red dirt dust (dust from
the ground in this area). Occupational hygiene monitoring has demonstrated that the
mean occupational exposures were generally well below their respective occupational
exposure levels (Wing, 2005; Wing & Oosthuizen, 2007). Despite this, there was
concern expressed by the staff that, in combination, the various contaminants may
present an additive or even a synergistic deleterious health effect (Interdepartmental
Group on Health Risks from Chemicals, 2008).

1.3 Justification and Significance
1.3.1 Justification
Toxicological reviews of the potentially irritant gases, aerosols and dusts identified
via the occupational hygiene surveys at the Murrin Murrin mine site, determined that
the predominant route of exposure would be via inhalation, with the lung being the main
target organ, possibly resulting in respiratory disease (Witschi, Pinkerton, Van Winkle,
& Last, 2008; Nemery, 2002; Cowie, 2002). If this were the case, this would potentially
cause a significant, short-term and long-term, health and economic impact. The aim of
this biological monitoring was therefore to detect possible adverse effects at an early
stage in order to prevent potential long-term occupational respiratory disease (Hendrick,
Burge, Beckett, & Churg, 2002; Parliament of Australia, 2004).

As stated by Morgan and Seaton “All occupational lung disease represents a failure
of preventive measures” (1995, p. 9). Atmospheric exposure measurements and
biological monitoring are therefore used to determine whether existing preventive
measures are adequate, and if not, that additional controls are implemented (Plog, 2002;
Hendrick et al., 2002). Prevention of disease is a fundamental principle of occupational
epidemiology (Checkoway, Pearce, & Kriebel, 2004). Hence an occupational
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epidemiological study of the workforce at the Murrin Murrin Operation was conducted.
The prevalence of respiratory symptoms and lung function for each worker and each
independent workgroup – that is, mining, ore leach, refinery, utilities, calcrete, pastoral
and administration – were investigated.
1.3.2 Significance
An epidemiological study of complex mixtures of low-level respiratory irritants in an
Australian lateritic ore mining and processing plant did not appear to have been
conducted previously. Each work area/department at the Murrin Murrin Operation has
its own unique profile of potential respiratory irritants, with limited periods of low-level
exposure not experienced in any other industry. Thus this epidemiological study
enabled the measurement of low-level exposures of these complex mixtures in each
work area as well as for the whole site. The findings therefore have the potential to
identify any additive or synergistic effects which may occur through interaction of a
combination of the potential respiratory irritants.
Although the outcome of this study is specific to the Murrin Murrin Operation, it
may also have some relevance to other lateritic mining operations using the high
pressure acid leach (HPAL) method of extraction such as those in Indonesia, Brazil,
Cuba, Colombia and New Caledonia (Intec, n.d.; Barnes, 1998; MiningTechnology.Com, 2010).

1.4 Purpose of the Study
This study was a longitudinal study of the Murrin Murrin workforce, looking for
possible early respiratory health effects due to potential exposure to various hazardous
substances associated with the mining and processing of ore for production of nickel
and cobalt. The purpose of the study was to conduct respiratory health surveillance of
the Murrin Murrin workforce to:
detect possible adverse respiratory health effects at an early stage, in order to
prevent potential long-term occupational respiratory disease, and then, if
necessary,
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to recommend interventions to prevent untoward health effects, and to enable
management to have a proactive approach for the protection of the workforce
(Hendrick et al., 2002).

1.5 Organisation of Thesis
Chapter 2 provides a critical review of existing literature regarding how air quality
can affect lung function and cause respiratory disease. The impact of respiratory disease
is discussed and the literature review then focuses specifically on occupational
respiratory disease, its aetiology, the health surveillance methodology to determine
occupational respiratory disease, and the potential confounding factors. It identifies the
gaps in current knowledge and research for the early detection of occupational
respiratory diseases, and states the case for pulmonary function tests in conjunction with
a respiratory questionnaire in assessing early respiratory changes due to occupational
exposures, which was the main aim of this study.
Chapter 3 provides an overview of the Murrin Murrin Operation process, from
mining of the ore, through its processing to produce the final nickel and cobalt products.
In doing so, the chemical hazards that workers may face on a daily basis are identified.
Chapter 4 focuses on the respiratory health issues presented by each hazardous
substance associated with the mining, the process plant, and specific work areas, and
relates this to the personal exposure assessments that were determined through the
occupational hygiene component of this study. It also discusses the effects of mixed
exposures on the respiratory system.
Described in Chapter 5 are the methods and procedures used to collect the data for
this biological effects monitoring study. This includes the study design, administration
of the respiratory questionnaire, the measurement technique, the equipment and quality
control, and statistical analysis.
Presented in Chapter 6 are the results of this study. The prevalence of respiratory
symptoms of the study group of workers at the Murrin Murrin Operation is compared
with those of a control group of caterers located close to the operation. The lung
function of the study group is compared both with their predicted values, and the control
group, and analysed with the sequential removal of the confounding factors known to
affect lung function. Also presented in Chapter 6 are the results of the initial and repeat
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lung function study, as well as the lung function for a cohort of refinery workers before
and after a work period. The results chapter also presents an analysis of the effect of
length of service, and the effect of smoking on lung function.
Chapter 7 provides a discussion of the results and the limitations of this research and,
finally, Chapter 8 provides the conclusions and recommendations that emerged from
this research.
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2. LITERATURE REVIEW
2.1 Introduction
It is known that occupational respiratory disease is a major contributor to the burden
of lung disease in Australia but the exact causes and statistics remain unknown
(Morrell, Kerr, Driscoll, Taylor, Salkeld, & Corbett, 1998). The extent to which the
occupational air quality at the Murrin Murrin Operation affects lung function remains
unknown. This study investigates this. This chapter provides the background for this
research and contains a critical examination of published epidemiological, experimental
and theoretical evidence relevant to this research.
The main literature review was conducted prior to the start of the study to shape the
experimental design and, therefore, the methodology is based on references current at
the start of the study in 2004.

2.2 Air Quality and Respiratory Impairment
It has been widely reported in the literature that air quality affects lung function and
thus morbidity and ultimately mortality (Ostrowski & Barud, 2006; Samet et al., 2000).
According to the European Lung Foundation (n.d.a) respiratory disease is the second
biggest killer globally after cardiovascular diseases (British Lung Foundation, n.d.) and
excessive exposure to hazardous substances at work via inhalation is known to cause
occupational lung disease, morbidity and mortality. Perhaps the most classic case in
history was documented by Ramazzini who uncovered the association of stonemasonry
and the exposure of silica dust, to silicosis (Wright, 1964; Checkoway et al., 2004).
Similarly, pneumoconiosis in miners was reported by Agricola in 1556 (Cantrell &
Volkwein, n.d.). A more recent case where poor air quality caused a significant number
of deaths was the London Smog Episode of 1952 where mortality in London was
affected by air pollution (Amdur, 1980). This was largely attributed to the burning of
coal by house owners wanting to keep warm during a cold winter, and industries such as
coal-fired power stations, resulting in an atmosphere dense with smoke particles, soot
and sulphur dioxide. This event influenced public perception of poor air quality
ultimately leading to the introduction of air quality guidelines (Bell, Davis, & Fletcher,
2004).
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Subsequently, there have been many studies of air pollutants measured both in cities
and other geographical areas throughout the world where air pollutants have been found
to be associated with respiratory impairment and mortality (Souza, Saldiva, Pope, &
Capelozzi, 1998; Wieringa et al., 1998; Samoli et al., 2008; Wong, Vichit-Vadakan,
Kan, Qian, & the PAPA Project Teams, 2008). Urban air pollution remains a significant
public health problem in many countries and is known to cause and aggravate existing
respiratory disorders and cardiovascular disease (Anderson, Atkinson, Peacock,
Marston, & Konstantinou, 2004). The main sources of air pollutants for the general
Australian population are considered to be:
particulates;
ozone (O3);
nitrogen dioxide (NO2);
carbon monoxide (CO);
sulphur dioxide (SO2).
(Australian Bureau of Statistics, 2009)

2.3 Impact of Occupational Lung Disease
2.3.1 Worldwide
According to Driscoll et al. (2005) in the year 2000 chronic obstructive pulmonary
disease (COPD) asthma and pneumoconioses caused by airborne particulates were
estimated to have caused up to 386,000 deaths worldwide; and the sum of years of
potential life lost due to premature mortality and the years of productive life lost due to
disability (Disability Adjusted Life Years – DALY’s) was estimated to be 3.7 million
and 1.6 million respectively. Nelson et al. (2005) estimated for the year 2000 13% of
COPD, 11% of asthma, and 9% of lung cancer, was occupationally related and
accounted for a sizable proportion of the global burden of disease, which could be
substantially reduced through application of proven risk prevention strategies. The
annual cost of occupational COPD in the U.S. population alone was estimated to be $5
billion, based on an assumed attributable fraction for COPD deaths due to occupational
exposure of 15% (Leigh et al., 2002). According to Blanc, et al., (2002) exposure to
workplace contaminants such as dust, gases, vapours, or fumes was associated with a
2.0-fold (95% CI [1.6–2.5]) increase in the risk of COPD.
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The European Lung Foundation (n.d.a) predicts that in 2020, there will be 11.9
million (community and occupational) deaths worldwide caused by lung diseases.
2.3.2 Europe
Sigsgaard et al., (2010) reported that in Europe in 2000, it was estimated that COPD,
asthma and pneumoconioses caused 52,700 deaths (39,300, 6,200, and 7,200
respectively). Therefore occupational respiratory disease was ranked third overall, with
mining occupations having the highest prevalence of occupational lung disease.
Furthermore, male manual workers have been reported to have twice the risk of
mortality from occupational respiratory disease than non-manual workers (Sigsgaard et
al., 2010).
2.3.3 Finland
The Finnish Institute of Occupational Health (2010) reported that in 2005 the number
of notified asbestos-induced cases was 807 and the number of cases of allergic
respiratory disease was 746. Karjalainen, Kurppa, Martikainen, Karjalainen, and
Klaukka (2002) determined the attributable fraction of work-related asthma to be 29%
for men and 17% for women. The overall incidence of pneumonia in Finland was
estimated to be 10.8 per 1,000 adults per year (European Lung Foundation, n.d.a).
2.3.4 Norway
Eagan, Gulsvik, Eide, and Bakke (2002) conducted an 11-year cohort study of a
population of 2,819 Norwegian subjects to evaluate the influence of occupational
exposure on the incidence of respiratory symptoms and asthma. They determined that
occupational exposure accounted for 14% of asthma cases and 6-19% of respiratory
symptoms.
2.3.5 USA
The most recent report from the NIOSH Work-Related Lung Disease (WoRLD)
Surveillance System (2009b) presents detailed data on occupationally-related
respiratory disease in the USA. Selected extracts quoted from the highlights are
provided below.
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2.3.5.1 Hypersensitivity pneumonitis
The annual number of hypersensitivity pneumonitis deaths in the USA has been
generally increasing, from less than 20 per year in 1979 to over 60 in 2004.
2.3.5.2 Work-related asthma
There were 4,132 cases of work-related asthma in the USA during 1993–2002.
About 68% of which represented asthma caused by occupational exposure, while 20%
represented pre-existing asthma aggravated by occupational exposure.
Nearly 20% of asthma cases were associated with miscellaneous chemicals, 13%
with mineral and inorganic dust, twelve percent with cleaning materials, 11% with
indoor air pollutants, and 4% with exposures to polymers, among others.
2.3.5.3 COPD
Mining industries were in the top five USA industries for COPD mortality, as were
trucking service and automotive repair and related services.
2.3.5.4 Respiratory conditions due to toxic agents
The estimated number of cases of respiratory conditions due to toxic agents in 2000
in the USA was 14,700.
The estimated rate of respiratory conditions due to toxic agents in the primary metals
industry (CIC 33) was 3.8 per 10,000 full-time workers in 2000.
2.3.5.5 Asbestos
Data from the Occupational Safety and Health Administration (OSHA) and the Mine
Safety and Health Administration (MSHA) indicate a trend towards lower asbestos
exposure levels from 1979 to 1999, concomitant with mandated reductions in the OSHA
permissible exposure limit (PEL). However, data indicate a steady increase in asbestos
exposure levels in the mining industry for the years 2000 through 2003 and a slight rise
in all other industries in the 2 years previous to 2003. Olsen et al (2011, p. 273) state
that “in [Western Australia] WA, 1631 people (1408 men, 223 women) were diagnosed
with malignant mesothelioma between 1960 and 2008”. Asbestos may be intersected
during exploration drilling and unearthed during mining operations as it is widely
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distributed in WA particularly in the “greenstone belts” (Department of Mines and
Petroleum, 2010c)
2.3.5.6 Silica
Over the past several decades in the USA, silicosis mortality has declined, from well
over 1,000 deaths annually in the late 1960s to fewer than 200 per year in the mid
2000s. The construction and mining industries accounted for at least one third of deaths
attributable to silicosis from 1990 through 1999 (Centers for Disease Control &
Prevention, 2008).
2.3.6 Germany
According to Loddenkemper (2006) 37% of all compensated occupational diseases
are attributable to occupational lung disease in Germany. Baur and Latza (2005, p. 597)
reported that the confirmed cases of non-malignant occupational respiratory diseases in
Germany were:
benign asbestos-associated diseases (1,975 cases);
silicosis/coal-worker's pneumoconiosis (1,158 cases);
obstructive airway diseases due to allergens (935 cases);
chronic obstructive bronchitis and/or emphysema in hard-coal miners
(414 cases);
obstructive airway diseases due to irritants and toxic agents (181
cases);
diseases caused by ionising radiation (171 cases);
diseases due to isocyanates (55 cases); and
22 cases of other rare occupational lung and airway diseases.
Baur and Latza (2005, p. 597) also reported that miners, bakers, chemical workers,
hairdressers and health care workers were affected the most.
2.3.7 United Kingdom
In the 1999 SWORD surveillance of work-related and occupational respiratory
disease report an increase was seen in most respiratory diseases in the United Kingdom.
There were 4,393 incident cases. Benign pleural disease was the single most frequently
reported condition (28% of all diagnoses reported) there were 1,168 (26%) occupational
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asthma cases and 1,032 (23%) cases of mesothelioma (Meyer, Holt, Chen, Cherry, &
McDonald, 2001).
The British Thoracic Society (2006) determined that mortality and morbidity due to
occupational lung disease was increasing, with a 70% rise in mortality due to
mesothelioma since 1992. It was estimated that 4,000 COPD deaths every year may be
associated with work exposures. Also, in 2006 the Health and Safety Executive, UK,
estimated that the true total lifetime cost of occupational asthma for male workers was
between £53.6 and £78.0 million (British Lung Foundation (n.d.a). Ayres, Boyd, Cowie,
and Hurley (2010) estimated the cost of occupational asthma to be as large as £70—
£100 million however, and, due to underreporting, may be as large as £95—£135
million.
The Health and Safety Executive (n.d.) determined that in the UK in 2009-2010 there
were 38,000 workers who had breathing or lung problems caused or exacerbated by
work.
2.3.8 South Africa
In South Africa, despite incomplete reporting, diseases with long latency periods
made up 76.2% of the cases of work-related respiratory disease. This is reflected in the
study by Girdler-Brown, White, Ehrlich, and Churchyard (2008) who determined that in
a cohort of former gold miners, 18 months after cessation of work, 50% had either
silicosis, tuberculosis or COPD. Moreover, Esterhuizen et al. (2001) reported that
pneumoconiosis was the most frequently reported disease, followed by inhalation
accidents; and that occupational asthma was the fourth most reported disease.
Overall it can be seen that the profile of occupational lung disease varies with each
country, geographical region, and type of industry, and is in constant flux due to
changes in industrialisation. According to Hendrick et al. (2002) occupational asthma
and chronic bronchitis are currently more prevalent than alveolar and interstitial
diseases. To this end, the World Health Organization (2010) has developed a strategy
for the prevention and control of chronic respiratory disease; and many workplace
regulatory authorities throughout the world have developed preventative strategies
(WorkSafe WA, 2004; Department of Mines and Petroleum [DMP], 2010a; Safe Work
Australia, 2010d; Health and Safety Executive, UK, n.d.; NIOSH, 2009a).
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2.3.9 The background general respiratory health of Australians
According to the Australian Bureau of Statistics (2009) lung disease is a significant
and growing health issue in Australia with 2.6 million cases of lung disease reported in
2007–2008. The Australian Bureau of Statistics also stated that more than 2 million
Australians reported having asthma during 2007–2008; and that each year lung disease
causes 19,200 deaths in Australia. According to the Australian Lung Foundation (2009)
one in five Australians over 40 is affected by COPD.
However, the degree to which occupational exposure to respiratory hazards affects
these statistics appears at present to be unknown. Although Safe Work Australia (2010c,
p. 3) states that “occupational respiratory diseases did not display a clear overall trend
of increase or decrease”, and it is difficult to separate work-related from non-workrelated respiratory disease (NIOSH, 2007).
Australia ranked fourth highest out of 16 high-income countries in the prevalence of
moderate to severe COPD (de Marco et al., 2004) and according to the Australian
Institute of Health and Welfare (2008) about 9–15% of asthma in adults may be caused
by occupational exposures, which can result in a significant time off work for those
suffering from the disease.

2.4 Occupational Respiratory Disease
The Australian Safety and Compensation Council (2006, p. 2) defined occupational
respiratory disease as “respiratory disease that is caused or exacerbated by work
factors”, and asserted that the causative agents are airborne contaminants “such as dust,
mist, fibres, fume, vapour or gas” which if inhaled and are “small enough in size to gain
access to the deeper, pulmonary areas of the lung” are likely to cause occupational
respiratory disease.
Except for inhalational accidents where excessive exposures results in obvious acute
lung injury (Sallie & McDonald, 1996; Shakeri, Dick, & Ayres, 2008) occupational
respiratory disease is often hard to distinguish from respiratory disease observed in the
general population (Hendrick et al., 2002) as respiratory disease may be caused by
environmental or occupational exposures and the contribution that each plays is often
not determined. These combined effects may be additive or even synergistic, as in the
case of smoking and asbestos exposure (Selikoff, Hammond, & Churg, 1968). Even in
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one discrete industry it is not easy to determine the causative agents of respiratory
disease. For example; Ross and Murray (2004) pointed out there are different airborne
exposures in the mining industry even for the extraction of one type of mineral due to
the different tasks and equipment used. In 1997, Mitchell called for an Australian
register of all occupational lung diseases, and again in 2006 Sim, Abramson and Radi
commented on the lack of data regarding occupational respiratory disease in Australia.
More recently, to address this Safe Work Australia (2010d) conducted a National
Hazard Exposure Worker Surveillance: Exposures to dust, gases, vapours, smoke and
fumes and the provision of controls for these airborne hazards in Australian
workplaces. Hence it is work in progress. The extent to which occupational factors
contribute to respiratory disease does not appear to have been determined and is
difficult to ascertain.

2.5 Epidemiology – Cause and Effect
All diseases have causes and consequences. The aetiology of workplace exposures to
airborne contaminants may be obvious if an apparent disease cluster or rare disease is
observed. For example, vinyl chloride was found to cause angiosarcoma, a rare cancer
of the liver (Creech & Johnson, 1974). Determining the aetiology of lung disease may
be obvious, for example, in the case where excessive exposure to silica dust causes
silicosis. Similarly the smog and its constituent smoke particles, soot and sulphur
dioxide that caused the London Smog Episode, caused and aggravated existing
respiratory disorders and cardiovascular diseases (Amdur, 1980). Likewise the cause
and effect of a single massive chemical exposure resulting in reactive airways
dysfunction syndrome (RADS) (Shakeri et al., 2008) is obvious. These are case series
reports where an apparent increase in a specific disease is reported and clear a cause and
consequence determined in each case. However, for more complex cases more complete
epidemiological studies are required with comparison groups and exposure assessments
(Checkoway et al., 2004).

2.6 Aetiology of Lung Disease
Epidemiological studies aim to determine the aetiology of disease and can be utilised
to determine the aetiology of occupational respiratory disease. Respiratory irritants via
inhalation may cause airways inflammation and subsequent damage of the upper and
lower respiratory tract, or chemical pneumonitis which is acute inflammation of the
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pulmonary parenchyma. Asthmagens can cause diseases of allergic and immunological
origin and provoke respiratory symptoms in sensitised individuals at very low
concentrations (Ryon & Rom, 1998).
The aetiology of lung disease is due to the inhalation of hazardous substances such as
dust, fibre, gas, vapour, mist, aerosol, fumes and smoke (Campbell, 2009) above a
threshold level (United States Environmental Protection Agency, 2009). The toxic
effect is reversible if the exposure (or dose) to the hazardous substance remains below
the threshold (the no-observed-adverse-effect level [NOAEL]) level and irreversible if it
exceeds this level. The American Thoracic Society (2003, p 787) states, “There are
convincing data to show that the level of exposure is a critical risk factor for sensitizerinduced occupational asthma”. Similarly Oudijk, Lammers and Koenderman (2003, p.
9) state that COPD:
appears to start as a reversible self limiting inflammatory reaction …
mediated by both monocytes and neutrophils .… After prolonged exposure
… a switch to chronicity takes place and an irreversible inflammatory
reaction is initiated which is clearly associated with neutrophils in the lung
tissue.
According to Barnes, Shapiro, and Pauwels (2003) the switch to chronicity, or
chronic inflammation, in the case of COPD results in fixed narrowing of small airways
and emphysema. There are histopathological differences between COPD and asthma in
that COPD mostly affects the bronchioles as well as the parenchyma, whilst there is an
inflammatory response in all airways with asthma, however, this is usually without
involvement of the lung parenchyma (Fabbri et al., 2003).
The pathophysiological effects of airborne contaminants on the respiratory system
are dependent on the physicochemical properties, the toxicity, and the dose of the
airborne contaminant or mixture of airborne contaminants (Tranter, 2004; Plog, 2002).
Normally, as the dose of the airborne contaminant increases so does the response on the
respiratory system that is, the dose-response relationship (Tranter, 2004). For gases, the
water solubility of an inhaled gas will determine the site of deposition, whilst the
duration of exposure and rate of breathing of an individual, and their susceptibility, will
influence the severity of the toxic effect (Sullivan & Krieger, 2001). For particulates
the aerodynamic diameter is of importance. Aerodynamic diameters in the 0.3-0.5 μm
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range may be deposited in the lower airways and alveoli, often resulting in diffuse
bronchiolar inflammation and obstruction as well as pulmonary oedema (Rosenstock,
Cullen, Brodkin, & Redlich, 2004). Acute or subacute exposure to toxic chemicals, as
described by Nemery (2002), results in inflammation of lung tissue. A vast number of
substances can therefore cause inhalation injury.
The immunological aspects of COPD are described by Cosio, Seatta and Agusti
(2009) as a cascade of inflammatory processes. The histopathological picture of a
typical respiratory insult is loss of ciliated epithelial cells of the airway and of type I
alveolar epithelial cells. Following this there is damage to the tight junction interface
between epithelial cells, sequentially leading to subepithelial and submucosal damage,
with effects on the smooth muscle and afferent parasympathetic sensory nerve endings
causing bronchoconstriction. This in turn initiates an inflammatory response where
neutrophils and eosinophils release mediators that cause further injury. According to
Ryon and Rom (1998) the repair mechanism is initiated by type II pneumocytes and
cuboidal cells.

2.7 Continuum of Respiratory Health Effects
As with most pathophysiological effects there may be a continuum of effects on the
respiratory system. These may be an acute and reversible effect due to a single or a
small number of sub-threshold exposures, or irreversible effects due to a single highlevel acute exposure, or repeated chronic exposure (Plog, 2002). Delayed onset from
acute exposure to toxic agents may occur days to weeks after initial insult (Schwartz,
2002). The consequences of such respiratory exposures may range from irritation,
allergy, cell damage, fibrosis, oedema, emphysema, cancer or systemic effects (Winder
& Stacey, 2004).
A continuum of effects on the pulmonary system begins with acute lung injury due to
damage to the epithelial-endothelial barrier of the lung, which may be due to a variety
of agents. This begins with an early inflammatory response with the release of humoral
mediators, which, if left unchecked, may progress with the development of chronic lung
injury (Jacono et al., 2006).
Meldrum (2001) and Banks (2001) both state that responses to irritants may be
viewed as occurring along a continuum. At one end of the continuum no effects would
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be observed, followed by reversible irritation, and ultimately irreversible effects would
be observed. The aim of respiratory health surveillance is to detect possible adverse
effects at an early stage in order to prevent potential long-term occupational respiratory
disease. Ammonia, hydrogen sulphide, nitrogen oxides and sulphur dioxide have been
shown to be associated with inflammatory changes in small airways. These respiratory
irritants at low-level repeated exposure and acute high-dose exposure are capable of
causing decrements in lung functions measured by spirometry (Boswell & McCunney,
1995).
Menzel and McClelland (1980, p. 264) categorise pulmonary responses to an array of
toxicants into five categories as follows:
1. Irritation of the air passages which results in constriction of the
airways. Oedema often occurs and secondary infection frequently
compounds the damage.
2. Damage to the cells lining the airways, which results in necrosis,
increased permeability, and oedema. This oedema is, in general,
intraluminal (within the airways) rather than interstitial (within the
cells of the airway).
3. Production of fibrosis, which may become massive and cause
obliteration of the respiratory capacity of the lung. Local fibrosis of
the pleura also occurs, restricting the movement of the lung and
producing pain through the irritation of the pleural surfaces.
4. Constriction of the airways through allergic responses. Allergic
alveolitis is a widespread response to the inhalation of some simple
compounds, as well as of complex organic materials capable of
producing specific antigenic responses.
5. Oncogenesis leading to primary lung tumours.
Gee and Mossman (1995, p. 197) focused on the cellular and molecular mechanisms
of occupational lung disease and describe the pathophysiology of acute lung injury as:
1. Direct toxic effects on type I cells and endothelial cells (ECs);
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2. Compliment activation;
3. Coagulation factors activation; and
4. EC

biochemical

response

and

polymorphonuclear

neutrophil

recruitment and activation that release protease and oxidants.
Gee and Mossman (1995, p. 197) also emphasise that “patients with the first group of
disorders, even when severe, frequently make a complete recovery, and lung fibrosis is
not the rule”.
There is a threshold level, which, if exceeded ultimately leads to irreversible lung
disease, and at sub-threshold levels the effects are reversible, as in the continuum
postulated by Meldrum (2001) and Banks (2001). The aim of occupational respiratory
health surveillance is to detect respiratory effects (should they exist) prior to the
development of chronic irreversible pulmonary disease.
The susceptibility of the target organ or tissue and its repair mechanisms also has an
impact on the reversibility/irreversibility of a pathophysiological effect (Eaton &
Gilbert, 2008). Higenbottam, Siddon and Demoncheaux (2001) recognise that
environmental pollution in its various forms, such as dust, fibre, gas, vapour, mist,
aerosol, fumes and smoke, may produce a variety of effects on the lungs, both localised
and general. Whilst Checkoway et al. (2004) point out that normally the risk is
proportional to the dose (exposure) for most pathophysiological mechanisms. However,
there are occasions where this is not so and toxicity follows a “non-linear or dynamic”
pattern, such as with occupational asthma where there is “development of specific
sensitivity”, and “in-migration of inflammatory cells following irritant exposure to the
airways” where there is a “positive feedback” (Checkoway et al., 2004, p. 309).
Notwithstanding, Crapo, Harmsen, Sherman and Musson (2000) emphasise that the
lung’s defence mechanism maintains lung homeostasis and keeps the inflammatory
response to foreign substances and antigens in check. Lafferty, Qureshi and Schnare
(2010, p. 1) capture this in their statement:
Selective induction of inflammatory responses to harmful environmental
exposures and tolerance to innocuous antigens are required to maintain
tissue homeostasis and integrity. Conversely, dysregulated innate immune
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responses manifest as sustained and self-perpetuating tissue damage rather
than controlled tissue repair.
Once this defence mechanism is breached, “disordered inflammation and immune
responses” occur, which ultimately leads to “progressive and chronic lung diseases”
(Crapo et al., 2000, p. 1983) most notably COPD or chronic asthma. COPD is usually a
combination of emphysema and chronic bronchitis, where the alveolar walls are
gradually destroyed (emphysema) and excessive mucus is produced as a consequence of
chronic bronchitis (Australian Lung Foundation, 2010). Asthma, known to be caused by
a variety of chemical and biological substances, is an inflammatory response
(hypersensitivity) that causes narrowing of the upper respiratory tract which results in
difficulty in breathing and wheezing (Chang-Yeung & Malo, 1994).

2.8 Mixed Exposures
As already discussed, exposure to low levels of airborne contaminants in the
workplace may cause acute inhalation injury and occupational asthma, although an
acute excessive exposure may result in substantial lung injury (Banks, 2001; Hudson &
Steinberg, 1999). Balmes (2002, p. 727) reports, however, that such acute excessive
exposures do not frequently occur and that “chronic recurrent exposures to lower levels
of irritants are much more common”. Furthermore, Balmes et al. (2003, p.787) state that
“the lungs of workers at risk are subjected to the total exposure burden of all airborne
contaminants in any workplace”. It therefore seems that many occupational diseases
have multiple causes (Muir, 1995).
Lung injury often results from interactions between two or more toxic agents
(Witschi & Hakkinen, 1984). Petsonk (2002) asserts that work-related asthma may be
caused by mixed exposures. On reviewing the disease suberosis, Alegre, Morell, and
Cobo (1990) believe that three different distinct diseases with three different
aetiological factors occur simultaneously due to mixed exposure to cork dust, toluene
diisocyanate and conidia.
It is now well established that certain occupational exposures are strongly associated
with an increased risk of COPD, and that, in combination, smoking and occupational
exposure may significantly magnify the risk of COPD. Blanc et al. (2009, p. 12) state,
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“On a population level, prevention of both smoking and occupational exposure, and
especially both together, is needed to prevent the global burden of disease”.
2.8.1 Low-level mixtures of respiratory irritants
Occupational exposure to low levels of mixtures of respiratory irritants (i.e., each
below its respective occupational exposure standard) is capable of causing respiratory
symptoms and a decrement in lung function (Barnhart, 1994; Kortenkamp, Faust,
Scholze, & Backhaus, 2007). Kremer, Pal, Boleij, Schouten, and Rijcken (1994)
identified a decrement in lung function for employees working greater than 10 years
exposed to a mixture of low-level lung irritants (i.e., polyester vapour and oil mist and
vapour workgroups). Similarly, Mustajbegovic et al. (2000. p. 439) detected decrements
in lung function associated with mixed exposures, in two chemical factories in Croatia,
even when the atmospheric levels of chemicals were “for the most part within
acceptable limits”. The effect on the lung by interaction between respiratory irritants
may be additive, synergistic or antagonistic (Witschi & Hakkinem, 1984). It is possible
to predict the respiratory response of a respiratory irritant if the physical and chemical
properties are known. It becomes more difficult, however, when there is a mixed
exposure. Historic examples of ‘cocktails’ of respiratory irritants include London smog,
characterised by sulphur dioxide and smoke from incomplete combustion of coal
combined

with

temperature

inversion.

Equally,

the

Los

Angeles

oxidising/photochemical air pollution, was characterised by hydrocarbons, nitrogen
oxides, and photochemical oxidants catalysed by intense sunlight and a meteorological
inversion (Amdur, 1980). More recently, environmental air pollution studies have been
conducted using spirometry and questionnaires. For example, the study by Yu et al.
(2001, p. 310) addressed the Adverse Effects of Low-Level Air Pollution on the
Respiratory Health of Schoolchildren in Hong Kong, determined that “children living in
a more polluted district” had increased respiratory symptoms and “significantly poorer
lung function”. Balmes (2002, p. 727) states that “although the contribution of low-level
irritant exposures to the overall burden of work-related asthma cannot be precisely
estimated the available data indicate that it is not likely to be inconsequential”. Further
research into the toxicology of low-level mixed exposures affecting the respiratory
system is warranted, particularly in the mining industry, in order to identify such
hazards and prevent occupational lung disease.
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2.9 Prevention of Lung Diseases
Both the World Health Organization and the International Labour Organization
(ILO) have targeted occupational lung disease for their preventive strategies due to its
high prevalence, the fact that it is severely disabling, and workplace exposures can be
avoided. Key to such preventive strategies is health surveillance (Takahashi et al.,
1998).
Occupational exposure to respiratory hazards still remains a significant worldwide
problem (Blanc et al., 2009). Different patterns of respiratory disease are seen
throughout the world, being more prevalent in newly industrialised regions (Hendrick et
al., 2002). There are a number of occupational lung disease surveillance databases
which highlight the impact of occupational lung disease, although direct comparison is
made difficult due to differences in reporting, classification, and medical diagnosis
(Hendrick et al., 2002).
Various countries throughout the world, including Finland, the UK, the USA, France
and South Africa have developed occupational respiratory disease surveillance systems.
For example, NIOSH (2009b) manage an occupational respiratory disease surveillance
system in the USA. However, as Elder et al., (2004, p 395) state “there are few such
comprehensive and systematic data collection systems in place to monitor the extent of
occupational respiratory disease in Australia”. Similarly, the Australian Safety and
Compensation Council (2006, p. iv) states “there is limited information on the extent of
work-related respiratory disease in Australia”. Therefore, the true incidence of
occupational respiratory diseases in Australia remains largely unknown. One such
surveillance scheme, SABRE, has been introduced in Victoria and Tasmania and is
currently being extended to New South Wales. This system will provide data on
occupational respiratory disease in those states (Monash University, 2004). The
feasibility of a national environmental health surveillance system for Australia was
considered in January 2008 by the Western Australian Environmental Health
Directorate, under guidance from the Australian Government Office of Health
Protection (Mullan, Ferguson, & Paech, 2008). Such surveillance schemes are an
important component in the development of comprehensive occupational respiratory
disease prevention strategies.

22

Health surveillance programs in the workplace will help pinpoint potential causative
agents and adverse health effects at an early stage, in order to prevent potential longterm occupational respiratory disease. Health surveillance is a secondary preventative
strategy. However, when used in combination with primary preventive strategies that
focus on the control of workplace exposures using the traditional hierarchy of controls
including education and training programs (Tranter, 2004) then prevention of
occupational respiratory disease is feasible. According to Hnizdo, Glindmeyer, and
Petsonk (2010, p. 797) “there are documented examples of spirometry monitoring
coupled with intervention successes”. They cite Musk, Peters, Bernstein, Rubin and
Monroe (1982) and Pahwa, Senthilselvan, McDuffie and Dosman (2003) where a
decline in forced expiratory volume in one second (FEV1) and forced vital capacity
(FVC) was reduced after introduction of a hierarchy of controls for fire-fighters and
granary workers respectively.

2.10 Distinguishing Occupational Respiratory Disease from
Background Environmental Respiratory Disease and Lifestyle
Factors
Several authors have determined that workplace exposure contributes to overall
mortality and morbidity of COPD (Hnizdo et al., 2002; American Thoracic Society,
2003; Trupin et al., 2003).
In 1965, Sir Austin Bradford-Hill (1897—1991) established nine criteria to
determine the strength of potential links between a causative agent and a disease
(causality). These include:
temporal relationship;
strength;
dose-response relationship;
consistency;
plausibility;
consideration of alternate explanations;
experiment;
specificity;
coherence.
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Checkoway et al. (2004, p, 12) state that “determining the potentially harmful effects
of occupational exposures typically involves estimating relative risks or changes in
physiological function in relation to exposure types and levels”. The assessment of
respiratory health risk requires recognition and evaluation of hazards by reviewing the
process, raw materials used, work practices and controls in place, followed by an
assessment of exposures through the determination of airborne contaminants using air
sampling techniques (Plog 2002; Safe Work Australia, 2010a). Following such a formal
process provides reliable information that can be used to determine the causes of
occupational respiratory disease and pave the way for prevention strategies and controls.
Using a formal epidemiological approach, the impact of work-related respiratory
disease can be established, by comparing incidences of respiratory disease in an
exposed (study) and a non-exposed (control) population. Excess incidence in an
exposed population (after correcting for confounding factors, such as smoking) allows
for the calculation of the population attributable risk (PAR %) – assuming the
proportion of exposed persons in the population is known (Health and Safety Executive,
UK, 2004).
2.10.1 Confounding
To distinguish occupational respiratory disease from background environmental
respiratory disease and lifestyle factors, such as the prevalence of smoking, it is
necessary to identify and eliminate these confounding factors where possible.
According to Checkoway et al. (2004, p. 89) “Confounding can be thought of as a
mixing of the effects of the exposure being studied with effects of other factors on risk
of the health outcome of interest”.
Conversely there may be a healthy worker effect which can occur when comparing
health outcomes between the study and control group. A potential exists for the health
impacts in this study to have been underestimated among the study group (Checkoway
et al., 2004). Age, gender and body mass index are all confounding factors that need to
be adequately controlled in the study design or analysis (Checkoway et al., 2004).

2.11 Occupational Health Surveillance
There is an international directive, ILO C176 Article11 (International Labour
Organization, 1998) for the provision of health surveillance in mining. The primary aim
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of occupational health surveillance is to maintain and protect worker health (Cooper &
Zavon, 1994). Health surveillance is the systematic collection, analysis, and
interpretation of health data to enable detection of early disease in individuals, followed
by interventions aimed at preventing further exacerbation (Centers for Disease Control
and Prevention, n.d.).
Such a health surveillance program should:
identify workers or work groups who are exposed to health hazards at
work;
assess their risk of suffering an adverse health effect from exposure to
these hazards;
evaluate their health to detect early signs and symptoms of adverse
health effects;
verify the effectiveness of workplace controls (National Offshore
Petroleum Safety Authority , n.d.); or
implement further workplace controls if the risk remains intolerable.
(Tranter, 2004).
It is necessary to recognise when respiratory disease is work related, to manage the
consequences and prevent its reoccurrence (Hendrick et al., 2002). The UK Health and
Safety Executive assert that the key to the formulation of effective treatment and
preventative strategies relies on the accurate diagnosis of occupational respiratory
disease (Health and Safety Executive, UK, n.d.). Fortunately, in the workplace, levels of
hazardous substances can be measured through air monitoring, and their respiratory
effects can be monitored by lung function tests (Hendrick et al., 2002) and diagnosis
can be made through a respiratory questionnaire and spirometry that complies with the
ATS/ERS criteria (American Thoracic Society, 1995; Miller et al., 2005; DMP, 2010a).
2.11.1 Workplace health surveillance in Australia
A senate inquiry (Parliament of Australia Senate Committee, 2006) into workplace
harm related to toxic dust and emerging technologies highlighted the need for robust
surveillance systems and early accurate diagnosis of loss of lung function. The
surveillance system in Australia is based primarily on workers’ compensation claims
(Safe Work Australia, 2011c). Safe Work Australia (2011c) has targeted occupational
respiratory diseases as one of eight identified occupational diseases for priority action.
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The current the Australian National Guidelines for Health Surveillance [NOSHC:
7039], in NOSHC, 1995c, p. 1) state “these guidelines are intended for use by the
appointed medical practitioner when planning and implementing a program of health
surveillance”. Schedule 3 of these guidelines requires that a workplace risk assessment
be conducted when one or more of 17 specified hazardous substances exist at a
workplace. The related National Model Regulations for the Control of Workplace
Hazardous Substances [NOHSC: 1005] 1994, Health Surveillance (Safe Work
Australia 2011d) require that a risk assessment be conducted in each workplace where
Schedule 3 hazardous substances exist, where other hazardous substances may cause
health effects, or “there is a valid biological monitoring procedure available and a
reasonable likelihood that accepted values might be exceeded”. The employer then is
required to provide health surveillance (Safe Work Australia 2011d, Section 14 c).
2.11.2 Department of Mines and Petroleum MineHealth Surveillance System
Health surveillance is driven by the statutory requirement in Western Australia under
the Mines Safety and Inspection Act 1994. The Department of Mineral and Petroleum
Resources (DMPR) under the Health Surveillance Program for Mine Employees states
“It is mandatory that all assessments required under the Act are completed in
accordance with these approved procedures”. This program has been established
according to DMPR “to promote the implementation of an effective health surveillance
system for mining industry employees” (Department of Consumer and Employee
Protection, 2010, p. 3).
The objectives of the health surveillance system for mining employees are to:
Assess the health status of all mining industry employees on a regular
basis;
Analyse collected data to detect adverse health effects at the earliest
opportunity;
Enable appropriate and timely corrective action to be taken in order to
safeguard the health and well-being of mining industry employees;
Provide data for future epidemiological studies.
(DMP, 2010a, p 2)
Mining industry employers in Western Australia are required under legislation to
establish and maintain a health surveillance system for employees. This health
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surveillance system requires a health assessment for mining employees which consists
of:
a work history;
a respiratory questionnaire;
a lung function test;
an audiometric (hearing) test; and
in some cases, a chest x-ray.
(DMP, 2010a, p. 2)
Further health assessments are required at least every five years for all mine
employees. One of the main objectives of this health surveillance is to determine the
respiratory health of the mine and process workers to “enable appropriate and timely
corrective action to be taken in order to safeguard the health and well-being of mining
industry employees” (DMP, 2010a, p. 2).
2.11.3 Spirometry and respiratory questionnaire: subjective instruments to
measure respiratory health
Beach (2002, p.1009) states that “lung function measurements provide an important
tool in the diagnosis and management of occupational lung diseases”. Used in
conjunction with a respiratory questionnaire, spirometry testing provides a powerful
diagnostic tool with adequate sensitivity and specificity (Post et al., 1998). Bellia et al.
(2003, p. 21) asserts that a validated respiratory questionnaire provides a “subjective
instrument of measurement in respiratory epidemiology”. That is why respiratory health
surveillance utilises a combination of a work history, a respiratory questionnaire and a
lung function test.
2.11.4 Health surveillance studies utilising the combined questionnaire and
spirometry
Various occupational respiratory health surveillance studies have been undertaken
utilising the combined questionnaire and spirometry tool. Some selected examples are
provided:
In a longitudinal follow-up study of manganese mine workers, Boojar
and Goodarzi (2002) using a respiratory questionnaire and spirometry
combination, observed a significant decrement in lung function in 145
manganese mine workers compared to a control population at
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approximately 4 years and 7 years after baseline measurements made
at the time of employment.
Vogelzang, van der Gulden, Folgering, and van Schayck (1998)
investigated lung function in swine-confinement workers. This
longitudinal study utilised a combined questionnaire and spirometry
approach and identified “a longitudinal decline in forced expiratory
volume in one second (FEV1) which was significantly associated with
the use of quaternary ammonia compounds as disinfectants and the
automated dry feeding system” (Vogelzang, van der Gulden,
Folgering, & van Schayck, 1998, p. 1048). The study also
demonstrated the value of the combined use of spirometry and a
respiratory questionnaire. In this study the questionnaire alone would
not have distinguished respiratory symptoms because a significant
number of pig farmers ceased to report their chronic symptoms.
However, there was a definite decrement in FEV1 in the cohort of 171
pig farmers over a 3-year period.
From referrals to family physicians, Mpofu, Lockinger, Bidwell, and
McDuffie (2002) observed decrements in lung function in a study of
farmers and their families. This research was predominantly about the
evaluation of a respiratory health program for Saskatchewan farmers
and their families in Canada. There are a myriad of exposures likely to
affect the respiratory health of farmers and their families. This was
addressed to a limited degree in this study through a qualitative
analysis of exposure to dust or fumes/chemicals. The protocol for this
program included spirometry and a respiratory questionnaire as well
as a health promotional component. Thus the study analysed the
association of pulmonary function and self reported respiratory
symptoms. The main outcome of the study was that “Individuals with
these symptoms or who smoked were more likely than individuals
without these symptoms and non-smokers to have lower than
predicted overall pulmonary function” (Mpofu, Lockinger, Bidwell, &
McDuffie, 2002, p. 1069).
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In a case study pulmonary effects were evident in workers exposed to
incinerator fly ash, when using the combined questionnaire and
spirometry tool (Boswell & McCunney, 1995).
In a longitudinal study conducted by Motley, Smart, and Valero.
(1956. p. 265) there was poor correlation with lung function testing
compared with radiography for diatomaceous earth workers. In the
initial study a decrement in lung function was detected in
compensation claimants employed in the diatomaceous earth industry.
In the repeat study combining radiography, spirometry and a
questionnaire, the decrement in lung function was not convincing,
although “the best lung function was present in those with no
radiographic abnormality”.
In longitudinal studies of cannabis smokers, Taylor et al., (2002)
found a relationship between cannabis smoking and a decline in lung
function. Taylor et al., (2002, p. 1060) concluded “Longitudinal
observations over 8 years in young adults revealed a dose-dependent
relationship between cumulative cannabis consumption and decline in
FEV1/VC”. “Dispelling the myth that cannabis smoking is relatively
safe” Taylor followed this up in a Position Statement of the Thoracic
Society of Australia and New Zealand stating that adverse respiratory
effects of smoking cannabis are similar to those of smoking tobacco…
(Taylor, & Hall, 2003, p. 310).
Case studies on the lung function of 30 fire-eaters prior to and after
their daily activity showed a mild decrease of airflows, which partially
correlated with number of years spent in this activity. After a 1-day
fire-eating activity, further airflow limitation increased. Up to 63% of
subjects tested improved some spirometric airflow value after
salbutamol inhalation (Cabrera et al., 2003).
A cross-sectional and cohort of respiratory morbidity study of longterm and former asbestos workers with substantial exposure in Brazil
(Algranti et al., 2000) and a case control study of asbestos workers in
China (Wang, Yano, Wang & Christiani, 2001) demonstrated
decreased pulmonary function, pleura thickening due to asbestos
exposure.
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In a cross-sectional study there were subtle decreases in pulmonary
function detected for a sub-population of tea packers from the start to
the end of a shift (Abramson et al., 2001).
In a cross sectional study Musk et al. (2000) concluded that no major
adverse respiratory health effects were associated with work in the
Australian alumina refineries studied.
In a cross-sectional cross-shift study Raulf-Heimsoth et al. (2007)
found significant cross-shift declines in lung function due to the
irritative effects of fumes and aerosols of bitumen.
Peters, Demers, Sehmer, Karlen, and Kennedy (2010) studied the lung
function of a cohort of 281 trades’ apprentices and concluded that
“early signs of respiratory trouble among young adults….are related
to the development of asthma and other respiratory illness later in
life” (Peters, Demers, Sehmer, Karlen, & Kennedy, 2010, p. 242).
The Queensland Mines Inspectorate determined that some Queensland
quarries had problems with the control of silica dust exposure, did not
have adequate exposure assessments, or health surveillance in place
for their workers. Hedges, Reed, Mulley, Djukic and Tiernan (2010)
therefore conducted a cross-sectional study of Respirable Crystalline
Silica (RCS) exposure in quarries in Queensland and determined loss
of lung function using an EasyOne® spirometer. They recommended
that frequent lung function measurements be made to detect
developing health problems due to cumulative exposures of RCS.
2.11.5 Reliability and validity of spirometry
In the past some authors have questioned the practical value of pulmonary function
tests for early changes for disorders such as chronic obstructive lung disease (West,
1987). The Health and Welfare Canada Task Force on Health Surveillance (Canadian
Public Health Association, 1986, p. 106) went even further to infer that “Spirometry is
indicated [only useful] to monitor established disease or for diagnostic purposes in
symptomatic individuals”. Rossignol, Seguin, and DeGuire (1996, p. 1259) found in a
Regional Public Health Program, “there were too many sources of variation for
spirometry to fulfil the objective of early detection of pulmonary function decline
related to exposure to welding fumes. Sobaszek et al. (1998, p. 223) reported for
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stainless steel welders that “there was no influence of the specific welding process on
the spirographic parameters, but a decrease in spirographic values after 25 years of
welding activity was evident”. Ulvestad et al. (2001) did not detect a decrement in lung
function, whereas they detected airways changes using acoustic rhinometry and detected
increased levels of exhaled nitrous oxide, associated with underground construction
workers exposed to dusts and gases. Nield and Burmas (n.d., Conclusion) representing
DMP, Western Australia, Resources Safety, concluded that the “use of screening
spirometry in healthy populations is questionable based on costs versus benefits to
stakeholders, thus MineHealth methodology is currently under review”. In their
presentation Nield and Burmas discussed the phenomenon of an improved lung function
response for individuals at a repeat/second test, which is considered to be due to an
individual’s ability to do better on a repeat spirometry test as they have mastered and
improved their technique, hence adding a form of confounding although such
intersession changes are likely to be considered measurement noise (Nield and Burmas,
n.d.).
For lung function tests to be valid they must be performed rigorously to the
American Thoracic Society and European Respiratory Society (ATS/ERS) criteria
(American Thoracic Society, 1995; Miller et al., 2005) and the Thoracic Society of
Australia and New Zealand (in Pierce and Johns, 1996). If these protocols are followed
rigorously, issues such as reproducibility, reliability, sensitivity, specificity and quality
control are addressed (Doherty, 2008). In so doing, the American College of
Occupational and Environmental Medicine (2010, p. 1) state that, “Spirometry, the most
frequently performed pulmonary function test (PFT) is the cornerstone of occupational
respiratory evaluation programs”. Spirometry has been recommended as an instrument
for health surveillance to help determine and prevent occupational respiratory disease
(Hankinson & Wagner, 1993; Harber & Lockey, 1993; American College of
Occupational and Environmental Medicine, 2000; Townsend, 2005).
Finkelstein et al. (1993, p. 532) determine that measurement in the home using
portable spirometers was valid when compared with the ‘gold standard’ of the
pulmonary function laboratory; and Johns and Pierce (2003, p.1) promote spirometry as
“the single most broadly useful non-invasive test for ventilatory lung function”. With
interpretation, spirometry is capable of detecting a range of decrements in pulmonary
function such as:
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inflammation of the respiratory system;
airway narrowing;
obstruction;
bronchospasm;
COPD;
asthma;
emphysema.
Johns and Pierce (2003) conclude that spirometry is particularly useful for
differentiating between obstructive and restrictive lung function problems.
2.11.6 Obstructive ventilatory defect
Obstructive ventilatory defects disturb air flow in and out of the lungs as
pathophysiological effects reduce the diameter of the airways causing airflow resistance
(usually from an inflammatory response) bronchospasm, oedema and increased mucus
secretions (NIOSH, 2003). Obstructive disorders include asthma, bronchitis, and
emphysema although the pathophysiological mechanisms are considered to be different
(Johns Hopkins School of Medicine's Interactive Respiratory Physiology, 1995).
Obstructive ventilatory defects are associated with a reduction in FEV1 in relation to
FVC and other measures. This results in a low FEV1/FVC%. The lower limit of normal
is considered to be approximately 70—75% (Pierce & Johns, 1996). Beach (2002)
asserts that FEV1/FVC% values < 50% imply severe obstruction.
According to Pellegrino et al. (2005, p. 953):
An obstructive ventilatory defect is described as a disproportionate
reduction of maximal airflow from the lung in relation to the maximal
volume (i.e., VC) that can be displaced from the lung. It implies airway
narrowing during exhalation and is defined by a reduced FEV1/VC ratio
below the 5th percentile of the predicted value.
2.11.7 Restrictive ventilatory defect
Johns Hopkins School of Medicine's Interactive Respiratory Physiology (1995, p. 1)
describes restrictive disorders as a “pulmonary deficit, such as pulmonary fibrosis
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(abnormally stiff, non-compliant lungs)”. However, it may also be caused by
“respiratory muscle weakness, paralysis, and deformity or rigidity of the chest wall”.
Such a restrictive pattern, according to Beach (2002, p. 1012) gives a “proportionate
reduction in both FVC and FEV1 and by reduction of TLC, VC, and other static lung
volumes. Whilst Pellegrino et al. (2005, p. 955) defines a restrictive ventilatory defect
as:
characterised by a reduction in total lung capacity (TLC) below the 5th
percentile of the predicted value, and a normal FEV1/VC. The presence of a
restrictive ventilatory defect may be suspected when VC is reduced, the
FEV1/VC is increased (85–90%) and the flow-volume curve shows a
convex pattern.
Spirometry therefore is considered very useful as a screening test of general
respiratory health, to establish as early as possible whether or not there is respiratory
impairment.
2.11.8 Assessing early respiratory changes due to occupational exposures
Spirometry has been proven to be particularly useful in assessing early respiratory
changes due to occupational exposures. Several researchers have demonstrated
decrements in lung function, using spirometry, due to exposure to low-level irritants
(Balmes, 2002; Dube, Puruckherr, Byrd, & Roy, 2002; El-Zein, Malo, Infante-Rivard,
& Gautrin, 2003) and mixtures of low-level respiratory irritants (Barnhart, 1994;
Kremer et al., 1994; Mustajbegovic et al., 2000; Ryon & Rom, 1998; Hendrick et al.,
1996; White, 1996; Harber et al., 2007).
Pasker et al. (1997) demonstrated very subtle pulmonary function changes due to
exposures to zinc oxide containing fumes. They demonstrated that it was possible to
detect a subclinical response. This study, of 57 workers exposed to zinc oxide
containing dust and 55 controls, not only used the questionnaire/spirometry approach
but also compared the forced oscillation technique (FOT) with spirometry. The study
investigated pre-shift and post-shift pulmonary function. The outcome was the
observation of a subtle decrease in pulmonary function, observed during night shift with
both spirometry and confirmed by FOT. Abramson et al. (2001) also detected an acrossshift decline in FEV1 among a cohort of tea packers. In a study of occupational asthma,
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Anees, Moore and Burge (2010) conclude that sufferers of the condition demonstrated a
rapid decline in FEV1 due to exposure; however, after removal from exposure, the effect
reverses and there is an improvement (a step-up) after which it then continues to decline
at a slower rate similar to individuals with normal lung function.
Johns and Pierce (2003, p. 92) state that:
Spirometry has the capacity to detect airway dysfunction long before
symptoms develop, bringing the opportunity to remove harmful exposures
before disability develops or becomes severe. These factors render
spirometry a critically useful investigation in the detection, management and
prevention of respiratory disease.
It has therefore been demonstrated conclusively in multiple studies, among a range of
populations and occupational exposure groups that, when used in conjunction with a
respiratory questionnaire, spirometry testing provides a powerful diagnostic tool with
adequate sensitivity and specificity (Post et al., 1998; Bellia et al., 2003, Hankinson
1986; Utell, Frampton, & Morrow, 1993; Hankinson, Kinsley, & Wagner, 1996; White,
1996; Luo, Hsu, Hsieh, Wong, & Chang, 1998; Sobaszek et al., 1998; Baur & Latza,
2005 Algranti et al., 2000; Musk et al., 2000; Abramson et al., 2001; Kern et al., 2001;
Meijer, Grobbee, & Heederik, 2001; Yu et al., 2001; Boojar & Goodarzi , 2002; Mpofu
et al., 2002; Murphy , Harrison, & Beach, 2002; Cabrera et al., 2003; Chénard et al.,
2007; Doherty, 2008; Forbes et al., 2009).
2.11.9 Reliability, validity, accuracy and precision of the EasyOne spirometer
After determining that spirometry in conjunction with a respiratory questionnaire
provides a powerful diagnostic tool with adequate sensitivity and specificity, a review
of spirometer’s, in particular the EasyOne spirometer, was conducted to ensure its
reliability, validity, accuracy and precision. According to Blanc et al. (2009, p. 8) The
EasyOne™ spirometer (ndd Medical Technologies, Zurich) “has been recognised for its
reliability, accuracy, and durability and has been widely used in epidemiologic
research”. Evaluations of the stability and accuracy of this specific spirometer have
been conducted by Walters, Wood-Baker, Walls and Johns (2006), Coates (n.d.),
Australian and New Zealand Horizon Scanning Network (2007), Skloot, Edwards, and
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Enright (2010), Gallo, Crapo and Jensen (2009), and Barr et al. (2008), justifying its use
in clinical, occupational and research settings.
2.11.10 Alternatives to spirometry
Alternative techniques to determine early effects of workplace exposures on the
respiratory system were reviewed prior to the commencement of this study. In general it
was found that such newer methods were yet unproven and access to most was
restricted to specialised respiratory laboratories due to the need for using specialised
equipment or invasive techniques such as lung biopsy, bronchoalveolar lavage, and
induced sputum (Balbi et al., 2007).
A new development in the area of respiratory screening is fractional exhaled nitric
oxide (FeNO) which functions as a “noninvasive, simple, well-tolerated, and
reproducible marker of airway inflammation” (del Giudice et al., 2004, p. 759).
Measurement of exhaled nitric oxide (eNO) in a breath test can be conducted to
determine airway inflammation particularly asthma (Taylor, Pijnenburg, Smith, &
Jongste, 2006). Portable instruments are becoming available making it more practical
under field conditions. However, the main limitation of this technique is the need for
predicted normal FeNO reference values for normal populations which are yet to be
established (Balbi et al., 2007; Taylor, Pijnenburg, Smith and Jongste, 2006).
Biomarkers are potential candidates for further research, though few have been
validated. Those showing most promise are sputum neutrophils, IL-8, serum tumour
necrosis factor, and C-reactive protein (Tzortzaki, Lambiri, Valchaki & Siafakas, 2007;
Kony et al., 2004).

2.12 Summary
This chapter has outlined that air quality can affect lung function and cause
respiratory disease (Ostrowski & Barud, 2006). It presented a critical review of existing
literature regarding the aetiology and impact of occupational lung disease, the possible
effects of low levels of mixed exposures, the confounding factors, and the health
surveillance techniques to enable detection of such effects.
The impact of respiratory disease is a major problem worldwide, and the total
lifetime cost considerable, but it can be avoided (Takahashi et al., 1998). Several
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countries have respiratory disease surveillance systems and some specifically for
occupational respiratory disease. The surveillance system in Australia is based primarily
on workers compensation claims (Safe Work Australia, 2011c). Hence there is a long
latency period and these data reflect historical workplace exposures and not emerging
new issues. Safe Work Australia (2011c) has targeted occupational respiratory diseases
as one of eight identified occupational diseases for priority action. Prior to this the
senate inquiry (Parliament of Australia Senate Committee, 2006) into workplace harm
related to toxic dust and emerging technologies highlighted the need for robust
surveillance systems and early accurate diagnosis of loss of lung function. During the
inquiry process the Australian and New Zealand Society of Respiratory Science
recommended regular lung function testing to detect early signs of respiratory
symptoms. Therefore, a top-down, bottom-up approach, employing an Australian
occupational respiratory health surveillance system to define the problem of workrelated respiratory disease so that specific workplace hazards can be targeted, plus a
risk-based approach at the local workplace level to identify, evaluate and control
respiratory hazards, is advocated.
This review determined that pulmonary function tests, providing they are performed
rigorously to the ATS/ERS criteria (Miller et al., 2005) detect airway dysfunction long
before symptoms develop (Johns & Pierce, 2003). Several researchers have been able to
detect such early respiratory changes. These studies have shown that pulmonary
function tests used in conjunction with respiratory questionnaires, conducted by
competent practitioners using reliable and accurate equipment, provide valid data. Thus
such an approach was adopted with the aim of determining whether exposure to a
specific spectrum of gases, aerosols and particulates present in each work area at the
Murrin Murrin Operation presented a respiratory health risk.
The main gaps in this research area appear to be that the extent to which occupational
respiratory disease contributes to work-related illness in Australia remains effectively
unknown. The extent to which occupational factors such as dust, gases, vapours, smoke
and fumes that contribute to respiratory disease also remains unknown. Very little is
known about mixed exposures, particularly in the mining industry, and research is also
needed into early detection of respiratory diseases in order to prevent them.
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This literature review, along with an overview of the Murrin Murrin mine and
processing plant processes (Chapter 3) plus the review of the respiratory health effects
presented by the hazardous substances associated with these processes (Chapter 4)
helped formulate the research methodology. This culminated in a longitudinal study of
the Occupational Respiratory Health Surveillance at Minara Resources, Murrin Murrin
Mine Site
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3. OVERVIEW OF THE MURRIN MURRIN OPERATION
PROCESS
3.1 Introduction
The Minara Resources’ Murrin Murrin Operation (Figure 3.1) is situated
approximately 60 kilometres equidistant from Laverton and Leonora, on the edge of the
Gibson Desert in Western Australia, in the north east Goldfields region (Figure 3.2).
The Murrin Murrin Operation mines lateritic ore in the locality, which is refined in to
nickel and cobalt at the processing plant.

Figure 3.1 Murrin Murrin Operation
(Source: Minara Resources, 2004a)

The project, commissioned in May 1999 by Anaconda Nickel Ltd, is a joint venture
between Murrin Murrin Holdings Pty Ltd, a wholly owned subsidiary of Minara
Resources Ltd (60%) and Glenmurrin Pty Ltd, a wholly owned subsidiary of Glencore
International AG (40%) (SPG Media Limited, 2007; Mining-Technology.Com., n.d.).
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The source of the laterite mineralisation, with its concentration of nickel and cobalt
in silicate minerals, was formed as a consequence of extensive weathering of olivinerich ultramafic rocks (Gaudin, Decarreau, Noack, & Grauby, 2005; Dalvi, Bacon, &
Osborne, 2004). The laterite ore, with its soft clay-like nature, lies close to the ground
surface and is therefore relatively easily mined using open cut mining techniques.
The ore is processed at the Murrin Murrin processing plant based on the Sherritt
International high pressure acid leach technology (Figure 3.3) (Taylor, 2000; WellesleyWood, 2002). In brief, the Murrin Murrin process prepares the ore prior to subjecting it
to sulphuric acid in high-temperature, high-pressure autoclave vessels to extract nickel
and cobalt from lateritic ores (Ozberka, Jankolab, Vecchiarellic, & Krysad, 1995;
Mining-Technology.Com., n.d.). Following this, the solid wastes are thickened and
neutralised, and the liquid containing nickel and cobalt is separated by counter current
decantation (CCD). The nickel and cobalt are precipitated out as mixed sulphides, and
eventually refined using solvent extraction and a range of chemical reagents.
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Figure 3.2 Location of the Murrin Murrin Operation
(Source: Minara Resources, 2004a)
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Figure 3.3 Murrin Murrin Process Flowsheet
(Source: Taylor, 2000)
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3.2 Murrin Murrin Technology
3.2.1 Mining
The soft lateritic ore is mined by the open pit method as they are near-surface
deposits. The pits are shallow because there is usually only an overburden of
approximately 10 metres overlying the ore body of about 20 metres in depth. The areas
of the ore body which have nickel-cobalt mineralisation occur in horizontal zones,
which allows for bulk mining methods to be employed. Excavators are used to extract
the ore which is transported by haul trucks to the Run of Mine (ROM) ore stockpile,
ready to be processed. The simplified geology showing the horizontal zones of the ore
body are pictured below.
Ferruginous Zone (FZ): The top laterite unit contains mainly iron
oxides as waste. A small amount of Ni/Co mineralisation appears at
the bottom of this zone.
Smectite Zone (SM): The middle laterite unit contains mainly
smectite clays and medium to high grade Ni/Co mineralisation
throughout the zone.
Saprolite Zone (SAP): The deepest laterite unit contains mainly
primary smectite clays and basic minerals referred to as serpentine
minerals. The grade of Ni/Co mineralisation varies significantly in the
saprolite zone.

Figure 3.4 Simplified Geology
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(Source: Minara Resources, 2004a)

The three ore types, shown in Figure 3.4, are mined separately and blended to
achieve the optimum nickel concentration as an ore feed from the ROM stockpiles.
The activities required to mine the ore include:
overburden removal by excavators and trucks;
some blasting of occasional areas of cap rock;
ore extraction by excavators and trucks.
The mining operations include the removal of ore from the ground and its
transportation to the ROM pad. The ROM pad is the first point of contact with the
processing plant.

3.3 Processing Plant
3.3.1 Ore leach
The purpose of the ore preparation facility is to crush the ore to a specified size and
add water to produce a slurry feed at the required density prior to feeding it into the acid
leach circuit. To achieve this, ore is blended from finger piles on the ROM pad by frontend loader. The ore is then loaded into a low-capacity ore bin which feeds a sizer
(similar to a crusher). The MMD Group of Companies’ sizer is the first point of size
reduction and breaks up any large lumps of ore, crushing the ore to less than 150mm.
3.3.1.1 Slurrying mill
The sizer product is conveyed to the slurrying or semi-autogenous grinding (SAG)
mill (Figure 3.5). The ore is prepared in the slurrying mill where it is ground to produce
a slurry feed of the correct particle size and density to feed the pressure acid leach
circuit, with a final slurry density of between 39% and 42% solids by weight, adjusted
by adding water.
As the slurry flows from the mill onto a vibrating screen the larger particles are
caught and then removed by conveyor to a low-grade stockpile. The slurry filtered
through the screen (approximately 1.7% nickel and 0.07% cobalt) is pumped to a slurry
storage tank which is eventually pumped into the acid leach section.
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Figure 3.5 Ore from Stockpile to the Slurry Mill
(Source: Minara Resources, 2004a)

3.3.1.2 High pressure acid leaching
The high pressure acid leach circuit is shown in Figure 3.6. The high pressure
leaching is carried out in titanium-lined autoclaves in which the ore slurry is mixed with
concentrated sulphuric acid. There are four autoclaves which operate at 255°C and 42
bar pressure (4200KPa) to dissolve out the nickel (Ni) and cobalt (Co) as soluble
sulphate salts.
The sulphuric acid for the leaching process is generated by the acid plant located
close by on the site. The leaching reaction extracts nearly all of the nickel and cobalt
into the solution (liquid) phase with the solids as residue. The nickel and cobalt is
released from the ore leaving residual waste material, which is returned to the slurry ore
preparation before ultimately being pumped out, after being neutralised, into the tailings
dam.
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Figure 3.6 High Pressure Acid Leach Circuit
(Source: Minara Resources, 2004a)

3.3.1.3 Counter current decantation (CCD) circuit
The slurry from the pressure acid leach circuit is fed into the CCD circuit. The CCD
circuit has seven 50-metre thickeners where the slurry is separated into two streams, the
residue solids, and soluble nickel and cobalt solution.
The CCD and solution neutralisation circuits are outlined in the simplified flow
diagram, (Figure 3.7).
Each CCD thickener mixes, washes and separates the solid residue waste from the
sought-after nickel and cobalt solution. The residue solids from the last thickener are
pumped to the tailings neutralisation circuit prior to disposal into a tailings dam, whilst
the nickel and cobalt sulphate solution from the first wash thickener gravitates to the
solution neutralisation circuit.
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Figure 3.7 Counter Current Decantation (CCD) Circuit
(Source: Minara Resources, 2004a)

3.3.1.4 Solution neutralisation circuit
The pressure leach solution (which contains dissolved nickel and cobalt sulphates)
passes into the neutralisation circuit to neutralise the pH which is less than pH 1.0. The
solution has to be neutralised prior to the recovery of nickel and cobalt in the refinery
because of its highly corrosive nature. Calcrete (a limestone-like mineral mined locally)
is added to neutralise the acid. The solution then enters the mixed sulphides
precipitation circuit, where hydrogen sulphide gas is introduced which converts the
solution into a mixed nickel/cobalt sulphide.
Initially, hydrogen sulphide is mixed with the nickel/cobalt solution from the first
wash thickener, to change the iron chemistry from ferric to ferrous iron which interferes
with the process, in order to maximise the nickel and cobalt extraction in the following
neutralisation stage.
As it flows through a series of four agitated tanks, the free sulphuric acid is
neutralised by the addition of calcrete slurry, which forms a gypsum precipitate. The
leachate is separated from the gypsum precipitate, filtered, and directed to the sulphide
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precipitation area for further treatment. The thickened solids underflow from the
thickener is returned to the CCD circuit to extract the residual nickel and cobalt liquor.
Eventually, the gypsum is removed, along with the solid residue, for disposal into the
tailings dam.
3.3.1.5 Mixed sulphide precipitation and slurry neutralisation circuits
Figure 3.8 below represents diagrammatically the mixed sulphide precipitation and
tailings slurry neutralisation circuits.

Figure 3.8 Mixed Sulphide Precipitation and Slurry Neutralisation Circuits
(Source: Minara Resources, 2004a)
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3.3.1.6 Mixed sulphide precipitation
The aim of the mixed sulphide precipitation circuit is to transform the nickel and
cobalt sulphate solution into solid mixed sulphides. In order to precipitate out the mixed
sulphides, hydrogen sulphide is introduced into the neutralised solution in four agitated
tank stages. The hydrogen sulphide reacts with the nickel and cobalt sulphate in solution
and forms a mixed (nickel and cobalt) sulphide solid precipitate. The precipitation
reaction also removes unwanted manganese and iron.
The solid precipitate is washed and then it thickens as it settles out of the solution.
The washed precipitate, still a slurry, is next filtered and then stored before being
refined on site or sold directly on the open market.
The wash (barren solution) is pumped to either:
the last wash thickener in the CCD circuit (approximately 40% of
flow); or
an evaporation pond (approximately 60% of flow).
3.3.1.7 Slurry neutralisation circuit
The pH of the waste solids in the underflow from the CCD circuit is neutralised
using calcrete slurry introduced into agitated tanks in the slurry neutralisation circuit.
The solids are disposed of in the tailings dam, and the liquid flows to the evaporation
pond.
3.3.2 Refinery
In the refinery, the mixed sulphides are refined to produce high-grade nickel and
cobalt powder which is then bonded into briquettes ready for purchase. This process is
carried out in numerous steps which are briefly outlined below and outlined in the
simplified flow diagram, Figure 3.9.
3.3.2.1 Mixed sulphide leaching
The mixed sulphide precipitate is taken from storage or directly from ore leach to the
refinery. Here the mixed sulphides are firstly washed and slurried with water to undergo
pressure oxygen leach in a stainless steel autoclave, to manufacture a 99.5% nickel and
cobalt solution.
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3.3.2.2 Iron/copper removal
Unwanted iron is removed after leaching by adding ammonia to the nickel/cobalt.
Zinc sulphide is also added to remove unwanted copper. Inevitably, during this process
a small amount (+9%) of nickel is removed in the precipitate along with the iron. The
solution is therefore thickened and filtered to remove the iron cake, and the residual
nickel in solution is returned back into the process through the ore leach feed.
3.3.2.3 Zinc/copper removal
The nickel solution, now free of iron, is reacted with anhydrous ammonia and
hydrogen sulphide which removes residual copper and zinc. Again the copper and zinc
form a precipitate, which is thickened and filtered out of solution as copper/zinc cake
waste.
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Figure 3.9 Refinery: Simplified Flow Diagram
(Source: Minara Resources, 2004a)

3.3.2.4 Solvent extraction
Cobalt is removed from the Ni/Co solution by using Cyanex 272, a solvent
extractant. For this process, a large volume of solution is mixed with a smaller volume
of organic extractant which separates out the cobalt in the organic phase and the solvent
becomes loaded with cobalt. Cobalt is then removed from the solvent with sulphuric
acid and the barren solvent is recycled through the cobalt hydrogen reduction circuit.
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Once the cobalt has been removed from the Ni/Co solution and separated from the
nickel, it is then concentrated into high-grade cobalt solution (raffinate) and pumped to
the cobalt hydrogen reduction circuit.
3.3.2.5 Hydrogen reduction of nickel and cobalt solutions
The nickel raffinate and cobalt raffinate are now separated and processed separately
by autoclave in two streams. Anhydrous ammonia and ammonium sulphate is added to
both the high-strength pure cobalt and nickel solutions prior to hydrogen reduction. The
nickel ammonium sulphate liquor is preheated prior to entering the nickel hydrogen
reduction autoclaves. Hydrogen gas is introduced under pressure and the nickel is
precipitated as a powder. The powder is recovered from the bulk liquor via a flash tank,
pan filter and dryer. The cobalt raffinate is similarly processed and precipitated as a
powder.
3.3.2.6 Briquetting and sintering
Next, the powdered nickel and cobalt from each reduction autoclave circuit is
compressed into pillow-shaped lumps (briquettes) which are then sintered in a furnace
at approximately 1120 degrees C prior to it being transported and sold to smelters
around the world. There are separate briquetting and sintering furnaces for nickel and
cobalt products.
3.3.3 Utilities
The Utilities Department or Utility Areas provide services such as electricity, gas,
water, and chemicals used in ore leach and the refinery. These services are required to
process and treat the crude ore and refine it into pure nickel and cobalt metal products.
These consumable products, which assist the processing areas to extract the nickel and
cobalt, are provided by a number of dedicated utility plants.
The plant layout of all facilities at the Murrin Murrin Operation is illustrated in the
diagram (Figure 3.10). It shows the relationship between the processing and utility
areas. A brief description of each of the utility areas is provided below.
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3.3.3.1 Sulphuric acid plant
The Murrin Murrin sulphuric acid plant is one of the biggest in the world with 4400
M tons per day acid production. The acid is used in the HPAL processing circuit to
leach the nickel and cobalt out of the ore in the ore leach area. The acid plant also
provides most of the heat required to drive the power and steam generation plant.
3.3.3.2 Power and steam generation plant
Power is essential for every area of the plant, and steam is used in the ore leach and
refining processes.
To meet the site’s energy requirements there are 3 x 55 tonnes per hour steam
boilers. The steam is used to drive 2 x 28-megawatt steam turbines. Additional power
may also be generated by the 20-megawatt gas turbine, and there are six standby diesel
generators and associated mechanical and electrical equipment. Energy is also recycled
from the ore leach autoclave flash system to preheat feed slurry into the HPAL circuit.
3.3.3.3 Water supply and water treatment plant
The water supply, critical to the Murrin Murrin processing plant, is sourced from the
borefields some 50 km away. Approximately one third of the raw water is treated by
reverse osmosis in the water treatment plant to produce high-quality demineralised and
potable water for use in the sensitive processing stages and for human consumption
respectively. The remaining two thirds are used directly as process water.
3.3.3.4 Natural gas supply
Natural gas supplied by the Goldfields Gas Transmission Pipeline is used in many
areas of the plant for various burners and as a heating source in the hydrogen sulphide
plant. Natural gas is also the source or primary feed for the hydrogen plant.
3.3.3.5 Hydrogen plant
Hydrogen is produced in the hydrogen plant on site by reacting natural gas with
steam. Hydrogen is used in the nickel and cobalt autoclave circuits (furnaces) to reduce
the powdered nickel and cobalt into briquettes and to sinter them, and for the production
of hydrogen sulphide gas produced in the hydrogen sulphide plant.
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3.3.3.6 Hydrogen sulphide plant
Hydrogen sulphide (H2S) is used in the process prior to and in the refinery, to
produce a mixed nickel and cobalt solid sulphide product. H2S is produced in the
hydrogen sulphide plant by reacting hydrogen and sulphur together. The sulphur is
pumped from the sulphur pit located in the sulphuric acid plant.
3.3.3.7 Sulphur stockpile
Sulphur is trucked in from external suppliers and stored as a large stockpile close to
the acid plant and hydrogen sulphide plant. Approximately 500,000 tonnes/year of
sulphur is used to produce sulphuric acid in the acid plant and hydrogen sulphide gas in
the hydrogen sulphide plant.
3.3.3.8 Oxygen/nitrogen (air separation) plant
The air separation plant produces oxygen and nitrogen from the air of the local
atmosphere. The plant uses a double column distillation/ pressure swing absorption
system to produce oxygen and nitrogen which are used in various stages of the
nickel/cobalt processing.
Nitrogen is used predominantly for the pressure acid leach autoclaves and for
purging in the hydrogen and hydrogen sulphide plants, whilst oxygen is used mainly in
the refinery area for the mixed sulphide pressure leach.
3.3.3.9 Air supply
Instrument air supply for the entire plant is provided from the air separation plant.
Air compressors are installed in most areas of the operation to provide high and low
pressure plant and dried instrument air.
3.3.3.10 Ammonia supply and storage
Ammonia is primarily utilised in the refinery in the hydrogen reduction areas.
Ammonia is transported to the site and stored in pressurised bullet storage tanks to be
distributed to the processing plant.
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3.3.3.11 Ammonium sulphate
Ammonium sulphate is used as a catalyst for the refining of nickel and cobalt in the
hydrogen reduction process. The excess of ammonium sulphate from the process is
reclaimed in a three-stage evaporation process and sold predominantly for fertiliser.
3.3.4 Calcrete plant
Calcrete (similar to limestone) is a strong alkaline substance used in the solution
neutralisation circuit to neutralise the acidic HPAL product prior to introducing it into
the refinery.
Calcrete is mined locally at the calcrete pit approximately 50 km from the processing
plant. This is transported to the calcrete plant close to the processing plant where it is
made into fine slurry for use in the neutralisation circuit.
3.3.5 Final products
The following products are produced by the Murrin Murrin processing plant:
nickel;
cobalt;
ammonium sulphate.
3.3.6 Packaging and transport of products
The final nickel product is packed in two tonne bulka bags or metal drums according
to customer requirements, whilst cobalt is packaged in metal drums. These products are
transported by road to the local port to be shipped to customers worldwide. Ammonium
sulphate fertiliser is trucked to the close-by Malcolm Siding rail head for transportation
to be sold locally.
In 2003/04, the Murrin Murrin Operation mined and processed 2.8 million tonnes per
annum of laterite ore to produce about 27,950 tonnes per annum of nickel and 1,982
tonnes per annum of cobalt briquettes (Minara, 2004b). In 2005, 28,240 tonnes of nickel
and 1,750 tonnes of cobalt were produced (Minara, 2005) and in 2006 approximately
32,000 tonnes of nickel were produced (Johnson, 2007).
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3.3.7 The Processing plant layout at the Murrin Murrin Operation

Figure 3.10 Processing Plant Layout
(Source: Minara Resources, 2004a)

The area names for each of the above area numbers are outlined in Table 3.1.
Table 3.1 Processing Plant Areas

10/1

Earthworks Contractors Area (during 43
construction phase)

Power Plant

10/2

Temporary Batch
construction phase)

Raw Water Dam

10/3

Construction Water Dam (during 44/2
construction phase)

Plant

(during 44/1
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Process Water Dam

31

Slurrying (SAG)
Preparation

Mill

-

Ore 44/3

Water Treatment Plant

32

High Pressure Acid Leaching

44/4

Caustic Storage

33

CCD Containment

45

Natural Gas Supply

33/2

CCD Containment Pond

46

Air Supply System

34

Neutralisation and Thickening

47

Fuel Farm

35

Ni/Co Precipitation and Barren Liquor 48
Neutralisation

Main Pipe Racks

36

Sulphide Grinding, Dissolution and 51
Impurity Removal

Hydrogen Sulphide Plant

37

Hydrogen Reduction

52

Ammonia Storage

38

Cobalt Reduction

54

Hydrogen Plant

39

Solvent Extraction

55

Oxygen Plant

41/1

Acid Plant

59

Ammonium Sulphate Plant

41/2

Acid Storage

71/1

Administration Office Area

41/3

Sulphur Storage

71/2

Workshop/Warehouse Area

42

Calcrete Plant

77

Tailings Dam
(Source: Minara Resources, 2004a)

Colloquially the areas are referred to by the area numbers above with a suffix of two
further zeros. For example:
ore leach – 3100, 3200, 3300, 3400 (thirty-one hundred, thirty-two
hundred, etc.);
refinery – 3500, 3600, 3700, 3800, 3900;
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utilities – 4100, 4300, 4400;
BOC plant (air supply system) – 4600;
calcrete plant – 4200.

3.4 Conclusion
The overview of the Murrin Murrin Operation process provides an indication of the
chemical hazards that workers potentially face on a daily basis. The area names and
numbers provide an indication of the processes occurring in that area and the chemical
hazards associated with the tasks conducted in those work areas. The overview of the
Murrin Murrin Operation process formed part of the exposure assessment strategy from
which the health effects presented by the hazardous substances associated with the
mining and process plant were determined. This is the subject of the next chapter.
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4. THE RESPIRATORY HEALTH EFFECTS PRESENTED BY
THE HAZARDOUS SUBSTANCES ASSOCIATED WITH THE

MINING AND PROCESS PLANT
4.1 Introduction
In the precursor occupational hygiene studies prior to this study at the Murrin Murrin
Operation a number of respiratory hazards associated with the complex chemical
extraction process of nickel and cobalt were identified and the following exposure
groups were identified as areas of concern:
ore leach, area 3100, operators – inhalable dust, cleaning under the
sizer;
refinery, area 3700, furnace operators – nickel dust;
refinery, area 3700, packaging operators – cobalt dust;
refinery, area 3800, operators – cobalt dust.
(Oosthuizen & Cross, 2004; Wing, 2005; Wing & Oosthuizen, 2007).
Workers in these areas were required to wear P2 respiratory protection that complied
with AS 1716 and was used in accordance with AS1715 as the work areas had been
previously demarcated as potentially hazardous.
Wing (2005, p. 120) discussed the potential for exposure to sulphuric acid mist (from
the acid plant in area 4100) “if operators were working near a leak in the process”.
Similarly, there is the potential for exposure to sulphuric acid mist at start-up of the acid
plant especially during a cold start-up. These exposure scenarios are avoidable as they
are “visible to the naked eye, so the identification of leaks prior to an exposure is
possible” (Wing, 2005).
Wing (2005) also identified other possible exposures, mainly associated with
problems with the process, including process failures or abnormal operating conditions.
The areas highlighted included:
hydrogen sulphide in utilities, Areas 4100/5100;
ore leach, Areas 3400 and 3510;
inhalable dust, hosing out the sizer tunnel – in ore leach, area 3100;
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nickel and cobalt dust – “working with dry production materials” – in
the refinery, area 3500;
“Exposure to high short term concentrations of Ammonia” – refinery,
area 5900.
Wing (2005) did not include the mining operations and calcrete pit in the scope of his
work.
Additional historical data from the Occupational Hygiene Database (Minara
Resources, 2005b) was accessed to identify worker exposures that may have occurred
prior to the study conducted by Wing. Most of these exposures were one-off incidents,
usually under abnormal working conditions, and, as far as can be established,
appropriate personal protective equipment was worn in each situation. These included:
calcrete dust exposure in the calcrete pit and plant;
intersection of chrysotile and anthophyllite asbestos in mining ore
bodies and during exploration drilling;
respirable dust levels for the mining blast crew and drillers;
respirable dust levels during preparation of ore samples in the
laboratory;
grinding and welding in confined space;
ammonia in the refinery sampling and analysis huts;
reclaiming nickel powder/waste when loading nickel bags into hopper
of the screening unit in the refinery;
loading nickel powder into bins/hoppers in the refinery;
welding fume during maintenance activities.
At the time when these data were collected it was noted that the majority of the dirty
work was being done by contractors, particularly during scheduled shutdowns. These
transient workers were not included in routine occupational hygiene monitoring and
their exposure profiles could not be established, particularly since they worked at
multiple mine sites. Regular contractors based on site were included in this study, these
included calcrete workers, and maintenance workers employed in the central works and
BIMS areas.
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4.2 The Specific Exposures Present in Each Work Area at the
Murrin Murrin Operation
The specific exposures present in each work area at the Murrin Murrin Operation
were determined to be as follows:
4.2.1 Mining
mineral dust;
general (red dirt) dust;
fibrous material (chrysotile and anthophyllite);
silica (from blast and drilling);
diesel emissions.
4.2.2 Ore leach
mineral dust;
sulphur dioxide/trioxide and sulphuric acid mist;
caustic soda;
hydrogen sulphide;
general (red dirt) dust.
4.2.3 Refinery
hydrogen sulphide;
hydrogen peroxide mist;
ammonia;
nickel dust;
cobalt dust;
mixed sulphides (nickel/cobalt sulphides);
organic solvent;
ammonium sulphate;
general (red dirt) dust.
4.2.4 Utilities
sulphur dioxide/trioxide and sulphuric acid mist;
sulphur dust;
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hydrogen sulphide;
diatomaceous earth;
lime dust;
caustic soda dust.
4.2.5 Calcrete plant and pit
calcrete dust;
diesel emissions.
(Oosthuizen & Cross, 2004).
The predominant route of exposure across the mining and processing operation was
considered to be inhalation, and the primary target organ the lung. This was determined
from the toxicological profile of each health hazard. A summary of the respiratory
health issues presented by each of these hazardous substances individually (a single
chemical) and the issues surrounding the toxicity of a combination of chemical agents
(chemical mixtures) is addressed below.

4.3 Respiratory Health Issues Presented by Each Hazardous
Substance
4.3.1 The inflammatory response
Insult due to any toxic agent will initiate an inflammatory response (Rote, 1998). The
extent of this response is dependent on the concentration, duration and frequency of
exposure of the toxic agent (Eaton & Gilbert, 2008). There is a continuum of effects: the
inflammatory response may resolve if the insult ceases, repair may occur with minimal
pathophysiological results (Teder et al., 2002) or it may result in permanent damage,
chronic injury, and possibly death.
4.3.2 Toxic effects of dusts and particulates
4.3.2.1 Dusts and particulates
Dust particle size is the major factor that dictates where particulates will be deposited
within the respiratory tract, and the area of deposition is a factor that influences the
eventual pathophysiological effect. The aerodynamic equivalent diameter (AED) is used
to predict where the particle will be deposited in the respiratory system (Kelly, 2002).
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Larger particles (greater than 10 μm) are generally deposited in the nares, particles in
the region of 10-5 μm are deposited in the large conducting airways, whilst those
between 0.5 and 5.0 μm are most likely to be deposited in the thoracic/bronchial region,
and particles of between 0.5 and 2.0 μm are more likely to be deposited in the alveoli
(World Health Organization, 1999; Witschi, Pinkerton, Van Winkle, & Last, 2008). The
convention is that particulate matter of 10μm or below (named PM10) will reach the
bronchi and lower regions of the respiratory tract, and that particulate matter of 2.5μm
or less (PM2.5) can penetrate deep into the respirable part of the lung, the alveoli (World
Health Organization, 1999). PM10 are the airborne particles with an aerodynamic
diameter smaller than 10 microns, and PM2.5 are airborne particles with an aerodynamic
diameter smaller than 2.5 microns.
Fibres as long as 200 μm and with a diameter of 3 μm are able to penetrate deep into
the lung (Winder & Stacey, 2004). The chemical nature of asbestos fibres renders them
relatively insoluble and therefore difficult to remove from the lung via its natural
defence mechanisms (Kelly, 2002).
The chemical properties of inhaled particulate matter has a significant effect on
pathophysiology which is dependent on the toxic nature of the particulate, its
concentration (level of exposure) and the duration of exposure (which, in combination,
equals the dose) (Kelly, 2002).
Dust inhalation may initiate pulmonary fibrosis which is dependent on the
physicochemical properties of the dust. Pneumoconiosis is the term used to describe
interstitial disease of the lung due to prolonged exposure from inhalation of significant
amounts of inorganic dust (Brichet, Desurmont, & Wallraet, 2002). A continuum of
effects – from reversible on termination of exposure, slight effects with little decrement
in lung function, to progressive massive fibrosis and the possibility of lung cancer – is
dependent on the physicochemical/toxic properties of the dust and the dose (Gee &
Mossman, 1995; Haspeter, Witschi, Pinkerton, Van Winkle, & Last, 2008).
There is strong evidence linking a significant decrease in lung function to long-term
excessive dust exposure (Parliament of Australia Senate Committee, 2006). Despite the
paucity of data in Australia on morbidity and mortality associated with toxic dust
exposure, this association has been well established internationally (Downs et al., 2007).
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Exposure to high levels of dust, irrespective of its physicochemical composition, will
affect lung function. The degree of toxicity and the severity of the effects on lung
function are dependent on the level of exposure and the physicochemical properties of
the dust. For example, dust exposure in young coal miners (Carta, Aru, Barbieri,
Avataneo, & Casula, 1996) and iron foundry workers (Gomes, Lloyd, Norman, &
Pahwa, 2001) increases the incidence of respiratory symptoms and decline of lung
function. Inhalable dust (PM10) exposure is a significant predictor of decreased lung
function (Downs et al., 2007).
4.3.2.2 Mineral dust and general (red dirt) dust
NIOSH (2001, p. 1) states that, “miners at noncoal surface mining operations are
often exposed to high levels of respirable dust”. The silica content of the respirable dust
is of major concern hence DMP (2010b, p. 1) require dust suppression where dust is
generated from operations that involve ground disturbance when using machinery, and
“along each open pit road and vehicle operating area, during dumping operations, at all
stockpile areas, stockpile stacking operations, stockpile tunnels and material reclaim
operations, and at all crushing and screening plant”.
Most of the dust from mining activities consists of coarse particles larger than 10 μm
in diameter most of which will be trapped in the nasal region and expelled from the
respiratory system (New South Wales Department of Health, 2007). However,
operations such as drilling, blasting, loading, unloading, and transporting can generate
sufficient respirable dust (Onder & Yigit, 2009) to warrant dust suppression controls,
regular dust monitoring, and health surveillance.
Dust storms are a seasonal event at the edge of the Gibson Desert where the Murrin
Murrin Operation is located. The main health concern associated with the red dirt dust
from the gravel roads and the surrounding bushland, is its potential to trigger respiratory
symptoms and exacerbate asthma. The New South Wales Department of Health (2003)
and the Health Department of Victoria (2010) both state that particles from dust storms
tend to be coarse and do not pose a serious health risk; and that they may worsen preexisting conditions such as asthma and emphysema.
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4.3.2.3 Fibrous material (chrysotile and anthophyllite)
In Western Australia, asbestiform minerals are found throughout the “greenstone
belts”, which host the state's major gold and nickel deposits (DMPR, n.d.). At the
Murrin Murrin mine site, chrysotile and anthophyllite has been intersected during
exploration drilling and identified in a few of the pits. Asbestos fibres are capable of
causing asbestosis, lung cancer and mesothelioma (International Agency for Research
on Cancer [IARC], 1998; Gibbons 2000; Winder & Stacey, 2004).
The risk of asbestos-related disease is dependent upon:
the concentration of respirable fibres in the air;
the length of time exposed;
the type of fibre present (amphibole asbestos or serpentine); and
the morphology of the fibres (fibre size and shape).
(DMPR, n.d., p. 5)
Asbestosis is a diffuse interstitial fibrosis of the lung parenchyma resulting from the
exposure and retention of a high concentration of asbestos fibres. The lung function
measured by spirometry in such cases presents as a restrictive ventilatory disorder (De
Vuyst & Gevenosis, 2002).
It was considered that the potential for exposure to asbestiform material would be
greatest during exploration drilling when asbestos is intersected. Asbestos has been
observed in the pit areas and upon delivery of ore to the mill. Despite this, air
monitoring has shown no significant risk to workers (Wing, 2005).
4.3.2.4 Silica
The mining industry has often been associated with silicosis (a pneumoconiosis)
caused by the silica content of dust which may cause massive fibrosis and lung cancer
(Haspeter et al., 2008; Winder & Stacey, 2004; IARC, 1986). Silicosis is considered to
be associated with occupations that have very high exposures to respirable silica dust.
On 1 January 2005 a revised national exposure standard of 0.1 mg/m3 (time-weighted
average [TWA], 8 hours) for quartz, cristobalite and tridymite came into effect
(Parliament of Australia Senate Committee, 2006).
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In Western Australia, particularly in open cut mining, the silica exposures are now
mostly well below the occupational exposure standard which is reflected by the Health
Surveillance Program for Mine Employees, Department of Industry and Resources,
WA, which has shown no significant decrement in lung function observed for this group
of WA mine workers over the past 5 years (Nield & Burmas, n.d.). The blast crew and
drillers are perhaps at the highest risk of dust and respirable silica exposure in the open
pit areas (Brichet, Desurmont & Wallaert, 2002) and the laboratory staff during
preparation of ore samples for laboratory analysis (Minara Resources, 2005b). The
potential for exposure to elevated levels of inhalable dust during operation of heavy
mining vehicles and during charging and blasting at the Murrin Murrin mine site was
identified (Minara Resources, 2005).
Exposure to silica dust has been associated with decreased lung function, and can be
a cause of fixed obstructive airway disease at doses below that which lung fibrosis
becomes clinically obvious (Parliament of Australia Senate Committee, 2006).
4.3.2.5 Calcrete dust
Calcrete, a limestone-like mineral mined in a local pit, is added to neutralise the acid
in the neutralisation circuit. Calcrete consists of calcium carbonate, magnesium
carbonate and silica. Although the silica content is often low, the exact proportion of
these components in calcrete varies from location to location (Chen, Lintern, & Roach,
2002).
Dust monitoring at the calcrete plant and calcrete pit has shown that levels of silica
were below the occupational exposure standard applicable at the time. However, the
exposure standard for silica was reduced in 2004 (NOHSC, 2004) as the previous
standards were not considered adequate for protecting workers from the risk of silicosis
and lung cancer (Rice et al, 2001; Safe Work Australia, 2010b).
There have been occasional excursions above the occupational exposure standard for
the respirable dust level, which were associated with the calcrete crushing circuit;
however, the crusher operators were required to wear respiratory protection (Minara
Resources, 2005b; Wing, 2005).
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4.3.2.6 Diatomaceous earth
Diatomaceous earth is an amorphous silica, derived essentially from the remains of
dead diatoms in marine sediments (Antonides, 1997; Harber, Dahlgren, Bunn, Lockey,
& Chase, 1998). It was used as a filtering agent in the acid plant area (Wing, 2005;
Minara Resources, 2001) but has since been substituted by perlite. Diatomaceous earth
is known to cause silicosis and lung cancer (Rice et al., 2001).
Regular dust monitoring in the acid plant area indicated that the levels of
diatomaceous earth dust have been well below the exposure standard (Minara
Resources, 2005b).
4.3.2.7 Sulphur dust
Sulphur is a non-metallic dust known to cause irritation and inflammation to the nose
and throat, and with long-term exposure it may cause chronic bronchitis (NIOSH,
2000). A large quantity of sulphur was stored as a large, open stockpile and used to
produce sulphuric acid in the acid plant and hydrogen sulphide gas in the hydrogen
sulphide plant. Operators unloading sulphur on delivery and loader operators removing
sulphur from the stockpile for the process were at most risk of exposure to sulphur dust;
however, respiratory protection was required in this area.
The sulphur stockpile was located at a safe distance from the main processing areas
due mainly to the potential fire risk and to prevent exposure to sulphur dust on windy
days. Eye and respiratory protection was mandatory in the vicinity of the sulphur
stockpile.
4.3.2.8 Lime dust
Hydrated lime was identified through a formal risk assessment process as a potential
health hazard in the utilities area 4100/5100, particularly for the operator and the
delivery driver who unloaded the lime. Lime has the potential to irritate the nose, throat
and respiratory system (International Program on Chemical Safety, 2001). However,
occupational hygiene monitoring showed levels to be below the occupational exposure
standard and were therefore deemed acceptable (Wing, 2005).
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4.3.2.9 Caustic soda
Inhalation of low levels of caustic soda (sodium hydroxide) as a dust, mist or aerosol
has the potential to cause irritation of the upper and lower respiratory system (Agency
for Toxic Substances and Disease Registry, 2002). High-level, short-term exposures of
sodium hydroxide via inhalation may be corrosive to the respiratory system and cause
oedema of the lung (obstructive lung disease) often with a delayed onset (International
Program on Chemical Safety, 2000; Hansen & Isager, 1991; Rubin, Bentur, & Bentur,
1992; California Office of Environmental Health Hazard Assessment, 1999). The risk
associated with caustic soda when tipping bags of the material into the process was
determined to be low through occupational monitoring (Wing, 2005).
4.3.2.10 Ammonium sulphate
Visible ammonium sulphate dust was generated during loading and unloading in the
ammonium sulphate shed. However, it did not exceed the occupational exposure levels
(Wing, 2005).
Ammonium sulphate dust is known to cause irritation of the respiratory tract and
impair respiratory function, especially in asthmatics (Scorecard Organisation, n.d.) and
the lung function in healthy adult volunteers was affected after a two- to four-hour
exposure to 1 mg/m3 (Organization for Economic Co-Operation and Development
Screening Information Data Sets, 2004)
4.3.3 Toxic effects of metals
4.3.3.1 Nickel dust
Certain species of nickel have been shown to be carcinogenic (IARC, 1990;
International Programme on Chemical Safety, 1991) and following the European Union
Risk Assessment (2008) conducted by the Danish Government, more stringent
occupational exposure standards for nickel and its compounds have been implemented
(Safe Work Australia, 2010b). The carcinogenicity appears to be uniquely associated
with occupational exposures during the smelting and refining of nickel (Nickel Institute,
2007). The Agency for Toxic Substances and Disease Registry (2005) state that:
The most serious harmful health effects from exposure to nickel, such as
chronic bronchitis, reduced lung function, and cancer of the lung and nasal
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sinus, have occurred in people who have breathed dust containing certain
nickel compounds while working in nickel refineries or nickel-processing
plants. (Agency for Toxic Substances and Disease Registry, 2005, p. 5)
To date, a number of epidemiological studies have established a link with nasal and
lung cancer at high exposures to a mixture of nickel compounds found during the
refining of sulphidic ores (Bates, 2008). Andersen, Berge, Engeland, and Norseth
(1996) identified the synergistic effect of smoking and nickel exposure in the causation
of lung and nasal cancer among nickel refinery workers. However, it has been argued
that such cancers have not been observed in the extraction and processing of lateritic
ore, which is the ore body mined and processed at the Murrin Murrin Operation (Doll,
1990; Goldberg et al., 1992).
Histologically, the early acute respiratory effect of inhalation of nickel dust is an
inflammatory response, with effects on the epithelial and endothelial cells and an influx
of alveolar macrophages (Klein & Costa, 2008). This may result in asthma, resolve if
the insult ceases, or this may lead to fibrosis, (Bates, 2008; Agency for Toxic
Substances and Disease Registry, 2005). In a study conducted by Cirla, Bernabeo,
Ottoboni, and Ratti (1985) a significant decrease in lung function (FEV1) was observed
with six out of the seven asthmatics exposed to 0.3 mg/m3 nickel sulphate for 30
minutes, whilst similar exposures to other metal salts did not affect lung function.
Safe Work Australia (2010b) Hazardous Substances Information System (HSIS)
defines nickel and compounds as hazardous. The current relevant occupational exposure
standards TWA (eight-hour, time-weighted average) exposure limit in the workplace for
nickel metal is 1mg/m3. Soluble inorganic and insoluble inorganic nickel compounds
have TWA’s of 0.1 and 0.2mg/m3 respectively (American Conference of Industrial
Hygienists, 2010)
On occasion, there have been exceedances of this standard at the Murrin Murrin
Operation, most notably for the refinery 3700 area furnace operators, as indicated in
precursor occupational hygiene studies conducted by Wing (2005) and Cross (2005).
However, respiratory protection is mandatory for workers in this area.
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4.3.3.2 Cobalt dust
The National Toxicology Programme concluded that there was clear evidence of
carcinogenic activity via inhalation in mice and rats exposed to cobalt dust (National
Toxicology Program, 1998; Bucher et al., 1999). IARC has determined that, with
chronic exposure, cobalt and cobalt compounds are possibly carcinogenic to humans
(IARC, 2006).
Acute inhalation effects of low doses of cobalt dust include respiratory irritation and
asthma. Occupational exposure to various forms of cobalt can cause bronchial asthma
(Swennen, Buchet, Stanescu, Lison, & Lauwerys, 1993; Linna et al., 2003) and effects
on lung function (Nemery, Casier, Roosels, Lahaye, & Demedts, 1992).
At higher doses, cobalt may cause a progressive interstitial fibrosis (Liu, Goyer, &
Waalkes, 2008). Respiratory symptoms may appear anywhere from a few months to
several years from exposure; symptoms may be reversible if removed from the dust
exposure, or there may be a delayed progression resulting in progressive interstitial
fibrosis (Mapel & Coultas, 2002).
Morgan (1995) describes three respiratory effects produced by exposure to cobalt as:
reversible airways obstruction, hypersensitive pneumonitis or alveolitis, and pulmonary
fibrosis. The fibrosis is said to be reversible if exposure to cobalt dust is terminated
early enough (Cugell, Morgan, Perkins, & Rubin, 1990). Swennen et al. (1993)
established a dose-effect relationship with decrements in forced expiratory volume in
one second/vital capacity (FEV1/FVC) and the levels of cobalt exposure. After
implementing effective exposure controls, a follow-up study was conducted after 13
years among the same workforce and cobalt exposure in this study was only influenced
negatively by smoking (Verougstraete, Mallants, Buchet, Swennen, & Lison, 2004).
The current Australian occupational exposure standard for cobalt metal dust is 0.05
mg/m3 for an eight-hour workday and 40-hour work week (Safe Work Australia,
2010b).
Monitoring results from regular occupational hygiene studies within the refinery at
the Murrrin Murrin Operation showed that certain operator groups, particularly area
3800 (cobalt area) were being exposed to concentrations of cobalt exceeding this
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exposure standard. However, it was common practice to wear respiratory protection
whilst working in these areas (Oosthuizen & Cross, 2004; Wing, 2005).
4.3.3.3 Mixed sulphides (nickel/cobalt sulphides)
As the exact speciation of the nickel and cobalt compounds of the mixed sulphides in
the process in area 3500 of the refinery remain essentially unknown, it is considered that
the mixed sulphides material could pose a possible health risk. It has been argued that
water-soluble nickel presents the greatest carcinogenic risk (Dunnick et al., 1995;
Grimsrud, Berge, Haldorsen, & Andersen, 2002) although Heller, Thornhill and Conrad
(2009) and Bates (2008) refute this. Cobalt sulphate is carcinogenic in rodents via
inhalation (Bucher et al., 1999). Because such chemical species are likely to be in the
mixed sulphides process material, the precautionary principle has been adopted. When
there is a process stoppage and material has to be emptied into a bunded area, the
product is maintained wet and the area hosed down to prevent any airborne dust until it
can be reintroduced into the process. Full protective clothing is used in such instances.
Dust levels in this area were invariably well below the occupational exposure standard
due to the wetting procedure (Wing, 2005; Cross, 2005).
4.3.4 Toxic effect of gases, solvents and vapours
4.3.4.1 Gases/fumes from blasting
According to the Department of Minerals and Energy (1999) during the mining
process workers could potentially be exposed to fumes from blasting. Such fumes
consist of carbon monoxide, sulphur dioxide and oxides of nitrogen which, in high
enough concentrations, may pose health effects, particularly for the respiratory system
(Mainiero, Harris, & Rowland, 2007). The risk in open pit mining is considered
negligible as the blasters move away from the area before detonation and fumes
generally disperse with the wind prior to workers entering the blasting zone.
4.3.4.2 Diesel emissions
Diesel exhaust fumes may cause respiratory disorders such as bronchitis,
emphysema, and lung cancer. According to NIOSH (2010) diesel exhaust is a potential
human carcinogen, presumed to be due mainly to polycyclic aromatic hydrocarbons
(Kelly, 2002).
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Diesel fumes contain a cocktail of hazardous substances including carbon monoxide,
nitrogen oxides, benzene, polycyclic aromatic hydrocarbons, sulphur dioxides, and
particulate matter. Short-term exposure of healthy human subjects to diesel exhaust at
high concentrations of diesel fumes induces airway inflammatory responses and affects
lung function (Rudell et al., 1996). Moreover decreased lung function has been
observed among garage workers, and bus drivers and conductors for a state transport
corporation (Chattopadhyay, Alam, & Roychowdhury, 2003).
Various studies have shown associations between increased respiratory symptoms,
including asthma, exacerbation of asthma, and exposure to diesel fume (Kagawa, 2002;
Stenfors et al., 2004; Gluck, Schutz, & Gebbers, 2003; Riedl & Diaz-Sanchez, 2005).
Respiratory effects – for example, goblet cell hyperplasia – were observed in a group of
Swiss custom officers who worked clearing diesel trucks for 40 hours a week over 5
years, whilst a control group of office workers experienced no such effect.
Diesel exhaust fumes are considered to be a significant hazard in underground
mining. The New South Wales Mines Safety Performance Branch (Driscoll, 2007)
considers diesel exhaust fumes a high priority exposure needing to be urgently
addressed.
The hazard of diesel fumes has been determined to be less significant for open pit
mining as exhaust fumes are not restricted to a confined-space environment and dilution
and dispersion of the emissions occurs readily. Nonetheless, drivers and mechanics of
diesel plant and machinery may be exposed to diesel fumes during their daily routine.
At the time of the study there was no established occupational exposure standard or
firmly established monitoring protocol for diesel fumes, therefore no atmospheric
monitoring was conducted (Adeeb, 2010).
4.3.4.3 Ammonia
Some people are more sensitive than others to ammonia. The odour threshold for
ammonia is reported to be between 5 and 50 ppm (parts per million) and upper
respiratory irritation occurs at between 30 and 50 ppm (World Health Organization,
1986). Upon inhalation, highly water-soluble gases such as ammonia may cause
immediate upper respiratory tract irritation (Schwartz, 2002). However, it has been
reported that there is a human physiological response and adaption to ammonia
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(Ferguson, Koch, Webster, & Gould, 1977). Ferguson et al. reported that workers could
be acclimatised to 100 ppm with occasional excursions to 200 ppm and that after
acclimatisation; exposures to ammonia at up to 100 ppm produced no discernable health
effects. Despite this, others have reported an intense irritation to the eyes, nose, and
throat that occurs at 100 ppm (Agency for Toxic Substances and Disease Registry, n.d.)
and that ammonia may also cause chemical bronchitis, oedema, and cough often with
blood-stained sputum (Tranter, 2004).
When exposure to ammonia is high or prolonged the odour is no longer detected by
the sense of smell (olfactory fatigue) which creates a high health risk. At extremely high
doses, greater than the immediately dangerous to life and health (IDLH) standard of 300
ppm (NIOSH , 1996a) death from asphyxiation is possible (Ross, Seaton, & Morgan,
1995).
Chronic irritation of the respiratory tract, chronic cough, asthma, and lung fibrosis
are the result of long-term repeated exposure to ammonia (Agency for Toxic Substances
and Disease Registry, n.d.). Decreases in lung function have been reported for fertiliser
workers exposed to ammonia (Ali, Ahmed, Ballal, & Albar, 2001; Rahman, Bråtveit, &
Moen, 2007). In contrast, Sundblad et al., (2007) reported ammonia levels at 25 ppm for
three hours did not significantly affect lung function. Ammonia was considered one of
the main components of a mixed exposure that caused a decrease in FEV1 among
livestock farmers. The mixed exposure consisted of ammonia, hydrogen sulphide, and
inorganic dust (Eduard, Pearce, & Douwes, 2009). Similarly, Preller, Heederik, Boleij,
Vogelzang, and Tielen (1995) and Reynolds et al., (1996) have suggest a causal link
between lung function decrements and exposure to a mixture of endotoxins and
ammonia among swine production workers.
4.3.4.4 Hydrogen sulphide
The odour threshold of hydrogen sulphide is approximately 0.5 parts per billion
(ppb) (Agency for Toxic Substances and Disease Registry, 2009). Hence, hydrogen
sulphide can be detected at very low levels, much lower than levels acknowledged to
cause health effects (Government of Western Australia, Department of Health, 2009)
because the odour of hydrogen sulphide may be detected at such low levels, there was a
perception on site that the emissions in the processing plant were likely to cause ill
health. However, the lowest concentration for adverse health effects is at least 500 times
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the odour detection limit (Government of Western Australia, Department of Health,
2009).
Hydrogen sulphide is a mucous membrane irritant, causing skin, eye and respiratory
irritation. At low concentrations (≤50 ppm) it can quickly cause irritation of the nose,
throat, and lower respiratory tract (Agency for Toxic Substances and Disease Registry,
2009). Richardson (1995) demonstrated a significant FEV1/FVC decrease among sewer
workers who were exposed to hydrogen sulphide as compared to a non-exposed cohort.
Airborne hydrogen sulphide levels above 100 ppm are considered immediately
dangerous to life and health (IDLH) (NIOSH, 1996b) via inhalation, causing
asphyxiation and possible unconsciousness. Delayed pulmonary effects such as oedema
and pneumonia may occur up to 72 hours after exposure (Nemery, 2002). At high
concentrations, inhalation of a small volume may lead to immediate loss of
consciousness, respiratory paralysis, and death (Agency for Toxic Substances and
Disease Registry, 2009).
4.3.4.5 Sulphur dioxide, sulphur trioxide and sulphuric acid mist
Sulphur dioxide, sulphur trioxide and acid mist are direct-acting respiratory irritants
that cause mild bronchoconstriction (Costa, 2008) and affect the mucus membranes of
the eyes nose and upper respiratory system. All have a pungent odour which can
overwhelm the respiratory system at high concentrations. The odour threshold for
sulphur dioxide is between 0.5 and 0.8 ppm (Tranter, 2004). There is a continuum of
effects from slight irritation at low exposure levels, to death from acute over-exposure,
and chronic respiratory disease due to long-term exposures (NIOSH, n.d.).
Bronchoconstriction has been demonstrated in exercising asymptomatic asthmatics at
sulphur dioxide levels as low as 1 ppm (Horstman, Seal, Folinsbee, Ives, & Roger,
1988). Although not as sensitive as asthmatics, males aged 55 or more are more
sensitive to the effects of sulphur dioxide than adolescents (Rondinelli, Koenig, &
Marshall, 1987). Co-exposures of low levels of sulphur dioxide with other air pollutants
have been shown to cause additive (Kagawa, 1983) and synergistic effects, as well as
decrements in lung function (Kleinman et al., 1981). One of the aims of this study was
to determine whether there may be an additive or synergistic effect of exposure to low
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concentrations of air contaminants at the Murrin Murrin mine site. Conversely, it has
been suggested that there is possible adaption to mixed pollutant exposures (Bell, 1977).
Winder (2004, p. 408) quotes the exposure-response to oxides of sulphur as:
1-5 ppm – mild bronchoconstriction;
5 ppm – alteration in lung function; and
5-10 ppm – some cases of bronchospasm.
IARC (1992, 5.5 Evaluation) has determined that “there is sufficient evidence that
occupational exposure to strong inorganic acid mists containing sulphuric acid is
carcinogenic to humans”. Epidemiological studies have shown lung cancer and
laryngeal cancer to be a risk in specific industries where there is exposure to sulphuric
acid aerosols, although often in these studies there are co-exposures or other
confounders such as cigarette smoking (National Industrial Chemicals Notification
Assessment Scheme, 2003). The National Toxicology Program (2000) stated that
sulphuric acid most often exists as a mist because of its low volatility and high affinity
for water, and that proximity to the source of the acid mist is the main determinant of
exposure to workers.
Proximity to the source is what Wing (2005, p. 119) was alluding to in relation to the
Murrin Murrin processing plant. He stated that:
All measured exposures to sulphuric acid mist were found to be below the
limit of detection, and therefore well below the exposure standard .… It can
be inferred that the exposures of [the area] 4100/5100 [sulphuric acid plant
and hydrogen sulphide plant respectively] operators to sulphuric acid mist
are acceptable under normal production conditions.
Process leaks may occur, and emissions are inevitable during start-up of the acid
plant (Dames & Moore, 1997). However, under these circumstances the area is
restricted to maintenance workers wearing the appropriate personal protective
equipment.
4.3.4.6 Hydrogen peroxide mist
Hydrogen peroxide mist may be generated during unloading of vehicles or when
hydrogen peroxide is introduced into the refinery process. Hydrogen peroxide is highly
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corrosive and if inhaled may cause severe irritation and inflammation of the respiratory
tract. Therefore full personal protective clothing was worn on delivery of consignments
of hydrogen peroxide by the supplier (Plog, 2002; Degussa, 2011).
4.3.4.7 Organic solvent
Organic solvents (volatile organic compounds [VOCs]) via inhalation have been
shown to cause respiratory symptoms (Koren, Graham, & Devlin, 1992). All organic
solvents have the ability to irritate the respiratory tract to some degree (Queensland
Health, 2002) and may affect the nose, throat and lungs and cause asthma-like
symptoms (New Zealand Department of Labour, 2009). Jaakkola and Jaakkola (2002, p.
246) state that the commonly used measure of total VOC “is an ambiguous concept”
and therefore may be misleading in determining adverse effects. Similarly (Rumchev,
Spickett, Bulsara, Phillips, & Stick, 2004) state that measuring total VOC’s has the
potential to underestimate the risk. Hence it is better to monitor for the individual
components of the solvent where possible as the respiratory effects are dependent on the
type of solvent. Asthmatics appear to be more susceptible to effects of solvents on the
airways. Often the solvent per se may not affect the lung; however, it may be a vehicle
for other chemicals dissolved within it that causes effects on the respiratory system
(Nemery, 2002). An organic solvent (“Shellsol 2046”, White Spirits) was used in the
process of extraction of nickel and cobalt in area 3900 of the refinery. Personal
monitoring for volatile organic compounds (Total VOCs) and individual constituents
was conducted in this area. Total VOCs were in the range of <0.1 to 20 (occupational
exposure standard 175 ppm, Safe Work Australia, 2011b) and extremely small
concentrations of toluene and naphthalene were also detected. Wing (2005, p. 110)
concluded that “these concentrations were found to be so far below the exposure
standards as to be insignificant”.
4.3.4.8 Welding fume
Welding occurred regularly during maintenance activities across the Murrin Murrin
Operation. Welding in confined spaces was highlighted as a hazard. Welding fume is a
mixture of particles and gases, the constituents of which depend on the materials being
welded, materials in the filler, electric parameters and shield gases, and surface
contaminants. The acute effect of welding fume is considered to be irritation of nasal
passages, throat and lungs (McMillan, 2002).
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Inhalation of welding fumes has been shown to cause bronchitis and pneumonitis and
the severity of symptoms appears to be dependent on the process or metals used.
Occupational asthma is more prevalent among welders than the general working
population and exposure to welding fume has resulted in short-term changes in
pulmonary function. Obstructive changes were observed more frequently among older,
smoking welders than controls; however, a restrictive pattern was observed more
frequently among non-smoking welders. Significant decrements in certain pulmonary
function parameters have been observed in some studies (Liss, 1996). Smoking appears
to potentiate the effects from welding fume (Occupational Safety and Health
Administration [OSHA], n.d.)
Studies of the long-term effects of welding fume indicate that lung cancer among
welders is 30 to 40 % greater than among the general population; however, other coexposures have also been implicated (NOHSC, 1990). However, IARC (1990)
concluded that there is inadequate evidence for the carcinogenicity of welding fumes
and gases in animals and limited evidence in humans, as there were confounding factors
such as smoking and concomitant asbestos exposure.

4.4 Effects of Co-Exposures (Mixtures of Hazardous
Substances) on the Respiratory System
Occupational hygiene monitoring at the Murrin Murrin Operation determined that
exposure to single hazardous substances were invariably well below the occupational
exposure standards (Oosthuizen & Cross, 2004; Wing, 2005). The concern of
employees that a ‘chemical cocktail’ from the mining activities and the refinery process
could result in adverse health effects was a major driver for this study.
Exposures to mixtures of hazardous substances have been shown to be more harmful
than single substance exposures. In reality, occupational exposures are usually to low
doses of a complex range of chemicals (Interdepartmental Group on Health Risks from
Chemicals, (2009). Exposure may be concurrent or sequential, and their effects may be
additive, antagonistic, potentiated or even synergistic (Zeliger, 2008).
It was recognised through a review of the toxicity of the majority of the occupational
hygiene hazards at Murrin Murrin that most of the substances have the potential to
affect the respiratory system and the main target organ is the lung (Hendrick, 2002). It is
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thus possible that additive, antagonistic, potentiated or even synergistic biological
effects could occur due to exposure to these combinations of atmospheric contaminants
(Zeliger, 2008). Furthermore, chemical interactions of substances in the process or when
released to the atmosphere could occur and secondary particles may be produced by
intermediate reactions of gases and particulate matter in the atmosphere from gaseous
emissions (World Health Organization, 2000). Some of the emissions at Murrin Murrin
included:
sulphur dioxide from the sulphuric acid plant and hydrogen sulphide
circuit flares;
oxides of nitrogen from the steam boilers and sintering plants;
carbon dioxide from the neutralisation circuits, power production and
hydrogen plant;
carbon dioxide from the hydrogen plant;
particulate emissions from the mining activities, stockpiles,
conveyors, exposed areas and vehicular movement;
process steam; and
increased sulphur dioxide emissions during acid plant start-up.
(Dames & Moore, 1997)
It has also been recognised that lifestyle factors, particularly cigarette smoking
(International Programme on Chemical Safety, 1999) may have an additive or
synergistic effect with other agents particularly on the respiratory system. Such
examples include:
asbestos and smoking (Leigh, Berry, de Klerk, & Henderson, 1996);
cobalt and smoking (Verougstraete, Mallants, Buchet, Swennen, &
Lison, 2004);
nickel and smoking (Heller, Thornhill & Conrad, 2009).
Like many other researchers, Mustajbegovic et al. (2000, p. 439) noted that “in a
population of workers exposed to low levels of pollutants respiratory symptoms were
primarily associated with smoking”. Hence cigarette smoking has not only been shown
to exacerbate respiratory symptoms, diseases, and disorders, but has camouflaged such
symptoms, and conversely has led to occupational exposures being wrongly blamed for
respiratory illness.
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Human variability in susceptibility and sensitivity to toxic chemicals may also
complicate the overall response to these exposures (Hattis, Erdreich, & Ballew, 1987).

4.5 Conclusion
Excessive exposures above the occupational exposure standards of NOHSC: 3008
(NOHSC, 1995b) and NOHSC: 1003 (NOHSC, 1995a) (Safe Work Australia 2010a) of
all the aforementioned gases and dusts are known to cause a range of respiratory
symptoms including:
decrease in lung function;
Asthma;
upper respiratory tract symptoms;
lower respiratory tract symptoms, and ultimately;
chronic pulmonary diseases, and
nasal or pulmonary cancer.
(Morgan & Seaton, 1995; Hendrick et al., 2002).
Exposures to any of these hazardous substances singly, or in combination, have the
potential to cause significant health issues. However, at the generally low levels
identified during the occupational hygiene monitoring, it is unlikely that any serious
untoward effects would occur. It is considered that health effects at the cellular level of
low-level exposure of each of these hazardous substances would be reversible,
providing a threshold level is not exceeded, although this remains contentious for
carcinogens (Stacey, 2004). The question of what these hazardous substances, in
combination at low concentrations, do requires investigation. In the industrial situation,
employees may be exposed to chemical mixtures at low concentrations (Carpenter,
Arcaro, & Spink, 2002). There is evidence of occupational respiratory diseases from
chronic low-level exposures to irritants below their occupational exposure standards
(Balmes, 2002; Mustajbegovic et al., 2000).
This current study provides a direct respiratory health assessment of the low-level
chemical mixtures that the employees in the various work areas were exposed to over
their length of service at the Murrin Murrin Operation. The main aim was to determine
whether there was any discernable effect on the respiratory system, and, if so, whether
further intervention, on top of the control systems already in place, may be required.
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The Senate Inquiry into Workplace Exposure to Toxic Dust highlighted the fact that
in Australia, “we do not have research into early detection” (Parliament of Australia,
2004, p. 43) and there is a “need for health surveillance of employees exposed to toxic
dust” and that “There is no point waiting until exposure has occurred and deleterious
changes have occurred” (Parliament of Australia Senate Committee, 2006, p. 44). This
study was based on this very sentiment. The methodology for early detection of
respiratory health effects at Minara Resources, Murrin Murrin Mine Site is provided in
the next chapter.
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5. RESEARCH METHODOLOGY
This chapter describes the methods and procedures used to conduct this study.

5.1 Introduction
The main purpose of this study was to conduct respiratory health surveillance of the
Murrin Murrin workforce to detect possible adverse respiratory health effects at an early
stage, in order to prevent potential long-term occupational respiratory disease. This
meant evaluating whether working at the Murrin Murrin Operation, or areas within the
Operation, affected the respiratory health of mine and process workers.
To do this, an initial study was conducted using a questionnaire to determine the
respiratory health of each member of the Murrin Murrin workforce, followed by a lung
function test. These data were then compared with a local control group. The lung
function of each individual, in the study and control groups, was also compared with
their predicted normal lung function values (Zapletal et al, 1977). This was followed up
by a repeat study of a sample (72) of the initial study group members approximately two
years later.
The study took place at the Murrin Murrin Operation between 17 February 2004 and
21 June 2006. The protocols for the methodology used in this study were derived from
the most current references available in 2004.

5.2 Application to Undertake Research Involving Human
Subjects
The research proposal was submitted and accepted by the Edith Cowan University
Human Research Ethics Committee. The confidentiality of the questionnaires and
spirometry data was guaranteed by maintaining records for a minimum of five years in
locked filing cabinets, and codifying the data for statistical analysis. The written consent
of all employees participating in the study was obtained prior to commencement of the
study.
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5.3 Study Group
5.3.1 Inclusion criteria
The study group consisted of all Murrin Murrin Operation mine and process workers.
For a population of 420 with a confidence interval of .99, the sample size required was
410, therefore the entire population was studied. Only two refused to participate
therefore the final study group was 418 (99.5%).
5.3.2 Exclusion criteria
Excluded from the study were any contract workers on short-term contracts such as
shut-down workers. Those temporarily occupying full-time positions were included.

5.4 Control Groups
5.4.1 Catering staff
A local group consisting of 40 catering staff who resided at the accommodation camp
approximately 8 km from the mine site constituted the control group. Only a few
members of the control group rarely, if ever, visited the mine site or processing plant.
These few were limited to those transporting employees to and from site and were on
site for a brief period away from the process areas. This control group was chosen for its
close proximity to the Murrin Murrrin Operation with the aim of eliminating any
location/environmental/climatic/geographical variables. They were chosen primarily for
their absence of exposure to hazardous substances.
An occupational hygiene survey identified pool chlorine as the only hazardous
substance at the accommodation camp. However, the controls were considered
adequate. The cleaning agents used were selected as they were non-hazardous. Both the
study group and control group worked a 12-hour shift; however, their work periods
(swings) varied.
5.4.2 Predicted normal values
To remove some of this variability, lung function data were also compared to predicted
normal values extracted from a European reference population of normal lung function,
who were non-smokers and free from respiratory disease (Zapletal, Paul, & Samánek,
1977). These data were computed into the spirometer readings by the supplier
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(NicheMedical, Leederville, WA). The manufacturers of the spirometer considered this
reference population the best reference population for an Australian population.
Predicted normal values were used to effectively remove confounding factors such has
height, weight (BMI) and gender differences.

5.5 Study Design: Initial Study
5.5.1 Comparison of the respiratory symptoms and lung function of the Murrin
Murrin study group with a control group.
Data derived through respiratory questionnaire and spirometry for the entire
workforce (418 study group members) were compared with data from a control group of
(40) catering staff residing close to the Murrin Murrin Operation.
5.5.2 Descriptive statistics of the study group compared with the control group
The parameters from the respiratory questionnaire for the study group were
compared with the control group, and descriptive statistics for respiratory symptoms,
smoking history and asthma status were determined.
5.5.3 Prevalence of lung disorders
The prevalence of lung disorders for the study group and control group were
calculated by dividing the number of persons with respiratory disorders by the total
number of individuals for that group and expressed as a percentage.
5.5.4 Linear regression analysis
The lung function parameters FEV1 and FVC, corrected for age, gender and height,
were compared using linear regression analysis with both the control group and the
predicted normal values (Zapletal et al., 1977). The linear model of height, plotted
against the lung function indices FEV1 and FVC (Cotes, 1993) was employed to
visualise the relationship between the study group, their predicted normal values
(Zapletal et al., 1977) and the control group data. A series of scatter plots with
regression lines (IBM® SPSS® PASW Statistics 18) were produced with sequential
removal of the confounding factors in order to observe their effect on lung function.
Regression analysis enabled the sequential removal of confounding factors, to
determine the goodness of fit (R2) value, and the Pearson’s correlation coefficient (r).
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5.5.5 Comparison of lung function with predicted normal values
The lung function of both the study group and the control group was compared with
their predicted normal values extracted from a reference population of 173 subjects with
normal lung function, who were non-smokers and free from respiratory disease
(Zapletal, Paul, & Samánek, 1977). This reference population was considered the most
appropriate reference population for an Australian population and was computed into
the spirometer readings by the supplier (NicheMedical, Leederville, WA).
Comparison with the predicted normal values removes the issue of confounding for
factors such as age, gender, height and weight.
5.5.6 Work area/department
The lung function data for populations from each work area/department were
analysed to determine if there were any statistically significant effects on lung function
due to working in any specific work area. Both the production and the maintenance
workers in each area/department were included in the initial and repeat study.
A dependent (paired samples) t-test was conducted to compare the lung function
parameters (FEV1 and FVC) for the never-smoker sub-group with their equivalent
predicted normal values (Zapletal et al, 2007) for individuals in each work area.

5.6 Study Design: Repeat Study
5.6.1 Longitudinal study of lung function
Any changes in respiratory symptoms since the initial questionnaire were requested
and noted.
Repeat spirometry measurements were conducted to establish rates of change in lung
function over time, to provide an identifiable picture of lung function of the repeat study
group. The advantage of utilising a longitudinal study is that it enables observations to
be made on the same individuals to focus on changes occurring within subjects and to
make population extrapolations that are not as prone to between subject variation (Yee
& Niemeier, 1996).
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Therefore repeat lung function tests were conducted on a sample of 72 of the original
418 members of the study group (i.e. 17%), approximately two years after the initial
study. As the attrition rate was 51%, the 72 employees from the remaining 213 study
population represented 34%.

The time interval from initial spirometry test to the

follow-up ranged from 173 to 845 days.
The change in lung function over time from the initial study to the repeat study was
determined for the 72 employees. The mean change, range of change and overall mean
change per year in lung function parameters (FEV1 and FVC) was calculated. These
calculations were made with the sequential removal of confounding factors (smoking,
asthma and pre-existing respiratory disorders).
A dependent t-test was conducted to determine whether there was any significant
difference from the initial lung function tests to the repeat tests.
5.6.2 Length of service at the Murrin Murrrin Operation
A disadvantage of longitudinal studies is the loss of study group members (or
attrition, 51% occurred during this investigation). Therefore an addition statistical
analysis of the effect of length of service (or period of employment) at the Murrin
Murrin Operation on lung function was conducted for the original 418 members of the
study group. The length of service for the 418 study group members ranged from one
month to six years.
A multivariate analysis (MANOVA) was conducted to determine whether there was
a significant difference in lung function with length of service.

5.7 Pre-Swing and Post-Swing Lung Function in a Cohort of
Refinery Workers
Lung function tests for a cohort of refinery workers were conducted as they arrived
for work on site prior to commencing work in the refinery, and on completion of their
work period on site before returning home for their rest break. This was done in order to
detect if there were any statistically significant decrements in lung function over a work
period (colloquially known as a swing).
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A dependent t-test was used to determine whether there was a significant difference
for the pre-swing lung function when compared with the post-swing lung function of
this group of refinery workers.

5.8 Study Instruments
5.8.1 Respiratory questionnaire
The prevalence of respiratory symptoms in the study and control groups was
determined using the Government of Western Australia, Mining and Petroleum
Resources (2004) respiratory questionnaire component of their health assessment form
(modified British Medical Research Council questionnaire, 1986) (Appendix A). This
was an internationally accepted standardised respiratory questionnaire.
The respiratory questionnaire was administered to each individual of the study and
control groups prior to lung function testing by a competent approved person, approved
by Resources Safety to carry out MineHealth Assessments on completion of
compulsory training in spirometry (i.e., lung function testing) to standards required by
Resources Safety and WorkCover WA. Data regarding each individual’s work history,
respiratory symptoms, smoking status and history, and asthma status was collected.
5.8.2 Measurement of lung function
5.8.2.1 Equipment
A portable handheld spirometer (EasyOne Model 2001 diagnostic spirometer, ndd
Medizintechnik AG, Zurich) was used to determine various lung function parameters
most notably forced expiratory volume in the first second (FEV1) and forced vital
capacity (FVC). These data were computed automatically by the spirometer and were
also expressed as predicted values (Zapletal et al., 1977).
5.8.2.2 Technique
Prior to commencing spirometry, it was necessary to measure accurately each
participant’s height (measured without shoes) and weight. These data were entered into
the instrument along with date of birth, ethnicity, gender, smoker status, and asthma
status.
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To gain the best possible lung function measurements it was necessary to explain and
demonstrate the test procedure and coach each participant during the procedure. To gain
optimum measurement of lung function the subjects were standing during the
procedure. All subjects were warned of possible dizziness due to the procedure and all
elected to stand, although precautions were taken for the possibility of a subject
fainting.
As a noseclip is not mandatory for forced expiratory maneuvers, no nose clip was
worn by any subject, although it is often recommended to prevent air escaping via the
nose at the end of the manoeuvre. However, this did not pose a problem in any of the
subjects (Spirxpert, n.d.; Lange, Mulholland, & Kreider, 2009). The participants were
observed to ensure maximal effort was expended and a true result obtained, in addition
to any liquid crystal display (LCD) message on the instrument (ndd Medizintechnik
AG, 2001) which indicates such an event. The participants progressed through the series
of lung function tests with a minimum of three manoeuvres until repeatability was
obtained. Any suboptimal efforts were excluded from the study in accordance with the
manufacturer’s EasyGuide (ndd Medizintechnik AG, 2002, and the ATS/ERS
guidelines (ATS, 1995; Miller, 2005; Johns & Pierce, 2003).
Records of all lung function data were maintained on the DMP respiratory health
assessment form as a backup to the computerised spirometer data. Confidentiality of
these documents was maintained by securing them in locked filing cabinets. The
computer records were password protected and codified so that individuals were not
identifiable.
5.8.2.3 Calibration and quality control
The spirometer accuracy was checked regularly during each batch of testing by a
lung function specialist using a certified 3.00 litre syringe, despite the fact that the
EasyOne spirometer maintains its calibration during routine use, has an in-built
calibration system, and does not require daily calibration as specified in international
spirometry guidelines (Walters, Wood-Baker, Walls, & Johns, 2006; Perez-Padilla et
al., 2006).
No deterioration over time was detected.
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The approved person’s lung function was also monitored during each batch of testing
to act as a biological control, and to check internal validity.
The manufacturer’s EasyGuide (ndd Medizintechnik AG, 2002) instruction booklet
was used to ensure the instrument was used correctly and to ensure quality of results.
For example, the height above sea level of the Murrin Murrin Operation was pre-entered
into the spirometer database to allow adjustment for barometric pressure (Spirxpert,
n.d.). The EasyOne Model 2001 automatically adjusts for the standardization of gas
volumes and environmental factors such as temperature, pressure and water vapour
(Lange, Mulholland, & Kreider, 2009).
5.8.2.4 Protocol
Lung function was measured following the American Thoracic Society/European
Respiratory Society protocol (American Thoracic Society, 1995; Miller et al., 2005).
5.8.2.5 Approved person
The study was conducted by a DMP competent approved person, approved by

Resources Safety to carry out MineHealth Assessments on completion of compulsory
training in spirometry (lung function testing) to standards required by Resources Safety
and WorkCover WA (Department of Mines and Petroleum 2010a).

5.9 Exposure Assessment
Personal atmospheric monitoring of the workplace hazardous substances was
conducted in each area of the site in a separate but associated study, and a detailed
occupational exposure history was compiled for each work group. A qualitative review
of the respiratory health effects presented by the hazardous substances associated with
the mining and process plant were discussed in Chapter 4.

5.10 Statistical Analysis
The Statistical Package for the Social Sciences (SPSS) (IBM SPSS Statistics 18,
2010) was used for all data analysis.
The results using this methodology are outlined in the following chapter.
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6. RESULTS
6.1 Initial Lung Function Study
6.1.1 Study group
The study population consisted of 384 male and 34 female (a total of 418) mining,
processing and administrative employees working at the Minara, Murrin Murrin mine
site.
6.1.2 Control group
The control group consisted of 27 male and 13 female (a total of 40) catering
personnel at the Murrin Murrin accommodation village 8 km from the mine site.
6.1.3 Predicted normal values
Lung function data of the study and control groups were compared with predicted
normal values (Zapletal et al., 1977) which were programmed into the spirometer.
Predicted normal lung function values are derived from a population asymptomatic of
lung function disorders and lifelong non-smokers. These values are computed into the
spirometer and the results for each test subject compared with the predicted values
relative to their gender, height and age. Both the study and control group test subjects
were therefore compared to their respective predicted normal value for each lung
function parameter (e.g., FEV1 and FVC).

6.2 Profile of the Study Group Compared With the Control
Group
The descriptive statistics for the study and control groups are compared in Table 6.1,
below.
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Table 6.1 Descriptive Statistics of the Study Group Compared with the Control Group
Study Group (n=418)

Control Group (n=40)

Male

92% (n=385)

68% (n=27)

Female

8% (n=33)

32% (n=13)

Mean Height (cm) & 177 ±7.99
Standard Deviation

173 ±8.86

Height Range (cm)

155-195

155-200

Mean Age (years) & 39 ±9.1
Standard Deviation

39 ± 12.7

Age Range (years)

19-67

19-63

Current Smokers

34% (n = 144)

39% (n = 16)

Ex-smokers

25% (n = 104)

28% (n = 11)

Non-smokers

41% (n = 170)

33% (n = 13)

6.3 Prevalence of Respiratory Symptoms in the Study Group
Compared With the Control Group
The prevalence of respiratory symptoms in the study and control group was
determined using the Government of Western Australia, Mining and Petroleum
Resources (MPR) questionnaire (2004) (modified British Medical Research Council
questionnaire). Thirteen participants of the study group (3%) and one participant in the
control group (3%) did not complete the questionnaire although all performed the lung
function test. Thus there were 405 study group and 39 control group participants who
completed the questionnaire. Any missing data was taken into account for the following
calculations and statistical analysis. Table 6.2 below provides the prevalence of
respiratory symptoms in the study and control groups.
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Table 6.2 Prevalence of Respiratory Symptoms in the Study Group vs. Control Group
Study
Group

Control
Group

n(%)

n(%)

Cough
Do you usually cough first thing in the morning?

19 (5%)

3 (8%)

2

Do you usually cough during the day or night?

31 (77%)

4 (10%)

3

Do you have a cough like this on most days for as much as three
months each year?

12 (3%)

0 (0%)

1

Phlegm
4

Do you usually bring up phlegm from your chest first thing in the
morning?

24 (6%)

3 (8%)

5

Do you usually bring up phlegm from your chest at any other time of
the day?

26 (6%)

2 (5%)

6

Do you bring up phlegm like this on most days for as much as three
months each year?

13 (3%)

1 (3%)

7

In the past three years have you had a period of increased cough and
phlegm lasting for three weeks or more?

3 (1%)

2 (5%)

8

Have you had more than one such period?

4 (1%)

0 (0%)

Breathlessness on Activity
9

Do you get short of breath when hurrying on level ground or walking
up a slight hill?

12 (3%)

2 (5%)

10

Do you get short of breath when walking with other people of your age
on level ground?

3 (1%)

2 (5%)

11

Do you have to stop for breath when walking at your own pace on
level ground?

0 (0%)

0 (0%)

Breathlessness at Rest
12

Do you ever get short of breath at rest?

5 (1%)

0 (0%)

13

Do you ever wake up in your sleep short of breath?

7 (2%)

1 (3%)

Wheezing
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14

Does your chest ever sound wheezy or whistling?

46 (11%)

8 (20%)

15

Do you get this on most days or nights?

9 (2%)

1 (3%)

16

Have you ever had attacks of shortness of breath with wheezing?

11 (3%)

2 (5%)

17

Was your breathing absolutely normal between attacks?

7 (2%)

2 (5%)

Therefore – converse of question 17 – not normal between attacks =

4 (1%)

0 (0%)

21 (5%)

3 (8%)

248 (61%)

26 (67%)

Used
to
calculate
Pack Years

Used to
calculate
Pack
Years

Breathing Difficulty
18

Does your chest ever feel tight or your breathing become difficult?
Smoking History

19

Do you, or did you, smoke more than 1 cigarette/day; a cigar/week; or
2 oz (50 g) pipe tobacco/month for at least one year?
Smokers and ex-smokers

20

How much do you (or did you) smoke each day? (no. of cigarettes).
Roll owns or pipes (number of grams/week)?

21

How old were you when you started smoking?

22

If you are an ex-smoker, how old were you when you gave up smoking
permanently?

104 (25%)
11(28%)

Smokers = (Q19-Q22 ) =

144 (34%)

15 (39%)

Therefore Non-Smokers =

154 (38%)

13 (33%)

Past Chest Illness
23

During the past three years have you had any chest illness which has
kept you from usual activities for a week or more?

24 (6%)

1 (3%)

24

Did you bring up more phlegm than usual during this illness?

7 (2%)

0 (0%)

25

Have you had more than one illness like this in the past three years?

4 (1%)

0 (0%)

35 (9%)

4 (10%)

37 (9%)

4 (10%)

Asthma
26

Have you ever had asthma?
Other respiratory illness

27

Have you ever had any other respiratory illness?
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Questions 20, 21 and 22 from the MPR (2004) questionnaire were used to determine
pack years (Connolly & Alpert, 2008; National Cancer Institute, n.d.) to assess the
effect of smoking on the FEV1 for the Ever Smokers of the study and the control
groups. The scatter plots showing these data are presented in the two figures below. The
R2 values and r values are given for each graph. The R2 value i.e. goodness of fit of the
regression line, and Pearson’s correlation coefficient (r) which measures the strength of
the relationship between two variables FEV1 and Pack Years.

Figure 6.1 The Effect of Smoking (Pack Years) on FEV1 (litres) for the Study Group Ever
Smokers (n=242) (R2 0.14) (r minus 0.46).

Figure 6.2 The Effect of Smoking (Pack Years) on FEV1 (litres) for the Control Group
Ever Smokers (n=24) (R2 0.21) (r minus 0.37).
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6.4 Prevalence of Respiratory Disorders
6.4.1 Control population
There were a total of five individuals in the control population (5/40 = 12.5%) with
abnormal spirometry results (ndd Medizintechnik AG, 2002; Johns & Pierce, 2003);
three with mild obstruction, one with mild obstruction and low vital capacity possibly
due to restriction, and one with low vital capacity possibly due to restriction of lung
volumes.
6.4.2 Study population
There were 26 individuals in the study population (26/418 = 6.2%) with abnormal
spirometry results (ndd Medizintechnik AG, 2002; Johns & Pierce, 2003); 18 with mild
obstruction, five with mild obstruction and low vital capacity possibly due to restriction,
and three with moderate obstruction and low vital capacity possibly due to restriction.
All were non-work-related, each with a history of respiratory illness and/or smoking.
The conditions for these 26 individuals were:
history of pneumothorax, former smoker;
triple by-pass/sleep apnoea/10% lung removed due to thrombosis,
BMI >35;
smoker 30 cigarettes/day, BMI >40;
smoker15 cigarettes/day, BMI >30;
smoker 25 cigarettes/day and asthmatic, BMI >30;
history of bronchitis, diabetic, asthmatic, BMI >30;
known poor lung function (reason not provided) BMI >35;
former smoker 20 cigarettes/day, BMI >30;
former smoker, possible asthmatic, BMI >35;
smoker 40 cigarettes/day;
asthmatic, former smoker;
asthmatic, occasional smoker;
former smoker, 12 cigarettes/day;
history of pneumonia, heart valve replacement, former smoker 30
cigarettes/day;
former smoker 30 cigarettes/day;
asthmatic, former smoker 20 cigarettes/day;
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known poor lung function (reason not given);
smoker 15 cigarettes/day;
smoker of a pack of hand-rolled cigarettes (“rollies”) per week BMI
>35;
asthmatic, occasional smoker;
two asthmatics, former smokers;
former smoker 50 cigarettes/day;
former smoker 30 cigarettes/day, asthma, history of pleurisy;
bronchitis, smoker 25+ per day, asthmatic (died of lung cancer shortly
after completion of the study);
history of pneumonia, possible asthma.
BMI classification according to the World Health Organization (n.d.).
These were pre-existing respiratory disorders (non-work related) as determined
through questionnaire.

6.5 Comparison of the Lung Function of the Study Group,
with Their Predicted Values, and the Control Group - With
Sequential Removal of Confounders
6.5.1 Lung function versus height
The linear model of height, plotted against the lung function indices FEV 1 and FVC
(Cotes, 1993) was employed to visualise the relationship between the study group, their
predicted normal values (Zapletal et al., 1977) and the control group data. A series of
scatter plots with regression lines (IBM® SPSS® PASW Statistics 18) were produced
with sequential removal of the confounding factors in order to observe their effect on
lung function.
6.5.2 Sequential removal of confounders
A series of graphs are presented below to compare the FEV1 and FVC of the study
group, their predicted values, and the control group, initially looking at all subjects of
the study group (n=418) and the control group (n=40) followed by sequential removal
of confounding of smoking, smoking and asthma, then smoking, asthma and non-workrelated respiratory disorders, ultimately ending up with comparison of the presumed
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healthy non-smokers sub-population of the study group (i.e., with all confounders
removed).
These are presented in a series of three figures, firstly comparing the FEV1 for all
subjects of the study group, their predicted values and control group; followed by FVC
for all subjects of the study group, predicted values and control group; and then with the
sequential removal of confounding as described above.
The R2 values and r values are given for each graph. The R2 value is the goodness of
fit of the regression line, and Pearson’s correlation coefficient (r) measures the strength
of the relationship between two variables; which for this series of graphs are FEV1 and
height, and FVC and height.
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6.5.2.1 All subjects study and control groups: FEV1 plotted against height

Figure 6.3 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for All
Subjects (n= 418) of the Study Group. (R2 0.42) (r 0.65).

Figure 6.4 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for All
Subjects (n=40) of the Control Group. (R2 0.38) (r 0.62).

Figure 6.5 Scatter Plot Showing the Relationship of the Predicted Values of FEV1 (litres)
and Height (cm) for All Subjects of the Study Group (n=418) (R2 0.77) (r 0.88).
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6.5.2.2 All subjects study and control groups: FVC plotted against height

Figure 6.6 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for All
Subjects (n = 418) of the Study Group. (R2 0.49) (r 0.70).

Figure 6.7 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for All
Subjects of the Control Group (n = 40) (R2 0.56) (r 0.75).

Figure 6.8 Scatter Plot Showing the Relationship of the Predicted Values of FVC (litres)
and Height (cm) for All Subjects for the Study Group (n = 418) (R2 0.84) (r 0.92).
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6.5.2.3 Removal of confounding of smoking: FEV1 plotted against height

Figure 6.9 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the
Study Group Never Smokers (n = 153) (R2 0.54) (r 0.74).

Figure 6.10 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the
Control Group Never Smokers (n = 13) (R2 0.60) (r 0.78).

Figure 6.11 Scatter Plot Showing the Relationship of the Predicted Values of FEV1 (litres)
and Height (cm) for the Study Group Never Smokers (n = 153) (R2 0.78) (r 0.88).
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6.5.2.4 Removal of confounding of smoking: FVC plotted against height

Figure 6.12 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the
Study Group Never Smokers (n = 153) (R2 0.57) (r 0.93).

Figure 6.13 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the
Control Group Never Smokers (n = 13) (R2 0.74) (r 0.94).

Figure 6.14 Scatter Plot Showing the Relationship of the Predicted Values of FVC (litres)
and Height (cm) for the Study Group Never Smokers (n = 153) (R2 0.86) (r 0.94).
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6.5.2.5 Removal of confounding of smoking and asthma: FEV1 plotted against
height

Figure 6.15 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the
Study Group Never Smokers/Non-Asthmatics (n = 136) (R2 0.55) (r 0.75).

Figure 6.16 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the
Control Group Never Smokers/Non-Asthmatics (n = 13) (R2 0.60) (r 0.78).

Figure 6.17 Scatter Plot Showing the Relationship of the Predicted Values of FEV1 (litres)
and Height (cm) for the Study Group Never Smokers/Non-Asthmatics (n = 136) (R2 0.78)
(r 0.89)
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6.5.2.6 Removal of confounding of smoking and asthma: FVC plotted against
height

Figure 6.18 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the
Study Group Never Smokers/Non-Asthmatics (n = 136) (R2 0.56) (r 0.75).

Figure 6.19 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the
Control Group Never Smokers/Non-Asthmatics (n = 13) (R2 0.74) (r 0.88).

Figure 6.20 Scatter Plot Showing the Relationship of the Predicted Values of FVC (litres)
and Height (cm) for the Study Group Never Smokers/Non-Asthmatics (n = 136) (R2 0.86)
(r 0.93).
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6.5.2.7 Removal of non-work-related respiratory symptoms: FEV1 plotted against
height

Figure 6.21 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the
Study Group on Removal of Individuals with Non-Work-Related Respiratory Symptoms (n
= 392) (R2 0.47) (r 0.69).

Figure 6.22 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the
Control Group on Removal of Individuals with Non-Work-Related Respiratory Symptoms
(n = 35) (R2 0.60) (r 0.77).

Figure 6.23 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the
Predicted Values of the Study Group on Removal of Individuals with Non-Work-Related
Respiratory Symptoms (n = 392) (R2 0.77) (r 0.69).
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6.5.2.8 Removal of non-work-related respiratory symptoms: FVC plotted against
height

Figure 6.24 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the
Study Group on Removal of Individuals with Non-Work-Related Respiratory Symptoms (n
= 392) (R2 0.51) (r 0.71).

Figure 6.25 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the
Control Group on Removal of Individuals with Non-Work-Related Respiratory Symptoms
(n = 35) (R2 0.70) (r 0.84).

Figure 6.26 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the
Predicted Values of the Study Group on Removal of Individuals with Non-Work-Related
Respiratory Symptoms (n = 392) (R2 0.84) (r 0.92).
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6.5.2.9 Removal of confounding of smoking, asthma, and non-work-related
symptoms: FEV1 plotted against height

Figure 6.27 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the
Study Group on Removal of Smokers, Asthmatics, and Individuals with Non-WorkRelated Respiratory Symptoms (n = 134) (R2 0.53) (r 0.73).

Figure 6.28 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the
Control Group on Removal of Smokers, Asthmatics, and Individuals with Non-WorkRelated Respiratory Symptoms (n = 12) (R2 0.69) (r 0.83).

Figure 6.29 Scatter Plot Showing the Relationship of FEV1 (litres) and Height (cm) for the
Predicted Values of the Study Group on Removal of Smokers, Asthmatics and Individuals
with Non-Work-Related Respiratory Symptoms (n = 134) (R2 0.77) (r 0.88).
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6.5.2.10 Removal of confounding of smoking, asthma and non-work-related
symptoms: FVC plotted against height

Figure 6.30 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the
Study Group on Removal of Smokers, Asthmatics and Individuals with Non-Work-Related
Respiratory Symptoms (n = 134) (R2 0.54) (r 0.73).

Figure 6.31 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the
Control Group on Removal of Smokers, Asthmatics and Individuals with Non-WorkRelated Respiratory Symptoms (n = 12) (R2 0.77) (r 0.88).

Figure 6.32 Scatter Plot Showing the Relationship of FVC (litres) and Height (cm) for the
Predicted Values of the Study Group on Removal of Smokers, Asthmatics and Individuals
with Non-Work-Related Respiratory Symptoms (n = 134) (R2 0.85) (r 0.92).
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6.5.3 Analysis of sequential removal of confounders
6.5.3.1 Goodness of fit (R2) values of FEV1 and FVC versus height as the
confounders are removed
Table 6.3 Goodness of Fit (R2) for the Regression Plots for FEV1 and FVC for the Study Group,
as the Confounders are Removed, Compared with Their Predicted Values
Linear
Regression

All
Subjects

Minus

Never
Smokers

Non-WorkRelated
Respiratory
Disorders

n=
FEV1 v
Height

FVC v
Height

Never
Smokers/
NonAsthmatic

Never
Smokers/
NonAsthmatic

Predicted
Value

No Nonwork-related
Respiratory
Disorders

418

392

154

137

134

R2 = 0.42

R2 = 0.47

R2 = 0.54

R2 = 0.55

R2 = 0.53

R2 = 0.77

R2 = 0.49

R2 = 0.51

R2 = 0.57

R2 = 0.56

R2 = 0.54

R2 = 0.85

It can be seen that there was an improvement in goodness of fit (R2) for the
regression plots of the study group relative to the predicted values as confounders were
removed. The confounders were smoking, asthma and non-work related (pre-existing)
respiratory disorders, and therefore the converse descriptions – never smokers, nonasthmatic, no non-work related respiratory disorders – are headings in the table above.
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6.5.3.2 r values of FEV1 and FVC versus height as the confounders are removed
Table 6.4 Pearson’s Correlation (r) for the Regression Plots for FEV1 and FVC Plotted Against
Height for the Study Group, as the Confounders are Removed, Compared with their Predicted
Values
Linear
Regression

All
Subjects

Minus

Never
Smokers

Non-WorkRelated
Respiratory
Disorders

n=

Never
Smokers/
NonAsthmatic

Never
Smokers/
NonAsthmatic

Predicted
Value

No Non-workrelated
Respiratory
Disorders

418

392

154

137

134

r = 0.65*

r = 0.69*

r = 0.74*

r = 0.75*

r = 0.73*

r = 0.88*

r = 0.70*

r = 0.71*

r = 0.93*

r = 0.75*

r = 0.73*

r = 0.92*

FEV1 v
Height

FVC v
Height

Note. * Correlation is significant at the 0.01 level.
It can be seen that there is an improvement in the Pearson’s correlation (r) for the
regression plots of the study group relative to the predicted values as confounders were
removed.
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6.5.3.3 Independent t-test of FEV1 for the study and control groups as the
confounders are removed
Table 6.5 Independent t-test – Comparison of FEV1 Between the Study and Control Groups
All Subjects

Study
n=

418

Control

Never Smokers

Study

Control

Never Smokers / Nonasthmatics

Study

Control

40

154

13

137

13

mean 3.9L

3.6L

4.1L

3.7L

4.1L

3.7L

S.D.

0.77L

0.71L

0.8L

0.69L

0.80L

0.74L

p

<0.05

>0.05

>0.05

Initially the FEV1 for the study and control groups appear to be significantly
different, but as the confounding was removed there appeared to be no significant
difference for FEV1 for these populations.
6.5.3.4 Independent t-test of FVC for the study and control groups as the
confounders are removed
Table 6.6 Independent t-test – Comparison of FVC Between the Study and Control Groups
All Subjects

Study
n=

Study

Control

Never Smokers / Nonasthmatics

Study

Control

40

154

13

137

13

mean 5.1L

4.6L

5.2L

4.6L

5.2L

4.6L

S.D.

1.01L

0.93L

0.99L

0.91L

0.99L

p

418

Control

Never Smokers

0.93L

<0.05

<0.05

<0.05

Overall, there appeared to be a significant difference in FVC between the study and
control group, even after the confounders were removed.
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6.5.3.5 Dependent t-test of FEV1 for the study group and their predicted values as
the confounders are removed
Table 6.7 Dependent t-test – Comparison of FEV1 for the Study Group and their Predicted
Values as the Confounders are Removed.
All Subjects
n=418

Minus Non-workrelated
Respiratory
Disorders

Never Smokers
n=154

Never
Smokers/Nonasthmatics

Never
Smokers, NonAsthmatic

n=137

No Non-workrelated
Respiratory
Disorders

n=392

n=134
Study

Predict
ed

Study

Mean

3.94L

3.96L

S.D.

0.74L

0.52L

p

>0.05

Predict
ed

Study

Predict
ed

Study

Predict
ed

Study

Predict
ed

4.0L

4.0L

4.1L

4.0L

4.1L

4.0L

4.2L

4.1L

0.67L

0.51L

0.71L

0.51L

0.69L

0.50L

0.62L

0.49L

<0.05

>0.05

<0.05

<0.05

There were mixed results on comparison of the FEV1 for the study group and
predicted values. There was no significant differences (p >0.05) between the study and
predicted values for FEV1 without removal of any confounders and for removal of ever
smokers; whilst there was a significant difference (p <0.05) when ever smokers and
asthmatics, and ever smokers and asthmatics plus those with respiratory disorders were
removed.

109

6.5.3.6 Dependent t-test of FVC for the study group and their predicted values as
the confounders are removed
Table 6.8 Dependent t-test – Comparison of FVC for the Study Group and their Predicted
Values as the Confounders are Removed.
All Subjects
n=418

Minus Nonwork-related
Respiratory
Disorders

Never
Smokers

Never
Smokers/Nonasthmatics

n=154

Never
Smokers,
NonAsthmatic

n=137
n=392

No Non-workrelated
Respiratory
Disorders
n=134

Study

Predict
ed

Mean

5.1L

4.8L

S.D.

0.93L

0.64L

p

<0.05

Study

Predict
ed

Study

Predict
ed

Study

Predict
ed

Study

Predict
ed

5.1L

4.8L

5.2L

4.9L

5.2L

4.9L

5.3L

4.9L

0.88L

0.63L

0.93L

0.63L

0.91L

0.62L

0.86L

0.60L

<0.05

<0.05

<0.05

<0.05

There were significant differences (p <0.05) between the study and predicted values
for FVC even on removal of confounding factors.

6.6 The Effect of Length of Service and Lung Function
6.6.1 Effect of length of service on the lung function for the presumed healthy
sub-group of the study group
The effect of length of service (DateDiff) on lung function for the presumed healthy
non-smokers of the study group (32%) is represented in the two regression plots below:
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Figure 6.33 Scatter Plot Showing the Relationship of FEV1 (litres) and Length of Service
(DateDiff – days) for the Presumed Healthy Sub-Group of the Study Group (n = 134) (R2
0.002) (r 0.04)

Figure 6.34 Scatter Plot Showing the Relationship of FVC (litres) and Length of Service
(DateDiff – days) for the Presumed Healthy Non-Smokers of the Study Group (n =134)
(R2 0.004) (r 0.07).
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6.6.2 Comparison of the effect of length of service on the FEV1 for the nonsmoker and smoker sub-groups of the study group
The effect of length of service and FEV1 for the study group non-smokers was
compared with the study group smokers in the two plots below:

Figure 6.35 Scatter Plot Showing the Relationship of FEV1 (litres) and Length of Service
(DateDiff – days) for the Non-Smoker Sub-Population of the Study Group (n = 174) (R2
3.262E-5) (r 0.01).

Figure 6.36 Scatter Plot Showing the Relationship of FEV1 (litres) and Length of Service
(DateDiff – days) for the Smoker Sub-Population of the Study Group (n = 143) (R20.037)
(r minus 0.19).
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6.6.2.1 MANOVA for the comparison of the effect of length of service on the FEV1
for the non-smoker and smoker sub-groups of the study group
A multivariate analysis (MANOVA) showed there was no significant difference (p
>0.05) with length of service between the study group non-smokers and the study group
smokers. However, this analysis showed a significant difference (p <0.05) in FEV1
between the non-smoker and smoker sub-groups of the study population. There was no
similar effect for the FVC between the non-smoker and smoker sub-groups of the study
population.

6.7 The Effect of the Area Worked and Lung Function
6.7.1 Comparison of the FEV1 with the FEV1 predicted values for individuals in
each work area
A dependent (paired samples) t-test conducted to compare the FEV1 and FEV1
predicted values for the never-smoker sub-group in each work area is shown in the
following table.
Table 6.9 Dependent t-test Comparing the FEV1 with the FEV1 Predicted Values for Individuals
in Each Work Area.
Work Area

Mean

Standard
Deviation

95% Confidence
Limits
Lower

Upper

Sig.
df

(2 –tailed)

Administration

-.060

.527

-.300

.180

20

.608

Mining
Production

.102

.506

-.129

.332

20

.368

Mining
Geologists

-.205

.393

-.830

.421

3

.374

Mining
Maintenance

-.037

.386

-.650

.577

3

.862

Ore Leach
Production

.140

.360

-.089

.369

11

.206

Ore Leach
Maintenance

.012

.404

-.259

.283

10

.923
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Refinery
Production

-.063

.413

-.268

.142

17

.526

Refinery
Maintenance

-.046

.421

-.279

.187

14

.679

Utilities
Production

-.227

.623

-.748

.293

7

.336

Utilities
Maintenance

.007

.572

-.522

.536

6

.974

Laboratory

.255

.508

-.135

.646

8

.170

Warehouse

.644

.479

-.118

1.405

3

.075

General
Maintenance

.208

.369

-.040

.456

10

.092

Electrical
Maintenance

.202

.208

.028

.377

7

.029*

Note. *p <0.05
The mean, standard deviation, degrees of freedom, and lower and upper confidence
limits for all individuals in each specific work area are provided.

A significant

difference (p <0.05) was observed for the electrical maintenance work area. No other
differences were observed for any other work groups (p >0.05).
6.7.2 Comparison of the FVC with the FVC predicted values for individuals in
each work area
A dependent (paired samples) t-test was conducted to compare the FVC and FVC
never-smoker sub-group in each work area is shown in table 6.10.
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Table 6.10 Dependent t-test Comparing the FVC with the FVC Predicted Values for Individuals
in Each Work Area
Work Area

Mean

Standard
Deviation

95% Confidence
Limits
Lower

Upper

Sig.
df

(2 –tailed)

Administration

.198

.526

-.041

.438

20

.099

Mining
Production

.376

.695

.060

.693

20

.022*

Mining
Geologists

-.400

.708

-1.526

.727

3

.341

Mining
Maintenance

.473

.791

-.786

1.731

3

.318

Ore Leach
Production

.322

.518

-.007

.651

11

.054

Ore Leach
Maintenance

.105

.409

-.170

.380

10

.415

Refinery
Production

.327

.587

.035

.618

17

.030*

Refinery
Maintenance

.235

.471

-.026

.495

14

.074

Utilities
Production

-.128

.610

-.638

.381

7

.570

Utilities
Maintenance

.395

.817

-.361

1.150

6

.248

Laboratory

.493

.705

-.049

1.034

8

.069

Warehouse

.829

.801

-.446

2.103

3

.130

General
Maintenance

.512

.510

.170

.855

10

.008*

Electrical
Maintenance

.512

.421

.160

.864

7

.011*

*p <0.05
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A significant difference (p <0.05) was observed for the following work areas:
mining production;
refinery production;
general maintenance;
electrical maintenance.
No significant difference was observed for the other work groups (p >0.05).

6.8 Repeat Spirometry of 72 Mine Site Workers Involved in
the Initial Study
Repeat lung function tests were conducted on a sample of 72 individuals from the
initial 418 mine site workers. This population consisted of 25 non-smokers/nonasthmatics, 43 smokers and four asthmatics from the original study group. Five of the
72 individuals had known non-work-related respiratory disorders. Not all repeat testing
was conducted at the same time interval. The time intervals from the initial spirometry
test to the follow-up ranged from 173 days to 845 days.
The following table shows the
mean change;
range of change;
overall mean change per year; of
FEV1 and FVC as the confounders are sequentially removed.

116

Table 6.11 The Change in Lung Function Over Time for the Repeat Study Group with
Sequential Removal of Confounders
Number of
Individuals
(n)

Lung
Function

Mean ±
Standard
Deviation

Range

Mean Time
Period±

(litres)

Parameter

Standard
Deviation

(litres)

Overall
Mean
Change
(ml/year)

(days)
All
Subjects

Smokers/
Asthmatics

NonSmokers/
NonAsthmatics

Presumed
Healthy,
NonSmokers

72

FEV1

-0.036±0.21

-0.54
to 0.39

623±198

-21

72

FVC

-0.007±0.33

-0.74
to 0.79

623±198

-4

47

FEV1

-0.068±0.22

-0.54
to 0.39

616±192

-40

47

FVC

-0.003±0.35

-0.74
to 0.79

616±192

-2

25

FEV1

0.024±0.17

-0.33
to 0.39

637±211

+14

25

FVC

-0.013±0.29

-0.60
to 0.40

637±211

-7

24

FEV1

0.033±0.17

-0.33
to 0.39

633±215

+19

24

FVC

<0.001±0.29

-0.60
to 0.40

633±215

0
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6.8.1 Comparison of the change in FEV1 over time for the presumed healthy,
non-smoker and the smokers/asthmatics sub-groups from the repeat study
The comparison of the change in FEV1 for the study group presumed healthy
subjects, and the smoker/asthmatic sub-group, over the period from the initial to the
repeat study is shown in Figures 6.37 and 6.38.

Figure 6.37 Scatter Plot Showing the Change in FEV1 (FEV1diff) in Litres, with the Period
of Time Between Initial and Repeat Spirometry for the Presumed Healthy, Non-Smoker
Sub-Group (n = 26) (R2 0.003) (r 0.058) (p >0.05).

Figure 6.38 Scatter Plot Showing the Change in FEV1 (FEV1diff) in Litres, with the Period
of Time Between Initial and Repeat Spirometry for the Smokers/Asthmatic Sub-Group (n =
47) (R2 0.031) (r minus 0.18) (p <0.05).
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In a dependent t-test there was no significant difference in FEV1 from the first
spirometry test compared with the repeat spirometry test for presumed healthy, nonsmoker sub-group (p >0.05). However, there was a significant difference (p <0.05) in
FEV1 from first spirometry test compared with the repeat spirometry test for the
smokers/asthmatics sub-group.

6.9 Cross-Swing Lung Function of a Cohort of Refinery
Workers
Lung function tests for a cohort of refinery workers were conducted as they arrived
for work on site prior to commencing work in the refinery, and on completion of their
work period on site before returning home on their rest break. There was a mixture of
dayshift and nightshift workers. There were 32 workers in total; however, five workers
were repeated on a second swing. This equated to seven production workers and five
maintenance workers from Crew A; 12 production workers from Crew B, three
production workers from Crew C, and 10 maintenance workers from Crew D; giving a
total of 37 pre-swing/post-swing observations.
6.9.1 Cross-swing change in lung function (FEV1 and FVC) all 37 observations
Table 6.12 Cross-Swing Change in Lung Function (FEV1 and FVC)
Range

Mean

Standard
Deviation

p

(Litres)

(Litres)

FEV1

-0.58 to +0.52

-0.03

0.25

>0.05

FVC

-0.72 to + 0.95

+0.01

0.35

>0.05

There was no significant difference (p >0.05) between the FEV1 and FVC values for
the 35 individuals (with 37 observations) from the start of a swing to the end of the
swing.
6.9.2 Repeat cross-swing change in lung function (FEV1 and FVC) for five
individuals
There was no significant difference (p >0.05) between the FEV1 and FVC values for
the five individuals from this cohort for their combined initial and repeat cross-swing
lung function data.
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6.10 Internal Reliability – Biological Control
As well as calibrating regularly during each batch of testing using a certified three
litre syringe as per the ATS/ERS recommended standard; the lung function of the
trained researcher was measured 41 times throughout the investigation to act as a
biological control, for calibration purposes and to demonstrate internal reliability. The
figures below (Figures 6.39 and 6.40) are scatter plots, and the table of descriptive
statistics (Table 6.13) of the FEV1 and FVC of the trained researcher over the study
period.

Figure 6.39 Scatter Plot Showing the FEV1 (litres) Measured at Various Time Intervals
[Diff] (days) Over the Study Period. (R2 0.056) (r minus 0.237) (p >0.05).

Figure 6.40 Scatter Plot Showing the FVC (litres) Measured at Various Time Intervals
[Diff] (days) Over the Study Period. (R2 0.066) (r minus 0.237) (p >0.05).
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Table 6.13 The Range, Mean and Standard Deviation of the Lung Function of the Biological
Control over the Study Period
Minimum

Maximum

Mean

Standard Deviation

FEV1 (litres)

3.73

4.46

4.13

0.166

FVC (litres)

4.40

5.96

5.29

0.307

The outcome of these results for the:
Initial study of the respiratory health surveillance of 418 employees at the
Murrin Murrin Operation, compared with two control populations;
Repeat study of 72 of these subjects; as well as the;
Cross-swing study of a cohort of refinery workers;
is discussed in the following Discussion chapter.
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7. DISCUSSION
7.1 Profile of the Study Group Compared With the Control
Group
A total of 418 mining, processing and administrative employees based at the Murrin
Murrin mine site constituted the study group. This group was compared with the control
group of 40 catering personnel at the Murrin Murrin accommodation village some 8
kilometres from the mine site. The caterers were chosen for their geographic proximity
to the mine site. The caterers rarely if ever visited the mine site or processing plant; the
only exceptions were perhaps the bus drivers or delivery personnel where their time on
site was limited. The control group were chosen for their proximity to the mine site to
minimise any respiratory effect due to geographical location (Hendrick, 2002; National
Institute for Occupational Safety and Health, 2009a).
7.1.1 Potential confounding due to the differences in the study and control
populations
The potential confounding due to differences in the profiles of the study and control
groups were:
the male to female employee ratio in the study group was 92% to 8%;
and for the control group it was 68% to 32%;
the height range and mean height was different, with the study group
range 155-200 cm, mean = 177 cm, and the control group range 155195 cm, mean = 173 cm; and
the smoking status was different in the study group compared with the
control group (i.e., 38% non-smokers and 33% respectively).
7.1.2 Factors influencing lung function
There are positive and negative factors that affect lung function. It is well recognised
that gender and height are the most important predictors of lung function with a linear
correlation, whilst the relationship between age is more complex with a non-linear
correlation (Pellegrino et al., 2005). It is known that excess BMI can impair lung
function (Cotes, 1993). Genetic factors indeed influence lung function, as does a healthy
lifestyle, body composition and respiratory muscle strength. Asthma is caused by both
genetic and environmental factors and has a pronounced effect on lung function (Ryon
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& Rom, 1998). Subjects with asthma or other respiratory disorders may well exclude
themselves from such a mining operation (healthy worker effect). However, the most
obvious negative factor is cigarette smoking, which has been determined to be the
single most preventable risk factor for COPD (Blanc et al., 2009). Diabetes mellitus and
obesity are amongst the disease states that have an indirect affect on lung function
(Ostrowski & Barud, 2006).
To overcome the effects of confounding, the study design included predicted normal
values (Zapletal et al., 1977) for gender, age, and height, computed into the software of
the spirometer, against which to compare each individual’s data. Potential confounding
due to smoking status, being an asthmatic and pre-existing respiratory disorders were
identified through the respiratory questionnaire and addressed during statistical analysis.
As to be expected, on statistical analysis (Simple Linear Regression, IBM® SPSS®
PASW Statistics 18) there was a positive correlation between lung function and height
and conversely a negative correlation with lung function and age (data not shown) for
both the study and control groups.
The lung function of the study group was considered significantly different from
both the control group and the predicted norm group (Zapletal, et al., 1977) as there was
almost a consistent significant difference (p <0.05) on comparison of their respective
FEV1s and FVCs. However, the R2 values (goodness of fit) for the regression analysis
appeared to become closer as the confounders related to poor lung function were
removed (logistic regression). The difference of 5% more smokers in the control group
was likely to account to some degree for the difference in prevalence of the non-work
related respiratory disorders, which was 12.5% for the controls compared with 6.2% for
the study group. There was a significant difference in both FEV1 and FVC between the
study group and their predicted values as all the obvious confounders (smokers,
asthmatics and those with non-work related respiratory disorders) were removed. This
may indicate the difference between a West Australian cohort (circa 2006) (i.e. the
study group) and a European cohort (circa 1977) (i.e. the predicted normal values).

7.2 Initial Study
Data from the initial study consisted of the responses to the respiratory symptoms
questionnaire and data from the lung function tests for both the study and control
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groups. The questionnaires and measurements required for spirometry were initially
conducted at the medical centre by appointment; however, as this proved impractical for
most employees, the investigator conducted the study in the various work-area offices,
and the accommodation office at the camp was used for the control group assessments.
The procedures and instruments for measuring height, weight and lung function
remained consistent and according to the ATS/ERS Guidelines (American Thoracic
Society, 1995; Miller et al., 2005) and the Thoracic Society of Australia and New
Zealand (Pierce and Johns, 1996).
7.2.1 Prevalence of respiratory symptoms in the study group compared with the
control group
A comparison of the prevalence of respiratory symptoms in the study and control
groups is given in Table 6.2 of the results chapter. These symptoms were determined by
administration of a respiratory questionnaire.
7.2.1.1 Summary of the comparison of the study and control group respiratory
symptoms
The pattern of respiratory symptoms determined from the questionnaire for the study
group differed only slightly from that of the control group, differing predominantly at
sub-question level where more detail was requested. The following contrasting
responses to the respiratory questionnaire where the responses were greater for the study
group are reported by exception.
Although a slightly larger proportion of the control group reported
they had a cough, proportionally more individuals in the study group
reported that they usually coughed during the day and night (77% vs
10%). Also, 12 of the study group versus none in the control group
reported it as a persistent cough;
Five of the study group reported that they had experienced being short
of breath at rest, in contrast to none in the control group;
Proportionally more of the study group (6%) compared with the
control group (3%) reported that during the past 3 years they had a
chest illness which kept them from their usual activities for a week or
more; and 2% of the study group reported that they brought up more
phlegm than usual during this illness.
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All these symptoms could be related back to individuals who were ever smokers or
had known non-work related respiratory disorders. Cigarette smoking is known to cause
coughing and particularly a persistent chronic cough that last longer than two to three
weeks (Kerstjens, Rijcken, Schouten, & Postma, 1997) and to result in cough and
phlegm (Heijdra, Pinto-Plata, Kenney, Rassulo, & Celli, 2002). Dyspnea, or shortness
of breath, may be due to asthma or other respiratory or cardiovascular disorders
(American Thoracic Society, 2003). The respiratory questionnaire was able to determine
that none of these symptoms were work related.
7.2.2 Prevalence of respiratory disorders
The prevalence of respiratory disorders was determined by administration of a
respiratory questionnaire and confirmed by spirometry (Section 6.4). In the control
population there were five individuals (5/40 = 12.5%) with poor spirometry results (ndd
Medizintechnik AG, 2002); three with mild obstruction, one with mild obstruction and
low vital capacity, possibly due to restriction, and one with low vital capacity possibly
due to restriction of lung volumes. In the study population there were 26 individuals
(26/418 = 6.2%) with poor spirometry results: 18 with mild obstruction, five with mild
obstruction and low vital capacity possibly due to restriction, and three with moderate
obstruction and low vital capacity possibly due to restriction. All were pre-existing nonwork-related (prior to working at Murrin Murrin) each with a history of respiratory
illness and/or smoking.
Subjects with interpretations on the spirometry report with mild obstructive
respiratory disorders included subjects with known asthma, bronchitis, and emphysema;
these disorders were also determined prior to spirometry through interview using the
respiratory questionnaire. Those diagnoses with low vital capacity possibly due to
restriction were mainly smokers however there were three cases where other respiratory
disorders that had been identified and medically treated. These interpretations provided
on the report from the EasyOne spirometer not only correspond with the detail provided
by the study group subjects but also to the pathophysiological profile of these
respiratory disorders (Johns Hopkins School of Medicine's Interactive Respiratory
Physiology, 1995).
A detailed analysis for the study group determined that there were 26 cases of nonwork-related respiratory disorders each either with a history of respiratory illness, or
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smoking, and elevated BMI, or a combination of these. These are listed in section 6.4.2
of the results section.
7.2.3 Comparison of the lung function of the study group, with their predicted
values, and the control group – with sequential removal of confounders
The lung function of the study group (Figure 6.3) was compared, with the:
control group (Figure 6.4); and
predicted values for the study group individuals (Figure 6.5).
This was followed by a series of evaluations after sequential removal of the obvious
confounding factors such as smoking, asthma and known non-work-related respiratory
symptoms. The confounding of age and gender was addressed by comparison with their
predicted values (Zapletal et al., 1977).
The series of analysis began with all subjects with no data removed from the study
group (418 individuals on site) or control group (40 caterers off-site). Next, the ever
smokers data were removed, followed by ever smokers and asthmatics, and finally the
ever smokers, asthmatics and the 26 individuals with known non-work-related
respiratory symptoms (Figures 6.3 – 6.32).
Two analyses were employed. Firstly, the FEV1 and FVC were plotted against height
to visualise the relationship of the study group versus the control group, and the
predicted normal values, and a simple linear regression employed. Secondly,
comparison of the means of the study group data versus the control group data
(independent t-test) and the predicted normal values (dependent t-test) was also
conducted (IBM® SPSS® PASW Statistics 18).
It can be seen from the first in the series of regression plots (Figures 6.3 – 6.5) that
the lung function data (FEV1 and FVC) for all subjects in the study group (418) and
control group (40) were more disperse than the predicted normal values (i.e., many
outliers). This was considered mainly due to confounding factors such as smoking and
individuals with known non-work-related respiratory disorders; whereas the predicted
values (Zapletal et al., 1977) were derived from a representative sample of a healthy,
non-smoking population.
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On more detailed examination of the respiratory questionnaire, the factors
contributing to this disperse nature (scatter) for the study group data compared with the
predicted values for these group individuals were outliers: those with poor lung
function, including the 26 cases determined to have non-work-related respiratory
disorders, a history of smoking, elevated BMI, or a combination of these; and those with
excellent lung function who reported a high level of physical activity, such as scuba
diving – known for ‘large lungs’ (Tetzlaff et al., 2006) – which were associated with the
best lung functions. The increased diversity in spirometry results for both the study and
control groups, as compared with the predicted values for the study group data, was
reflected in the R2 (linear regression goodness of fit) values for the FEV1 or FVC versus
height linear model as shown in Figures 6.3 – 6.5.
There was an improvement in the (goodness of fit) R2 values and the Pearson’s
correlation (r) values for the series of regression plots depicted in Figures 6.3 through to
6.32, for the study group relative to the predicted values, as the confounders of
individuals with known non-work-related respiratory disorders;
ever smokers; and
asthmatics,
were sequentially removed, and they more closely resembled the predicted values.
These data are summarised in Tables 6.3 and 6.4. It can be seen that the study group
lung function data never fully resembles the predicted value data, that could be due to
the fact that the study group was from an Australian population whereas the Zapletal et
al. (1977) lung function data was derived from a cross-section of healthy children,
adolescents and adults from a European population. These predicted values were the
manufacturer’s recommendation as best reflecting the Australian population and were
programmed into the spirometer, as there are no similar Australian predicted values.
This population difference in lung function between the study group and their predicted
values was also demonstrated through a series of t-tests summarised in Tables 6.7 and
6.8. The results demonstrate that overall there was a consistent significant difference in
FVC even as the confounders were removed (p <0.05) and a significant difference in
FEV1 when the confounding of smoking, asthma and other non-work-related respiratory
symptoms were removed from the data (p <0.05) thus demonstrating that overall there
was a significant difference in FEV1 and FVC between the study group and the
predicted values. This is consistent with the linear regression where there was more
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scatter of data around the line of best fit for the study group data compared with the
predicted values for these data (comparison of Figures 6.27 with 6.29 for FEV1, and
Figures 6.30 and 6.32 for FVC).
7.2.4 Length of service
7.2.4.1 Study group
The effect of length of employment at the Murrin Murrin site (length of service) on
lung function was investigated using linear regression plots, and by Multivariate
Analysis of Variance for the main study group presumed healthy workers (i.e., nonsmokers, non-asthmatics, and no non-work-related respiratory symptoms) (IBM®
SPSS® PASW Statistics 18).
The regression plots for FEV1 and FVC for the presumed healthy workers were
relatively flat indicating no decrease or increase in FEV1 or FVC with length of service
(Figures 6.33 and 6.34). In addition, the Pearson’s Correlations were not significant (p
>0.01) also indicating there was no effect of length of service on the lung function for
the study group.
7.2.4.2 Contrast between the non-smoker and smoker sub-groups of the study
group
On analysis, a contrast was shown between the non-smoker (Figure 6.35) and smoker
(Figure 6.36) sub-groups. There was an evident decrease in FEV1 with length of service
for the smoker sub-group whilst there was no decrease for the non-smoker sub-group
with length of service (IBM® SPSS® PASW Statistics 18). Again, the dispersion of the
data was evident as the R2 values were small (R2 3.262E-5 and R2 0.037 respectively).
However, the Pearson’s correlation for length of service for the smoker sub-population
was significant at the 0.01 level indicating a decrement in FEV1 over time for the
smokers. In addition, the Multivariate Analysis of Variance (MANOVA) (Section
6.6.2.1) showed no significant difference in FEV1 with length of service between the
non-smokers and smokers (p >0.05). However, there was a significant difference in
FEV1 between non-smokers and smokers (p <0.05).
Therefore there was no decrease in FEV1 for the study group presumed healthy
workers with length of service at the Murrin Murrin mine site and processing plant. In
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contrast there was a decrement in FEV1 due to smoking associated with time (length of
service) indicating that there was no work-related effect using this study protocol for
this study period.
7.2.5 Effect of area worked and lung function
A dependent t-test (IBM® SPSS® PASW Statistics 18) was conducted to determine
if there were any statistically significant changes in FEV1 and FVC (Tables 6.9 and 6.10
respectively) compared with their predicted values for the never-smoker populations in
the 16 work areas studied. There appeared to be a degree of variation in the mean values
of FEV1 (Table 6.9) and FVC (Table 6.10) across the workgroups; however, this was
considered to be within the between-subject variation in lung function (Spirxpert, n.d.).
There were insufficient observations to conduct statistical analysis for two of these
work areas, calcrete and pastoral, when the ever smokers were removed from the data.
Statistical analysis revealed that there was no significant difference in lung function for
most work areas. There were significant findings which indicated a slightly positive
increase in lung function. There was a significant difference (p <0.05) in FEV1 for the
electrical maintenance group; and a significant difference (p <0.05) in FVC for the
mining production, refinery production, general maintenance and electrical maintenance
workers.
These increases were considered to be slight increases as the various regression plots
relating to lung function over time for the non-smokers and presumed healthy worker
groups were essentially flat (horizontal) indicating no decrease in lung function.
Therefore there was no decrease in lung function for the never-smoker populations in 14
work areas studied at the Murrin Murrin mine site and processing plant.

7.3 Repeat Study
The initial aim was to conduct the repeat spirometry study at a 1-year interval.
However, due to work commitments this was not possible; therefore this was extended
to a 2-year interval. Ultimately the mean time period for the repeat spirometry tests was
1.7 years (range 173-845days) because the Murrin Murrin workforce had a high attrition
rate at the time (i.e., workers leaving employment) of approximately 51% (Minara
Resources, Human Resources, personal communication). Hence repeat lung function
tests were conducted on a sample of 72 of the initial 418 mine site workers to include a
129

cross-section of workers known to have been employed for approximately six months or
longer, purposely including those known to have poor lung function (five of the 72).
This sample consisted of 29 non-smokers (four of these were asthmatic) and 43
smokers, from the original study group. Best attempts were made to gather a crosssection of workers from all work areas. A comparison of their initial and repeat lung
function tests were statistically analysed to determine if there was a decrement in lung
function over time from initial to repeat test. It has to be noted that the difference in
time interval (173-845days) has the potential to create bias as there may be a dilution of
a possible effect on lung function associated with the shorter exposure time on site.
7.3.1 Difference in lung function over time
Table 6.11 shows the change in lung function over time for the repeat study group,
plus the change in lung function with time on sequential removal of the confounding
factors of smoking, asthma, and other non-work-related respiratory symptoms. The data
indicate that there was a decrease in both FEV1 (21 ml/year) and FVC (4 ml/year) for all
72 cases of the repeat study group. The decreases were most marked for the smokers
and asthmatic sub-group (with FEV1 a decrease of 41 ml/year and FVC 2 ml/year).
However, as the confounders were removed, ultimately resulting in the presumed
healthy sub-group, there was no decrease in FEV1 and FVC. In fact, there was a slight
increase in FEV1 of 19 ml/year. This slight increase was possibly due to a learning
effect; that is, improved spirometry technique due to an individual’s ability to do better
on a repeat spirometry test as they have mastered and improved their technique (Nield
& Burmas, n.d.).
The range of change in FEV1 and FVC was narrower for the non-smokers/nonasthmatics than for the smokers/asthmatics, which matched the range for all subjects
(72) individuals, indicating that smokers, asthmatics and those with known non-workrelated respiratory symptoms were mostly responsible for the largest decreases and
increases (outliers) in lung function. This was confirmed by reviewing the respiratory
questionnaires of these individual outliers. These were for individuals with either
known non-work-related respiratory disorders or heavy smokers. This was reflected in
the standard deviation for all subjects which were comparatively large (Table 6.11). The
greatest decrement in FEV1 was observed for an individual with known non-workrelated respiratory symptoms (recent pneumothorax, and a smoker). The greatest
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decrement in FVC was observed in an asthmatic diabetic individual. The outliers in
FEV1 and FVC for the presumed healthy sub-group were for one individual whose
questionnaire indicated nothing abnormal, and the spirometry reports were normal on
both occasions. The only distinguishing difference was that one spirometry session was
quality B and the repeat spirometry C, both considered to be acceptable (ndd
Medizintechnik AG, 2002). There were also improvements in FEV1 and FVC for the
presumed healthy sub-group for two different individuals. The reasons for these
improvements were not determined, but may be due to increased physical activity,
improved spirometry technique, or a recovery from a respiratory illness which was not
ascertained during interview for the respiratory questionnaire.
As demonstrated in Table 6.11, the mean change for FEV1 of minus 40 ml/year for
the smokers/asthmatic sub-group was statistically significant (p <0.05). This decrement
was also considered biologically significant, significant beyond the natural decrease in
FEV1 with age (Kerstjens, Rijcken, Schouten, & Postma, 1997; Oasys, 2006). This
significant decrement over time appeared to be associated with the smokers and
asthmatics because on analysis when these confounders were removed (i.e., the nonsmokers/non-asthmatics sub-group) there was no significant difference in the means for
FEV1 from the initial to the repeat study (p >0.05) (IBM® SPSS® PASW Statistics 18).
To remove further confounding, the data from five individuals with known nonwork-related respiratory symptoms were removed. One of these individuals had a
decrement of 330 ml over a 732-day period (equivalent to 165 ml/year). On removal of
all known confounding data, the resulting presumed healthy sub-group had a mean
change of plus (an increment of) 19 ml/year and no change in FVC (neither a positive or
negative change).
In contrast, for the smokers/asthmatics sub-group there was a decrease in FEV1
(minus 40 ml/year) and a relatively small decrease in FVC (minus 2 ml/year) (Table
6.11) which appears to be the typical profile of the early effects of mild smoking
(Kerstjens et al., 1997; Heijdra, Pinto-Plata, Kenney, Rassulo, & Celli, 2002).
Overall, there was no decrease in lung function for the presumed healthy sub-group,
over the time from initial spirometry to the repeat spirometry, for the Murrin Murrin
Operation personnel, whereas there was a decrease in lung function for the
smoker/asthmatic sub-group in this repeat study.
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7.4 Cross-Swing Lung Function in a Cohort of Refinery
Workers
Lung function tests for a cohort of refinery workers were conducted as they arrived
for work on site prior to commencing work in the refinery, and on completion of their
work period on site before returning home on their rest break (known as a swing)
(Section 6.9 of the results chapter). All but three of these were smokers. Despite this,
there was no significant change in lung function from the start of swing to the end of
swing for this cohort of refinery workers.
Twenty-nine of the 32 refinery workers were smokers. Three members of this cohort
had mild obstruction as diagnosed by spirometry, one had a history of pneumothorax
and was a current smoker, and one was an asthmatic and a smoker. Another with normal
spirometry had a history of non-work-related pneumonia and smoked 20 cigarettes per
day.
7.4.1 Cross-swing FEV1
The cross-swing FEV1 results in Table 6.12 in the results chapter show that the
maximum decrease in FEV1 was minus 0.58 L, with a maximum increase in FEV1 of
0.52 L. The maximum decrease in FEV1 was observed for a smoker with a history of
(non-work-related) pneumonia. The maximum increase (improved) FEV1 was observed
in a heavy smoker with a history of (non-work-related) bronchitis.
There was a mean decrease for the cohort of minus 0.03 L, from the start to
completion of the work period, for the cross-swing refinery worker cohort. This 30 ml
decrease was not significant (p >0.05).
7.4.2 Cross-swing FVC
The maximum decrease in FVC for this cohort was minus 0.72 L, with a maximum
increase in FVC of 0.95 L. The 0.72 L decrease was observed for a mild smoker, and
the improvement in FVC of 0.95 L was observed for a heavy smoker with a history of
non-work-related bronchitis. Despite these large volume changes, both were recorded as
normal spirometry (ndd Medizintechnik AG, 2002) on the spirometer records.
The maximum negative change (minus 0.72 L) was a 12% change over a period of
14 days. Although it was recorded as normal spirometry (ndd Medizintechnik AG,
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2002) a follow-up of this individual was requested on the grounds that such a decrease
is considered of clinical significance even in normal subjects (American Thoracic
Society, 1995; Wang & Petsonk, 2004; Mason, Broaddus, Murray, & Nadel, 2005). The
spirometry from this individual has since been consistently classified as normal
spirometry (Mary Morrissey, Minara Resources, personal communication, March,
2011).
Despite the large standard deviation, with some individuals showing changes of up to
17% in their lung function, there was no statistical significant difference (p >0.05) in
lung function for this cohort from the beginning of the swing to the end of the swing for
either FEV1 or FVC for these 37 observations (Table 6.12). Nor was there a statistical
significant difference (n= 10, p >0.05) in the repeat cross-swing lung function for five
of these refinery workers.

7.5 Limitations
No matter how well a study is conducted there will always be limitations, such as
study design, attrition, missing data, unknown confounding factors, instrumentation,
and data analysis (Checkoway et al., 2004).
7.5.1 Main study
It was considered that there was no selective failure to participate as all the control
group members agreed to participate and only two of the 420 study-group members
refused to participate. However, there was attrition during collection of the initial studygroup data as workers were joining and leaving employment at the Murrin Murrin
Operation. Work rosters were used to capture all employees in each work area until the
final number of 418 was reached. This may have produced a ‘healthy worker effect’
(Checkoway et al., 2004) whereby individuals with work-related respiratory disorders
left the Murrin Murrin workforce, which was considered unlikely.
7.5.2 Repeat study
Follow-up of workers leaving the workforce was purposefully not included in the
study design and in the ethics protocol hence there was loss of follow-up in the repeat
study. However, best attempts were made to gather a cross-section of workers from all
work areas hence there may have been some selection bias, as well as a potential
‘healthy worker effect’ due to the possibility of individuals with work-related
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respiratory disorders leaving the workforce. Attrition is reported to be a major limitation
of longitudinal studies (Checkoway et al., 2004). Attrition was an issue with this study.
The attrition rate of approximately 51% over this period would have introduced new
workers with less time on site (causing a dilution of the effect) therefore attempts were
made to focus on the longer-serving members of the workforce and limiting it to those
with service of greater than six months; in the event, the range of length of service was
from 0.47 years to 2.3 years, with a mean of 1.7 years. Smokers and those with known
non-work-related respiratory symptoms were included with the intention of seeking any
potential synergistic effect.
Due to the attrition rate impeding the repeat study, the length of service (time worked
on site, [minimum 1 month, maximum 8 years with a mean of 2.5 years]) in the initial
study was also analysed.
7.5.3 Missing data
Missing data can seriously affect the outcome of a study, and can distort or missrepresent the sample (IBM SPSS Statistics 18, 2010).
Every attempt was made to acquire all data. It was very rare for individuals not to
divulge information and, since anonymity was assured, it is likely that the
questionnaires completed by interview by an ‘approved person’ were answered
truthfully. For example, Patrick et al. (1994) states that reporting of smoking is usually
accurate.
Two sets of data were excluded as the quality rating for the spirometry tests did not
meet the quality criteria; one person rushed the test and did not complete it, and the
other was disqualified due to inadequate effort, which was also indicated as a
substandard quality rating on the spirometer read-out (ndd Medizintechnik AG, 2002).
The remaining spirometry data met the strict protocol requirements.
Therefore most data was missing at random and the IBM® SPSS® PASW Statistics
18 excluded these cases for that particular value during statistical analysis.
7.5.4 Variability
Variability may occur due to misclassification of the spirometry results due to the
difference in the outcome between sessions, where in one session the data for an
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individual are within the normal range, but at another session they are outside that
range. This is likely to create within- and between-subject variability. The intraindividual standard deviation of repeated measurements of FEV1 and FVC in a healthy
adult is considered to be about 200 ml and about 340 ml respectively (Rozas &
Goldman, 1982). To reduce within-session variability the ATS/ERS criteria (American
Thoracic Society, 1995; Miller et al., 2005) and the manufacturers (ndd Medizintechnik,
2002) guidelines were rigorously applied. Moreover a single competent person collected
all data using the same instrument to conduct the spirometry tests.
7.5.4.1 Intra-individual variation
Intra-individual variation is mainly due to physiological issues, environmental issues,
the instrumentation and the conduct of the lung function tests. Physiologically lung
function is known to vary mainly due to stature and age (Chinn, Cotes, & Martin, 2006).
However, the largest variability in this study was due to confounding factors: non-workrelated factors such as smoking, non-work-related respiratory diseases such as asthma,
effects of overweight and cardiovascular diseases such as diabetes, which are known to
have a pronounced effect on lung function (Poirier et al., 2006). The standard deviation
of results on occasions was considered high (for example, in the cross-swing study of
the refinery workers) but observed to be caused by the confounders introduced by
individuals with known non-work-related respiratory disorders, and smoking. The study
protocol was strictly adhered to in order to limit all but the physiological issues.
7.5.4.1 .1 Internal validity – biological control
A biological control with known normal lung function was incorporated into the
study protocol to monitor intra-individual variation in lung function. The lung function
of the trained researcher was repeatedly measured throughout the investigation to act as
a biological control to demonstrate internal validity. There was no significant (p >0.05)
decrease in lung function for this individual over the study period, and although there
was an apparent decrease normally attributed to age this was not significant (r - 0.24 for
both FEV1 and FVC) (Figures 6.39 and 6.40). This was consistent with the study
findings. The standard deviation in FEV1 was 166 ml, and for FVC was 307 ml, which
is consistent with the intra-individual standard deviation, quoted by Rozas & Goldman
(1982).
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7.5.4.2 Between-subjects variation in FEV1
Between-subjects variation in lung function is largely affected by subjects with
respiratory disorders, although there have been shown to be diurnal variation (Spirxpert,
n.d.).
As demonstrated in Tables 6.5 and 6.7:
The mean ± SD for FEV1 for all subjects in the study group was 3.94
± 0.74;
The mean ± SD for FEV1 for cases with no known non-work-related
respiratory symptoms in the study group was 4.0±0.67;
The mean ± SD for FEV1 for all subjects in the control group was
3.6±0.77.
7.5.4.3 Between-subjects variation in FVC
As demonstrated in Tables 6.6 and 6.8:
The mean FVC for all subjects in the study group was 5.1±0.93;
The mean ± SD for FVC for cases with no known non-work-related
respiratory symptoms in the study group was 5.1±0.88;
The mean ± SD for FVC for all subjects in the control group was
4.6±1.01.
7.5.4.4 Effect of learning
It has been suggested that the effect of learning the spirometry technique may
improve the lung function results of a repeat test (Nield & Burmas, n.d.). Such variation
is more likely to be due to the difference in equipment used and the variety of people
conducting the spirometry test. However, if spirometry is conducted to the ATS/ERS
criteria this variation should be eliminated.
7.5.4.5

Climate or other factors

It is possible that climate or other factors may have confounded the results. To
eliminate the possible effect of climate a control population close to the Murrin Murrin
operation was chosen.
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To reduce possible bias of atmospheric pressure during lung function testing, the
spirometer was pre-programmed with the altitude of the Murrin Murrin operation. The
model of spirometer used for this study was pre-programmed to remove any effects of
temperature and relative humidity at the time each lung function test was performed.
7.5.5 Internal validity
Internal validity is the assurance that can be given to a cause and response
relationship in a study (Checkoway, et al., 2004). In this study the lung function data of
smokers acted effectively as a positive control, whilst the lung function of a healthy
non-smoking person (biological control) effectively acted as a negative control for
internal validity.
7.5.5.1 Smokers decrease in lung function
A consistent negative effect on FEV1 among smokers was demonstrated throughout
this study. This was seen on analysis of the ever smokers for both the study and control
groups with FEV1 plotted against pack years. Here, a significant decrement in FEV1 was
observed (Figures 6.1 and 6.2). Both of these gave a negative correlation significant at
the 0.01 level. Similarly, there was a decrement in FEV1 for smokers with length of
service (time worked on site) (Figure 6.36) significant at the 0.05 level. Again, a
decrement in FEV1 was observed in the repeat study. Here, there was a significant
difference (p <0.05) in FEV1 from the first spirometry test compared with the repeat
spirometry test for the smokers/asthmatics sub-group (Figure 6.38).
As the confounder of smoking was removed from most data an improvement
appeared with lung function data, specifically FEV1, as smoking appeared to affect FVC
to a lesser extent.
7.5.5.2 Biological control (lung function of the approved person)
The lung function of the approved person conducting the lung function tests was
taken on 41 occasions during each batch of testing for calibration purposes and for
internal validity. The linear regression plots of both FEV1 and FVC versus time
difference between spirometry were effectively horizontal indicating that there was little
to no change in FEV1 and FVC with time (Figure 6.39 and 6.40). The dispersion of the
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data was evident as the goodness of fit R2 values were small (R2 = 0.056 and R2 = 0.066
respectively).
On further analysis, the Pearson’s correlation for:
FEV1 with time was r = minus 0.237; p >0.05; and
FVC with time was r = minus 0.258; p >0.05.
This indicates that there was no significant difference in both lung function measures
and that there was a negative relationship, perhaps starting to indicate the effect of age
(Sharma & Goodwin, 2006).
It is considered that this study protocol was sensitive enough to detect a decrement in
lung function due to smoking over the study period, and that there was no significant
difference in FEV1 and FVC with time for the biological control.

7.6 Correlation with the Known Work-Area Exposure Levels
Because there was no overall decrement in lung function for the Murrin Murrin
Operation employees for this study period, the correlation with the known occupational
exposure levels in each work area became redundant. The absence of an effect on lung
function is considered to be reflective of the actual work-area exposure levels which
were invariably well below the regulatory occupational exposure standards.

7.7 Reasons for the Absence of an Effect on Lung Function for
the Main Study and Repeat Study and the Cohort of Refinery
Workers
The outcome of this study was that there was no overall decrement in lung function
for the Murrin Murrin Operation employees for the period each individual worked on
site, or when working in specific work areas at the mine site or the processing plant for
this study period. This result was consistent in all phases of the study. Statistical
analysis showed that with length of service on site, in the repeat study, and the
biological control over the study period, there was no overall decrease in lung function.
In contrast, the effect of smoking was detected across all phases, acting as internal
validity (positive control) that an effect could be detected by these research tools.
The results of the study provide evidence that primary preventive measures aimed at
protecting workers are effective. Point source emissions are contained within the
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environmental operating licence limit and the workplace exposures are generally
maintained to levels below their respective occupational exposure standards. In
instances where exceedances were likely, adequate personal protective controls were
implemented. The data therefore suggest that the mine and process plant safety and
environmental programs were effective. These primary preventive measures include:
plant and process design;
plant integrity and maintenance;
controlled process chemistry;
plant and process controls;
process

operation

and

control,

including

instrumentation,

training/competency, and operating procedures.
Secondary preventative measures (backup controls) were also in place to detect
process upsets and equipment failure, for example, control-room instrumentation and
control-room operators. Tertiary preventative measures included strategically placed
emission monitoring alarms around the processing plant, emergency response planning
and training, and finally emergency evacuation and respiratory protection as a last resort
in their hierarchy of control. Improvements to their program have been implemented
such as dust reduction projects in the nickel and cobalt buildings.
It is essential, however, that Minara Resources continuously monitor and review
these controls to ensure their effectiveness and to make further improvements where
possible.

7.8 Addressing the Smoking Issue
It is important not to ignore the effect of smoking – although this is a lifestyle choice,
not strictly a workplace issue – by providing the opportunity for employees to enter a
smoking cessation program, as Australian workplaces will ultimately benefit in the long
term.
DMP (2010b) recognises that smoking is a contributory risk factor to worker health,
and promotes the health of people engaged in mining operations. Implementing a Health
Ownership Model (Cameron, 2010) by addressing both workplace health needs and
individuals’ health needs, in this case by encouraging and supporting employees to quit
smoking, will be beneficial to both the company and the individual.
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7.9 Summary
This research set out to determine if there was a possible adverse respiratory effect of
concurrent and repeat exposures to complex mixtures of low-level airborne chemicals at
the Murrin Murrin operation. The overall outcome of this study was that there was no
overall decrement in lung function for the Murrin Murrin Operation employees for the
period each individual worked on site, or when working in specific work areas at the
mine site or the processing plant for this study period. It could be argued that this time
period may be too short to pick up a long-term effect, however, since commissioning
the processing plant had been open for more than 5 years, and mining activity prior,
with the maximum length of service in this study of 8 years. The length of service of
participants ranged from 1 month to 8 years, (mean of 2.5 years). Also, this result was
consistent in all phases of the study. Statistical analysis showed that length of service on
site, in the repeat study, and the biological control over the study period, was not related
to a decrease in lung function. In contrast, the effect of smoking was detected across all
phases, acting as internal validity (positive control) that an effect could be detected by
these research tools.
The conclusions and recommendations arising from this study are provided in the
next and final chapter.
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8. CONCLUSION AND RECOMMENDATIONS
The concern shown by the employees at the Murrin Murrin Operation that workplace
emissions may be harming their respiratory health appears to be dispelled by this study.
The purpose of this study was to detect possible adverse respiratory health effects at
an early stage in order to prevent potential long-term occupational respiratory disease in
the Murrin Murrin workforce, and then, if necessary, to recommend interventions to
prevent untoward health effects, and enable management to have a proactive approach
to the protection of the workforce. No work-related respiratory health effects were
detected for this workforce relative to the workforce’s length of service and over the
study period. There are, of course, limitations to this study as it really only addresses
some of the more acute respiratory health issues and insufficient time elapsed to
examine any long-term effects.

8.1 Initial Study
8.1.1 Prevalence of respiratory symptoms in the study group compared with the
control group
In combination, the respiratory symptoms established from the questionnaire and
from spirometry determined that in the control group population there were 12.5%
individuals with non-work-related respiratory disorders compared with 6.2% in the
study group. All these symptoms were related back to individuals who were Ever
Smokers or had known non-work-related respiratory disorders. A detailed analysis of
the data from the 418 participants in the study group discovered that there were 26 cases
of non-work-related respiratory disorders.
8.1.2 Length of service
On statistical analysis, with these 26 individuals and the smokers’ data removed (i.e.,
the presumed healthy workers sub-group) there was no overall decrement in lung
function for the Murrin Murrin Operation employees with length of service (p <0.01).
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8.1.3 Effect of area worked
In addition, there was no decrease in FEV1 associated with the Never Smokers in the
14 work areas studied at the mine site or processing plant when compared with their
predicted FEV1 values.

8.2 Repeat Study
Similarly, in the repeat study, there was no significant difference in FEV1 from the
first spirometry test compared with the repeat spirometry test for the presumed healthy
sub-group (p >0.05).

8.3 Cross-Swing Study of a Cohort of Refinery Workers
The cross-swing study of a cohort of 35 refinery workers indicated there was no
(before and after) decrement in lung function from the start of a swing to the end of a
swing (p >0.05). In addition, for a repeat cross-swing study for five of these individuals,
again, there was no significant difference (p >0.05) between the FEV1 and FVC values.

8.4 Effect of Smoking
A constant theme throughout the findings of this study was the negative effect due to
cigarette smoking. There were decrements in lung function measured for the smokers in
the study and control groups. There was a significant difference in FEV1 between nonsmokers and smokers with length of service (p <0.05) and a significant difference (p
<0.05) in FEV1 from first spirometry test compared with the repeat spirometry test for
the smokers/asthmatics sub-group in the repeat study. This in effect acted as internal
validity indicating that spirometry was sensitive enough to detect a decrease in lung
function due to smoking in the initial and repeat studies (Kerstjens, Rijcken, Schouten,
& Postma, 1997).

8.5 Summary
It has been demonstrated in this research that, when used in conjunction with a
respiratory questionnaire, spirometry testing provides an effective diagnostic tool with
adequate sensitivity to detect effects on lung function. It must be noted that this study
was not about validation of spirometry, but the detection of possible adverse respiratory
health effects at an early stage using the respiratory questionnaire in conjunction with
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lung function testing, which it appears to do well. Asthmatics (non-work related) were
identified both through the questionnaire and by spirometry. In this study, an effect due
to smoking was observed while there was no obvious effect on lung function for the
presumed healthy sub-group, for the study period. This combination (spirometry plus
questionnaire) was able to identify individuals with non-work-related respiratory
symptoms. Furthermore it was determined that there was no overall decrement in lung
function for the presumed healthy workers with length of service or any specific work
area. That there was no significant difference in FEV1 from the first spirometry test
compared with the repeat spirometry, and there was no cross-swing decrement in lung
function for this cohort of refinery workers.
Thus it can be concluded that spirometry in combination with a respiratory
questionnaire is sensitive enough to detect an effect on lung function, however, no
workplace effect was noted, using this study protocol.

8.6 Recommendations
The reasons for the absence of a work-related effect on lung function at the Murrin
Murrin Operation using this study protocol, over this study period, would appear to be
due to the primary, secondary and tertiary preventative measures implemented at the
mining and process areas. These preventative measures included a hierarchy of controls
including isolation, engineering, administrative and personal protective equipment, as
well as occupational hygiene monitoring, and health surveillance. However, it cannot be
assumed that these preventative measures will remain adequate over the longer term.
The aim of occupational hygiene is to ensure exposure to hazardous substances does not
affect employee health. Therefore it is recommended that, through continuous
improvement, this level of protection is maintained, and even improved upon where
possible by proactively reviewing workplace health risk assessments and conducting
health monitoring.
As asthma and other pre-existing respiratory disorders may be exacerbated by
occupational exposures, these subjects should be monitored more closely than other
employees for possible respiratory health effects. It is equally important not to ignore
the effect of cigarette smoking, although this is a lifestyle issue rather than a workplace
issue. Individual health ownership to protect those with asthma and, to help smokers
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quit smoking should be encouraged within the workplace this will be beneficial to both
the company and the individual.
Suggestions for further research;
extend this longitudinal study to identify long term trends at the Murrin Murrin
operation;
expand this study to review the respiratory health of people who have worked in
the WA mining industry for periods in excess of 15 years;
examine the respiratory health of shutdown workers such as the boilermakers,
welders, and confined space workers who carry out the majority of the ‘dirtier’
maintenance work and are more likely to be exposed to higher levels of
respiratory health risks.
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TABLE OF ABBREVIATIONS
AED
ANZSRS
ATS
BIMS
BMI
CCD
CCH
CI
CIC 33
cm
Co
CO
COPD
DALYs
DMP
DMPR
EC
eNO
ERS
FeNO
FEV1
FEV1/FVC
FEV1/FVC%
FOT
FVC
FZ
HPAL
HSIS
H2S
IARC
IBM
IDLH
ILO
IL-8
km
L
LCD
MANOVA
m3
mg
mg/m3
ml
MPR
MSHA
n
Ni
NIOSH
NOHSC

aerodynamic equivalent diameter
Australian and New Zealand Society of Respiratory Science
American Thoracic Society
Brambles Industrial Maintenance Services
body mass index
counter current decantation
Commerce Clearing House (a Wolters Kluwer business)
confidence interval
census industry code (primary metal industries)
centimetre = one hundredth of a metre
Cobalt
carbon monoxide
chronic obstructive pulmonary disease
disability adjusted life years
Department of Mines and Petroleum
Department of Mineral and Petroleum Resources
endothelial cells
exhaled nitric oxide
European Respiratory Society
fractional exhaled nitric oxide
forced expiratory volume in one second
the ratio of forced expiratory volume in one second to forced
vital capacity
the ratio of forced expiratory volume in one second to forced
vital capacity – as a percentage
forced oscillation technique
forced vital capacity
ferruginous zone
high pressure acid leach
hazardous substances information system
hydrogen sulphide
International Agency for Research on Cancer
International Business Machines – a company that
manufactures and sells computers and computer software
immediately dangerous to life and health
International Labour Organization
interleukin 8
kilometres
litre(s)
liquid crystal display
multivariate analysis of variance
cubic metre
milligram = one thousandth of a gram
milligram per cubic metre
millilitre = a thousandth of a litre
Mining and Petroleum Resources
Mine Safety and Health Administration
sample size
nickel
National Institute for Occupational Safety and Health
National Occupational Health and Safety Commission
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NO2
o
C
OSHA
O3
p
PAL
PAPA
PAR%
PEL
PFT
pH
PM2.5
PM10
ppb
ppm
RADS
RCS
ROM
r
R2
SABRE
SAG
SAP
SD
SO2
SM
SPSS
SWORD
TLC
TWA
UK
μm
US
VOC
VC
vs
WoRLD
≤
>
<

nitrogen dioxide
degrees centigrade
Occupational Safety and Health Administration
Ozone
(or p-value) a measure of how likely the sample results are,
assuming the null hypothesis is true; the smaller the p-value,
the less likely the sample results
pressure acid leach
public health and air pollution in Asia
population attributable risk – as a percentage
permissible exposure limit
pulmonary function test
a measure of the acidity or alkalinity of a solution
fine particles in the (ambient) air 2.5 micrometres or less in
size
fine particles in the (ambient) air 10 micrometres or less in
size
parts per billion
parts per million
reactive airways dysfunction syndrome
respirable crystalline silica
run of mine
Pearson’s correlation coefficient – a standardised measure of
the strength of relationship between two variables
coefficient of determination. The goodness of fit of a statistical
model describes how well it fits a set of observations
surveillance of Australian workplace based respiratory events
semi-autogenous grinding
saprolite zone
standard deviation
sulphur dioxide
smectite zone
Statistical Package for the Social Sciences
surveillance of work-related and occupational respiratory
disease
total lung capacity
time-weighted average
United Kingdom
micrometre(s) = one millionth of a metre
United States
volatile organic compounds
vital capacity
versus
work-related lung disease
equal to or less than
more than
less than
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GLOSSARY OF TERMS
Allergy
All subjects
Approved Person

Asthmagen
Biological Control
BOC Plant
Bulka Bags

Crew
Cross-Swing

Dependent t-test
Ever Smokers
FEV1diff
Independent t-test
Length of Service
Never Smokers
Non-work-related
respiratory
symptoms
Pack Years
Predicted (normal)
Values
Presumed Healthy

Rollies
Sig

A reaction of the immune system to something that does not
bother most people.
All individuals in the study (and control) group.
A person approved by the Department of Mines and
Petroleum, Resources Safety, Western Australia, to carry out
MineHealth Assessments on completion of compulsory
training in spirometry (lung function testing).
Any substance that is causally related to the development of
asthma symptoms.
The lung function of a subject with stable respiratory function
recorded regularly as part of an ongoing quality control
program.
The production and supply of compressed and bulk gases.
Large lightweight bags, usually made of woven
polypropylene, with four cross corner loops, capable of
holding 1m3 or 1 tonne, can be handled by crane, Hyab,
forklift.
A group of workers operating and maintaining (in this
instance) the refinery.
Lung function tests for a cohort of refinery workers were
conducted as they arrived for work on site prior to
commencing work in the refinery, and on completion of their
work period on site before returning home on their rest break.
A test using the t-statistic that establishes whether two
means collected from the same sample (or related
observations) differ significantly.
A person who has ever been a cigarette smoker or cigar
smoker.
Change in FEV1 from the initial to the repeat lung function
test.
A test using the t-statistic that establishes whether two
means collected from independent samples differ
significantly.
The duration of service in the company (at Minara
Resources, Murrin Murrin mine site).
A person who has never been a cigarette smoker or cigar
smoker.
Respiratory symptoms determined to be other than work
related.
A way to measure the amount a person has smoked over a
long period of time.
Spirometry reference values from groups of relatively healthy
persons (non-smokers, with no known respiratory disorders).
The sub-group of the study (and control) group on removal of
those subjects who were ever-smokers, and those with
known non-work related respiratory disorders. Therefore the
never-smokers, with no known non-work related respiratory
symptoms (I.E., The known confounders removed).
Hand-rolled cigarettes.
Statistical significance.
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Spirometry
Swing

A test that can help diagnose various lung conditions.
A work pattern – from arrival for work on site, to completion
of work period on site, before returning home for a rest break.
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